<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002815.pub2" GROUP_ID="MOVEMENT" ID="836999110214375871" MERGED_FROM="" MODIFIED="2014-05-13 20:21:24 +0100" MODIFIED_BY="Ema Roque" REVIEW_NO="" REVMAN_SUB_VERSION="5.2.7 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2014-05-13 20:16:51 +0100" MODIFIED_BY="Ema Roque">
<TITLE>Physiotherapy for Parkinson's disease: a comparison of techniques</TITLE>
<CONTACT>
<PERSON ID="11897098747534352804100318182624" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Claire</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Tomlinson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>c.l.smith.1@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Robert Aitken Institute</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9107</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2014-05-13 20:12:40 +0100" MODIFIED_BY="Ema Roque">
<PERSON ID="11897098747534352804100318182624" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Claire</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Tomlinson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>c.l.smith.1@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Robert Aitken Institute</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9107</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="89222716525465117406110405202549" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Clare</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Herd</LAST_NAME>
<SUFFIX/>
<POSITION>Research Coordinator</POSITION>
<EMAIL_1>c.p.herd@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Clinical and Experimental Medicine</DEPARTMENT>
<ORGANISATION>College of Medical and Dental Sciences</ORGANISATION>
<ADDRESS_1>University of Birmingham</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+ 44 121 415 9107</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14796" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Carl</FIRST_NAME>
<MIDDLE_INITIALS>E</MIDDLE_INITIALS>
<LAST_NAME>Clarke</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Clinical Neurology</POSITION>
<EMAIL_1>c.e.clarke@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Clinical and Experimental Medicine</DEPARTMENT>
<ORGANISATION>College of Medical and Dental Sciences</ORGANISATION>
<ADDRESS_1>University of Birmingham</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B18 7QH</ZIP>
<REGION>West Midlands</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+ 44 121 507 4073</PHONE_1>
<PHONE_2/>
<FAX_1>+ 44 121 507 5442</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="04371434063380363954100510172711" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Charmaine</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Meek</LAST_NAME>
<SUFFIX/>
<POSITION>Research Physiotherapist</POSITION>
<EMAIL_1>c.meek@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Primary Care Clinical Sciences</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Primary Care Clinical Sciences Building</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0121 414 2684</PHONE_1>
<PHONE_2/>
<FAX_1>0121 414 6571</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="DFF11D4682E26AA2012E60F300DFB50C" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Smitaa</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Patel</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>s.a.patel@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Edgbaston</ADDRESS_1>
<ADDRESS_2/>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9115</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="18323" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Rebecca</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Stowe</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Systematic Reviewer</POSITION>
<EMAIL_1>r.l.harrison@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Edgbaston</ADDRESS_1>
<ADDRESS_2/>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9107</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="11150" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Katherine</FIRST_NAME>
<MIDDLE_INITIALS>HO</MIDDLE_INITIALS>
<LAST_NAME>Deane</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer in Research Related to Nursing</POSITION>
<EMAIL_1>k.deane@uea.ac.uk</EMAIL_1>
<EMAIL_2>Katherine.deane@unn.ac.uk</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Edith Cavell Building</DEPARTMENT>
<ORGANISATION>University of East Anglia</ORGANISATION>
<ADDRESS_1>Colney Lane</ADDRESS_1>
<ADDRESS_2/>
<CITY>Norwich</CITY>
<ZIP>NR4 7UL</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1603 597047</PHONE_1>
<PHONE_2/>
<FAX_1>+44 1603 597019</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="6EAC2C8882E26AA201AFF01275DD14C1" ROLE="AUTHOR">
<PREFIX>Miss</PREFIX>
<FIRST_NAME>Laila</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shah</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>l.shah@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>07817572697</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Robert Aitken Institute</ADDRESS_1>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0121 415 9107</PHONE_1>
<PHONE_2/>
<FAX_1>0121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15434" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Catherine</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Sackley</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>c.sackley@uea.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Faculty of Medicine and Health Sciences</DEPARTMENT>
<ORGANISATION>University of East Anglia</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Norwich</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13795" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Keith</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Wheatley</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Medical Statistics</POSITION>
<EMAIL_1>k.wheatley@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cancer Research Clinical Trials Unit, School of Cancer Sciences</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>Edgbaston</ADDRESS_2>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9119</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="18322" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Natalie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Ives</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Statistician</POSITION>
<EMAIL_1>n.j.ives@bham.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Birmingham Clinical Trials Unit</DEPARTMENT>
<ORGANISATION>University of Birmingham</ORGANISATION>
<ADDRESS_1>Edgbaston</ADDRESS_1>
<ADDRESS_2/>
<CITY>Birmingham</CITY>
<ZIP>B15 2TT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 121 415 9113</PHONE_1>
<PHONE_2/>
<FAX_1>+44 121 415 9135</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2013-01-22 13:12:18 +0000" MODIFIED_BY="Ema Roque">
<UP_TO_DATE>
<DATE DAY="31" MONTH="1" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="1" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-05-13 20:16:51 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-05-13 20:16:51 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Conclusions not changed</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-05-13 20:14:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Search updated to 31 January 2012</P>
<P>New studies added, conclusions unchanged</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="29" MONTH="11" YEAR="2000"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-01-27 10:25:23 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2013-01-27 10:25:23 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2013-01-27 10:25:23 +0000" MODIFIED_BY="[Empty name]">
<NAME>Parkinson's UK</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-01-27 10:25:12 +0000" MODIFIED_BY="[Empty name]">
<NAME>Department of Health</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">Physiotherapy for the treatment of Parkinson's disease</TITLE>
<SUMMARY_BODY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>In spite of various medical and surgical treatments for Parkinson's disease (PD) patients gradually develop significant physical problems. Physiotherapists aim to enable people with PD to maintain their maximum level of mobility, activity and independence through the provision of the appropriate treatment. A range of approaches to movement rehabilitation are used, which aim to enhance quality of life by maximising physical ability and minimising secondary complications over the whole course of the disease. Evidence has shown that physiotherapy has short-term benefits in PD, however which approach of physiotherapy is most effective remains unclear.</P>
<P>Only randomised controlled trials were included in this review. These were studies where a group of participants were given one physiotherapy intervention and were compared with another group who received a different physiotherapy intervention. The participants were assigned to a group in a random fashion to reduce the potential for bias.</P>
<P>A total of 43 randomised trials involving 1673 participants (average trial size of just 39 participants) were identified as suitable for this review. The trials assessed various physiotherapy interventions, so they were grouped according to the type of intervention being used (general physiotherapy, exercise, treadmill training, cueing, dance or martial arts). However, despite this grouping, the physiotherapy interventions delivered and the outcomes assessed varied so much that the results of the individual trials could not be combined.</P>
<P>This review highlights that a wide range of different physiotherapy techniques have been tested to treat PD. Considering the small number of participants, the wide variety of physiotherapy interventions and the outcomes assessed, there is insufficient evidence to support the use of one approach of physiotherapy intervention over another for the treatment of PD.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Despite medical therapies and surgical interventions for Parkinson's disease (PD), patients develop progressive disability. The role of physiotherapy is to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person. The overall aim is to optimise independence, safety and wellbeing, thereby enhancing quality of life. Trials have shown that physiotherapy has short-term benefits in PD. However, which physiotherapy intervention is most effective remains unclear.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-01-31 15:42:10 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness of one physiotherapy intervention compared with a second approach in patients with PD.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Relevant trials were identified by electronic searches of numerous literature databases (for example MEDLINE, EMBASE) and trial registers, plus handsearching of major journals, abstract books, conference proceedings and reference lists of retrieved publications. The literature search included trials published up to the end of January 2012.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-01-26 23:01:52 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials of one physiotherapy intervention versus another physiotherapy intervention in patients with PD.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Data were abstracted independently from each paper by two authors. Trials were classified into the following intervention comparisons: general physiotherapy, exercise, treadmill training, cueing, dance and martial arts.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 43 trials were identified with 1673 participants. All trials used small patient numbers (average trial size of 39 participants); the methods of randomisation and concealment of allocation were poor or not stated in most trials. Blinded assessors were used in just over half of the trials and only 10 stated that they used intention-to-treat analysis.</P>
<P>A wide variety of validated and customised outcome measures were used to assess the effectiveness of physiotherapy interventions. The most frequently reported physiotherapy outcomes were gait speed and timed up and go, in 19 and 15 trials respectively. Only five of the 43 trials reported data on falls (12%). The motor subscales of the Unified Parkinson&#8217;s Disease Rating Scale and Parkinson&#8217;s Disease Questionnaire-39 were the most commonly reported clinician-rated disability and patient-rated quality of life outcome measures, used in 22 and 13 trials respectively. The content and delivery of the physiotherapy interventions varied widely in the trials included within this review, so no quantitative meta-analysis could be performed.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Considering the small number of participants examined, the methodological flaws in many of the studies, the possibility of publication bias, and the variety of interventions, formal comparison of the different physiotherapy techniques could not be performed. There is insufficient evidence to support or refute the effectiveness of one physiotherapy intervention over another in PD.</P>
<P>This review shows that a wide range of physiotherapy interventions to treat PD have been tested . There is a need for more specific trials with improved treatment strategies to underpin the most appropriate choice of physiotherapy intervention and the outcomes measured.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parkinson&#8217;s disease (PD) is a complex neurodegenerative disorder (<LINK REF="REF-Rubenis-2007" TYPE="REFERENCE">Rubenis 2007</LINK>) with wide reaching implications for patients and their families. Whilst disability can occur at all stages of the disease (<LINK REF="REF-Deane-2001a" TYPE="REFERENCE">Deane 2001a</LINK>), PD is progressive in nature. Patients face increased difficulties with activities of daily living (ADL) (<LINK REF="REF-Kwakkel-2007" TYPE="REFERENCE">Kwakkel 2007</LINK>) and mobility such as gait, transfers, balance and posture (<LINK REF="REF-Keus-2007" TYPE="REFERENCE">Keus 2007</LINK>). Ultimately this leads to decreased independence, inactivity and social isolation (<LINK REF="REF-Keus-2007" TYPE="REFERENCE">Keus 2007</LINK>), resulting in reduced quality of life (<LINK REF="REF-Schrag-2000" TYPE="REFERENCE">Schrag 2000</LINK>).</P>
<P>The management of PD has traditionally centred on drug therapy with levodopa viewed as the 'gold standard' treatment (<LINK REF="REF-Rascol-2002" TYPE="REFERENCE">Rascol 2002</LINK>). However, even with optimal medical management, patients with PD still experience a deterioration of body function, daily activities and participation (<LINK REF="REF-Nijkrake-2007" TYPE="REFERENCE">Nijkrake 2007</LINK>). For this reason there has been increasing support for the inclusion of rehabilitation therapies as an adjuvant to pharmacological and neurosurgical treatment (<LINK REF="REF-Gage-2004" TYPE="REFERENCE">Gage 2004</LINK>; <LINK REF="REF-Nijkrake-2007" TYPE="REFERENCE">Nijkrake 2007</LINK>) and a call for the move towards multidisciplinary management of this multidimensional condition (<LINK REF="REF-Robertson-2003" TYPE="REFERENCE">Robertson 2003</LINK>; <LINK REF="REF-Rubenis-2007" TYPE="REFERENCE">Rubenis 2007</LINK>).</P>
<P>The physiotherapist is a member of the multidisciplinary team (<LINK REF="REF-Robertson-2008" TYPE="REFERENCE">Robertson 2008</LINK>; <LINK REF="REF-Rubenis-2007" TYPE="REFERENCE">Rubenis 2007</LINK>) and strives to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person (<LINK REF="REF-Deane-2001a" TYPE="REFERENCE">Deane 2001a</LINK>; <LINK REF="REF-Plant-2000" TYPE="REFERENCE">Plant 2000</LINK>). Physiotherapy for PD focuses on transfers, posture, upper limb function, balance (and falls), gait, physical capacity and (in)activity utilising cueing strategies, cognitive movement strategies and exercise to optimise the patient&#8217;s independence, safety and wellbeing, thereby enhancing quality of life (<LINK REF="REF-Keus-2004" TYPE="REFERENCE">Keus 2004</LINK>; <LINK REF="REF-Keus-2007" TYPE="REFERENCE">Keus 2007</LINK>).</P>
<P>Referral rates to physiotherapy for people with PD have historically been low (<LINK REF="REF-Mutch-1986" TYPE="REFERENCE">Mutch 1986</LINK>; <LINK REF="REF-Yarrow-1999" TYPE="REFERENCE">Yarrow 1999</LINK>). However, in recent years the number of referrals has increased, with a survey by Parkinson&#8217;s UK in 2008 reporting that 54% of the 13,000 members surveyed had seen a physiotherapist, compared with 27% in a survey undertaken in 1998 (<LINK REF="REF-PDS-2008" TYPE="REFERENCE">PDS 2008</LINK>; <LINK REF="REF-Yarrow-1999" TYPE="REFERENCE">Yarrow 1999</LINK>). This rise in referrals may be attributed to two factors. Firstly, guidelines such as those published by the National Institute for Health and Clinical Excellence (NICE) (<LINK REF="REF-NICE-CG35-2006" TYPE="REFERENCE">NICE CG35 2006</LINK>) recommend that physiotherapy be made available throughout all stages of the disease, raising the profile of the intervention. This has been further supported by the publication of Dutch physiotherapy guidelines (<LINK REF="REF-Keus-2004" TYPE="REFERENCE">Keus 2004</LINK>) (updated guidelines were due for publication in 2013), which provide specific information for physiotherapists involved in the management of PD. Secondly, there has been a substantial increase in the number of trials completed over the last decade (particularly in the last five years), offering supportive evidence for the inclusion of physiotherapy in the management of PD (<LINK REF="REF-Keus-2009" TYPE="REFERENCE">Keus 2009</LINK>).</P>
<P>A recent Cochrane review (<LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>) assessed the effectiveness of physiotherapy intervention versus no physiotherapy intervention in patients with PD. The review provided evidence for the short-term benefit (&lt; three months) of physiotherapy intervention in the treatment of PD. Further, it suggested that there was no difference in treatment effect between the different types of physiotherapy interventions being used, though this was based on indirect comparisons. This now needs to be confirmed by examining head-to-head trials of physiotherapy interventions. This would be of interest to both clinicians and patients so that appropriate physiotherapy interventions which provide greater benefit can be delivered to PD patients (<LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>).</P>
<P>The present Cochrane review was first published in 2001, and included only seven randomised controlled trials with a total of 142 participants (<LINK REF="REF-Deane-2001b" TYPE="REFERENCE">Deane 2001b</LINK>). The methods of physiotherapy varied so widely across the trials that the data could not be combined. This, along with the presence of methodological flaws, small sample sizes, and the possibility of publication bias, led Deane et al to conclude that there was insufficient evidence to support or refute the efficacy of any given approach of physiotherapy over another in PD (<LINK REF="REF-Deane-2001b" TYPE="REFERENCE">Deane 2001b</LINK>). This review updates the previous Cochrane review. It aims to compare the effectiveness of one approach of physiotherapy intervention versus another approach of physiotherapy intervention in patients with PD. </P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness of one physiotherapy intervention compared with a second approach in patients with PD.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials (including the first phase of cross-over trials) comparing a physiotherapy intervention with another physiotherapy intervention were considered for inclusion in the review. Only trials that implemented random methods of treatment allocation were included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with a diagnosis of PD (as defined by the authors of the studies).</P>
<UL>
<LI>PD of any disease stage (i.e. early or diagnostic, maintenance, or complex phase).</LI>
<LI>Any duration of PD.</LI>
<LI>All ages.</LI>
<LI>Any drug therapy.</LI>
<LI>Any duration of physiotherapy treatment (although trials of less than one day of treatment were excluded).</LI>
</UL>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-01-26 23:19:24 +0000" MODIFIED_BY="[Empty name]">
<P>Physiotherapy interventions aim to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person. Physiotherapy encompasses a wide range of techniques, so we were inclusive in our definition of physiotherapy intervention (including those not directly delivered by a physiotherapist) with trials of general physiotherapy, exercise, treadmill training, cueing, dance and martial arts being included.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>1. Gait outcomes such as:</P>
<P>a. two- or six-minute walk test (m), measures the number of metres a person can walk in two or six minutes thereby providing a measurement of walking endurance (<LINK REF="REF-Kersten-2004" TYPE="REFERENCE">Kersten 2004</LINK>);</P>
<P>b. walking speed:</P>
<P>i. 10- or 20-metre walk test (s), measures the time in seconds that a person takes to walk 10 or 20 metres thereby providing a measurement of gait speed (<LINK REF="REF-Kersten-2004" TYPE="REFERENCE">Kersten 2004</LINK>),</P>
<P>ii. velocity (m/s), measures the rate of change of position, recorded in metres per second (<LINK REF="REF-Trew-2005" TYPE="REFERENCE">Trew 2005</LINK>);</P>
<P>c. cadence (steps/min), measures the number of steps taken in a given period of time, which is then converted into the number of steps taken per minute (<LINK REF="REF-Trew-2005" TYPE="REFERENCE">Trew 2005</LINK>);</P>
<P>d. stride length (m), measures the average distance (in metres) between two successive placements of the same foot (<LINK REF="REF-Whittle-1996" TYPE="REFERENCE">Whittle 1996</LINK>);</P>
<P>e. step length (m), measures the average distance (in metres) between successive foot to floor contact with the opposite feet (<LINK REF="REF-Trew-2005" TYPE="REFERENCE">Trew 2005</LINK>);</P>
<P>f. Freezing of Gait Questionnaire, a validated questionnaire for the assessment of freezing of gait. The questionnaire consists of six items and scores range from 0 to 24, with higher scores corresponding to more severe freezing of gait (<LINK REF="REF-Giladi-2000" TYPE="REFERENCE">Giladi 2000</LINK>).<BR/>
</P>
<P>2. Functional mobility and balance outcomes such as:</P>
<P>a. timed up and go (s), measures the time taken in seconds for a person to get up from a chair, walk a certain distance (usually three metres), turn around and walk back to the chair and sit down (<LINK REF="REF-Podsiadlo-1991" TYPE="REFERENCE">Podsiadlo 1991</LINK>);</P>
<P>b. Functional Reach Test (cm), &#8220;the maximal distance one can reach forward beyond arm&#8217;s length, while maintaining a fixed base of support in the standing position&#8221; (<LINK REF="REF-Duncan-1990" TYPE="REFERENCE">Duncan 1990</LINK>);</P>
<P>c. Berg Balance Scale, a validated questionnaire designed to measure functional standing balance of the older adult. The measure consists of 14 items and score ranges from 0 to 56; with 0 to 20 = high fall risk; 21 to 40 = medium fall risk; and 41 to 56 = low fall risk (<LINK REF="REF-Berg-1992" TYPE="REFERENCE">Berg 1992</LINK>; <LINK REF="REF-Qutubuddin-2005" TYPE="REFERENCE">Qutubuddin 2005</LINK>);</P>
<P>d. Activity Specific Balance Confidence. a 16-item self-report questionnaire that asks individuals to rate their confidence that they will maintain their balance in the course of daily activities. Each item is rated from 0% (no confidence) to 100% (complete confidence) (<LINK REF="REF-Powell-1995" TYPE="REFERENCE">Powell 1995</LINK>; <LINK REF="REF-Talley-2008" TYPE="REFERENCE">Talley 2008</LINK>).<BR/>
</P>
<P>3. Data on falls such as:</P>
<P>a. number of patients falling, e.g. falls diary;</P>
<P>b. Falls Efficacy Scale, a 10-item patient-reported questionnaire that measures how confident a person is at carrying out various ADL. Items are rated from 1 to 10, with higher scores correlating with lower levels of confidence, and a total score of 70 or more indicating that a person has a fear of falling (<LINK REF="REF-Tinetti-1990" TYPE="REFERENCE">Tinetti 1990</LINK>);</P>
<P>c. Falls Efficacy Scale International, a 16-item questionnaire that includes the 10 original items of the standard Falls Efficacy Scale as well as six items regarding higher functioning and social activities. Each item is rated on a scale of 1 to 4, with 1 being &#8216;not concerned at all&#8217; and 4 being &#8216;very concerned&#8217; (maximum score out of 64) (<LINK REF="REF-Yardley-2005" TYPE="REFERENCE">Yardley 2005</LINK>).<BR/>
</P>
<P>4. Clinician-rated impairment and disability measures such as:</P>
<P>a. Hoehn and Yahr, a scale used to describe how symptoms of Parkinson's disease progress. Scale ranges from 0 to 5, with higher levels indicating greater disability (<LINK REF="REF-Hoehn-1967" TYPE="REFERENCE">Hoehn 1967</LINK>);</P>
<P>b. Unified Parkinson's Disease Rating Scale (UPDRS), designed to assess motor impairment and disability in Parkinson&#8217;s disease. Higher scores correspond to greater disability (<LINK REF="REF-Fahn-1987" TYPE="REFERENCE">Fahn 1987</LINK>):</P>
<P>i. total, score ranges from 0 to 176,</P>
<P>ii. mental, score ranges from 0 to 16,</P>
<P>iii. ADL, score ranges from 0 to 52,</P>
<P>iv. motor, score ranges from 0 to 108;</P>
<P>c. Webster Rating Scale, an assessment of severity of disease and clinical impairment against 10 items using a scale of 0 = normal to 3 = maximum impairment (bradykinesia, rigidity, posture, upper extremity swing, gait, tremor at rest, facies, seborrhoea, speech, and self care). Scores ranges from 0 to 30, with higher scores indicating greater disease severity and disability (<LINK REF="REF-Webster-1968" TYPE="REFERENCE">Webster 1968</LINK>);</P>
<P>d. Columbia University Rating Scale, an assessment of motor impairment and ADL against 13 items, using a five-point scale for each to give a total score between 0 = normal to 65 = maximum disability (<LINK REF="REF-Yahr-1969" TYPE="REFERENCE">Yahr 1969</LINK>).<BR/>
</P>
<P>5. Patient-rated quality of life such as:</P>
<P>a. Parkinson's Disease Questionnaire-39 (PDQ-39), a PD specific health-related quality of life questionnaire containing 39 items divided into eight domains. Scores range from 0 to 100 with higher scores corresponding to poorer quality of life (<LINK REF="REF-Jenkinson-1997" TYPE="REFERENCE">Jenkinson 1997</LINK>; <LINK REF="REF-Peto-1995" TYPE="REFERENCE">Peto 1995</LINK>);</P>
<P>b. PDQUALIF, a PD specific health-related quality of life questionnaire containing 32 items in seven dimensions and one item of global health-related quality of life. The total score ranges from 0 to 128 with higher scores indicating poorer quality of life (<LINK REF="REF-Welsh-2003" TYPE="REFERENCE">Welsh 2003</LINK>);</P>
<P>c. PDQL, a PD specific health-related quality of life questionnaire containing 37 items grouped into four subscales. Item scores range from 1 to 5. The PDQL-Summary Index ranges from 37 to 185, with higher scores reflecting better quality of life (<LINK REF="REF-Deboer-1996" TYPE="REFERENCE">Deboer 1996</LINK>);</P>
<P>d. Short Form-36 (SF-36) or 12 (SF-12), a generic short form health survey consisting of 36 or 12 questions. The SF-36 consists of eight scaled scores assessing vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. Scores range from 0 to 100 with higher scores corresponding to better quality of life (<LINK REF="REF-Ware-1992" TYPE="REFERENCE">Ware 1992</LINK>).<BR/>
</P>
<P>6. Adverse events e.g. fractures, pain.<BR/>
</P>
<P>7. Compliance e.g. participant adherence, treatment fidelity.<BR/>
</P>
<P>8. Economic analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>We undertook a systematic search of the literature up to the end of January 2012 for publications or abstracts describing relevant trials. This included searching the following.</P>
<P>1. General biomedical and science electronic databases (without date limiters) including the Cochrane Movement Disorders Specialised Register, <I>The Cochrane Library</I>, MEDLINE (1966 to 2012), EMBASE (1974 to 2012), CINAHL (1982 to 2012), ISI-SCI (1981 to 2012); the rehabilitation databases AMED (1985 to 2012), REHABDATA (1995 to 2012), REHADAT (1990 to 2012), PEDro (1929 to 2012), GEROLIT (1979 to 2012); the English language databases of foreign language research and third world publications LILACS (1982 to 2012), MedCarib (17th Century to 2012) and IMEMR (1984 to 2012).</P>
<P>2. The Cochrane Central Register of Controlled Trials (CENTRAL), the CentreWatch Clinical Trials listing service, the metaRegister of Controlled Trials, ClinicalTrials.gov, RePORT, National Institute on Disability and Rehabilitation Research (NIDRR) and National Research Register (NRR).</P>
<P>3. Handsearching of general (Lancet, BMJ, JAMA) and specific journals <I>(Movement Disorders</I>,<I> Neurology</I>,<I> Archives of Physical Medicine and Rehabilitation</I>,<I> Clinical Rehabilitation</I>,<I> Physiotherapy</I>, <I>Physical Therapy</I>) from 2001 to the end of January 2012.</P>
<P>4. The reference lists of retrieved papers and review articles.</P>
<P>5. Abstract books and conference proceedings. This included The XIII International Congress on Parkinson's disease (1999), The International Congress of Parkinson's Disease and Movement Disorders (1990, 1992, 1994, 1996, 1998, 2000, 2002, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012), World Congress on Parkinson's Disease and Related Disorders (2009) and The American Academy of Neurology 51st annual meeting (1999).</P>
<P>6. Grey literature databases (including theses): Conference Proceedings Citation Index (1982 to 2012), DISSABS (1999 to 2012), Conference Papers Index (1982 to 2012), Index to Theses (1970 to 2012), Electronic Theses Online Service (EThOS) (16<SUP>th</SUP> Century to 2012) and ProQuest dissertations and theses databases (1861 to 2012).</P>
<P>The search strategies are listed in full in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-01-26 23:26:08 +0000" MODIFIED_BY="[Empty name]">
<P>From the search results, two review authors (CLT, CPH, SP or LS) independently screened the abstracts of potentially relevant studies, with the full paper being obtained if the abstract did not provide sufficient information to determine eligibility for inclusion in the review. Disagreement was resolved by referral to a third review author (RS, CM or NI). Authors of potentially eligible studies were contacted for further information if details of their trial were unclear.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (CLT, CPH, SP or CM) independently assessed the eligible papers or abstracts for trial details and outcome data. These were validated by discussion with any discrepancies resolved by consensus. Trial details were recorded on a standard trial description form and included: trial name, trial group, authors, randomised comparison, treatment schedule (including duration, number of sessions, type of intervention), other therapy, eligibility criteria, method of randomisation, allocation concealment, blinding, accrual period, number of participants randomised, number of dropouts, duration of follow-up, outcomes reported, use of intention-to-treat analysis and publication date(s). The outcome data extracted included data on gait, functional mobility and balance, falls, clinician-rated disability scale and patient-rated quality of life, adverse events, compliance or withdrawals and health economics where available.</P>
<P>Authors of any eligible unpublished studies were contacted to ask if further details and the data for their trial could be provided.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (CLT, CPH, SP or CM) assessed the methodological quality of the full papers by recording the eligibility criteria (for example specified inclusion (and exclusion) criteria - low risk), method of randomisation (for example used computer random number generator - low risk) and blinding (for example blinding of assessors - low risk), concealment of allocation (for example use of central randomisation service - low risk), similarity of participants in treatment groups at baseline (no difference in baseline characteristics between treatment groups as stated in trial publication - low risk), co-intervention(s) constant (for example drug therapy stable - low risk), comparable treatment arms (for example similar treatment duration and frequency - low risk), whether an intention-to-treat analysis was performed (intention-to-treat analysis and withdrawals &lt; 10% - low risk, withdrawals &gt; 10% - unclear risk, per protocol analysis - all unclear risk) and the number of participants lost to follow-up and missing values (withdrawals below 10% - low risk) (see the risk of bias tables under 'Characteristics of included studies').</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment arms of the included studies were classified and divided according to the types of interventions administered:</P>
<P>1. general physiotherapy;</P>
<P>2. exercise;</P>
<P>3. treadmill training;</P>
<P>4. cueing;</P>
<P>5. dance;</P>
<P>6. martial arts.</P>
<P>Disparate study designs in the included trials resulted in a lack of overlap in the collated physiotherapy methods and outcome measures such that data could not be combined in a meaningful way.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 78 randomised trials of physiotherapy intervention in PD patients were identified; 29 studies were excluded (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). The reasons for excluding these trials were: not randomised or not properly randomised (n = 12), cross-over study with data for the different phases not adequately separated (n = 4), treatment given in trial not usually used by physiotherapists (such as whole body vibration technique) (n = 4), no outcome measures relevant to our review (n = 2), multidisciplinary therapy rehabilitation trial (n = 2), trial duration under one day (n = 1), insufficient information available for inclusion in review (n = 1), unsuitable comparator arm (n = 1), study was confounded (n = 1) and comparison of physiotherapy delivery rather than technique (n = 1). There were also six ongoing trials for which data were not yet available (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>). Therefore, there were 43 trials available for inclusion in the review, compared to seven in the 2001 review (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<P>The number of participants randomised into each of the 43 trials ranged from eight to 210 participants, with 1673 participants randomised in total (giving an average trial size of 39 participants) (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). The assessment period ranged from two weeks to 24 months. The mean age of the participants in the trials was 67 years, 62% were male, the mean Hoehn and Yahr stage was 2.4, and they had had PD for approximately seven years.</P>
<P>There were 14 three-arm trials. Eight trials compared two different experimental physiotherapy interventions with placebo or no intervention (<LINK REF="STD-Almeida-2012" TYPE="STUDY">Almeida 2012</LINK>; <LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-Mak-2008" TYPE="STUDY">Mak 2008</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>; <LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK>; <LINK REF="STD-Thaut-1996" TYPE="STUDY">Thaut 1996</LINK>). The placebo or no intervention arms of these trials were not included in any analysis for this review (see <LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>). Six trials compared three different physiotherapy techniques (<LINK REF="STD-Chaiwanichsiri-2011" TYPE="STUDY">Chaiwanichsiri 2011</LINK>; <LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>; <LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>; <LINK REF="STD-Toole-2005" TYPE="STUDY">Toole 2005</LINK>). There was also one four-arm trial comparing two types of dance (waltz or foxtrot and tango) and martial arts with no intervention (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>See the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> risk of bias in included studies tables, risk of bias graph (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) and risk of bias summary (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Trial design</HEADING>
<P>A total of 40 trials had a parallel design and three had a cross-over design (<LINK REF="STD-Burini-2006" TYPE="STUDY">Burini 2006</LINK>; <LINK REF="STD-Miyai-2000" TYPE="STUDY">Miyai 2000</LINK>; <LINK REF="STD-Shiba-1999" TYPE="STUDY">Shiba 1999</LINK>). Most trials looked at the short-term effect of therapy by assessing the participants at baseline and immediately or shortly after the physiotherapy intervention period (which ranged from two weeks to 24 months). Of the parallel design trials 21 reported additional data at assessment points after the treatment period had finished; this may have been at only two weeks or up to 12 months after the end of the treatment period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Sample size</HEADING>
<P>Only 13 studies (30%) (<LINK REF="STD-Braun-2011" TYPE="STUDY">Braun 2011</LINK>; <LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>; <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>; <LINK REF="STD-Hackney-2010" TYPE="STUDY">Hackney 2010</LINK>; <LINK REF="STD-Hirsch-1996" TYPE="STUDY">Hirsch 1996</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Morris-2009" TYPE="STUDY">Morris 2009</LINK>; <LINK REF="STD-Picelli-2012" TYPE="STUDY">Picelli 2012</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>; <LINK REF="STD-Smania-2010" TYPE="STUDY">Smania 2010</LINK>; <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>) reported a sample size calculation in the trial report, which was achieved by seven studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Eligibility criteria</HEADING>
<P>The eligibility criteria for the trials were broad and varied considerably across the trials. The level of detail provided on the eligibility criteria was also variable, with some studies providing a detailed description of the entry criteria and others just stating 'patients with Parkinson&#8217;s disease'. Only four trials (<LINK REF="STD-Pelosin-2010" TYPE="STUDY">Pelosin 2010</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>; <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>) stated that a diagnosis of PD by the United Kingdom Brain Bank Criteria (<LINK REF="REF-Gibb-1988" TYPE="REFERENCE">Gibb 1988</LINK>) was required. It is vital that eligibility criteria are well-defined so that the trial participant population can be determined.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Randomisation method and concealment of allocation</HEADING>
<P>A total of 24 trials (56%) described the randomisation method used, of which only eight trials used low risk methods (for example computer random number generators). No details of the randomisation method used were provided for the remaining 19 trials. Further, only 20 trials (47%) either stated or gave adequate information that allowed the assessment of whether an adequate concealment of treatment allocation procedure had been used. Four trials were considered to be low risk by virtue of having used a central independent randomisation service, with the other 16 considered high risk (that is concealment of treatment allocation was potentially compromised as sealed envelopes, picking a card or picking from a hat were used).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Blinding of assessors</HEADING>
<P>It would be impossible to blind participants and therapists to randomised treatment allocation in trials of physiotherapy. Therefore, such trials are open label by nature, and they are consequently liable to the possibility of both performance and attrition bias. However, blinding of assessors could be employed to try and reduce the possibility of bias; 23 (53%) of the 43 studies used blinded assessors, seven used unblinded assessors so were classed as high risk, and in the other 13 studies this information was not provided (classed as unclear risk).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Co-interventions</HEADING>
<P>Information on co-interventions was provided in 24 trials (56%), with participants continuing with their standard PD medication. In 20 trials the drug therapy was kept stable (low risk) throughout the duration of the trial, whereas five trials allowed variation (unclear risk). The remaining trials did not describe drug therapy (unclear risk).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Similarity of treatment groups at baseline</HEADING>
<P>A description of the baseline characteristics of the trial participants is important to determine whether the trial results are generalisable and to compare characteristics of the two arms to ensure that the randomisation methods were successful. Six trials (<LINK REF="STD-Diehl-2011" TYPE="STUDY">Diehl 2011</LINK>; <LINK REF="STD-Joudoux-2011" TYPE="STUDY">Joudoux 2011</LINK>; <LINK REF="STD-Khallaf-2011" TYPE="STUDY">Khallaf 2011</LINK>; <LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>; <LINK REF="STD-Shen-2011" TYPE="STUDY">Shen 2011</LINK>; <LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK>) did not provide any information on the baseline characteristics of the participants entered into the trial; 31 (of the 37) trials that reported baseline data gave this information split by treatment group; 25 trials reported sufficient data that showed participants to be similar at baseline. In six trials the baseline characteristics of the withdrawn participants were not given (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>; <LINK REF="STD-Mak-2008" TYPE="STUDY">Mak 2008</LINK>; <LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK>; <LINK REF="STD-Picelli-2012" TYPE="STUDY">Picelli 2012</LINK>; <LINK REF="STD-Smania-2010" TYPE="STUDY">Smania 2010</LINK>; <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>). Along with the six trials that did not supply baseline data, this meant that 274 (16%) of the 1693 randomised participants were not characterised.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Data analysis</HEADING>
<P>Ten trials stated intention to treat as the primary method of analysis, although it was not always clear if participants who withdrew from the trial were included in the analysis. The number of participant withdrawals was classed as low risk (&#8804; 10% of trial participants withdrew) in five of the 10 trials. Four trials used per protocol as the method of analysis (unclear risk). In the other 29 trials the method of analysis was not described (unclear risk), of these trials seven were considered high risk in terms of the proportion of participants that withdrew (that is &gt; 10%), and in 13 trials the number of participant withdrawals (if any) was not described (unclear risk).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Available trial information and data</HEADING>
<P>A total of 13 trials were reported in abstract form; further information was requested from the authors (two were not contactable: <LINK REF="STD-Khallaf-2011" TYPE="STUDY">Khallaf 2011</LINK>; <LINK REF="STD-Shiba-1999" TYPE="STUDY">Shiba 1999</LINK>) with four (<LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>; <LINK REF="STD-Robichaud-2012" TYPE="STUDY">Robichaud 2012</LINK>; <LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>) providing additional information and seven (<LINK REF="STD-Diehl-2011" TYPE="STUDY">Diehl 2011</LINK>; <LINK REF="STD-Hass-2006" TYPE="STUDY">Hass 2006</LINK>; <LINK REF="STD-Joudoux-2011" TYPE="STUDY">Joudoux 2011</LINK>; <LINK REF="STD-Loureiro-2010" TYPE="STUDY">Loureiro 2010</LINK>; <LINK REF="STD-Shen-2011" TYPE="STUDY">Shen 2011</LINK>; <LINK REF="STD-Sigurgeirsson-2009" TYPE="STUDY">Sigurgeirsson 2009</LINK>; <LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK>) being unsuccessful. A total of 30 trials were reported as full publications; further information was requested from authors for 26 trials with 13 providing additional information.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>See 'Summary of results' table for included trials (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>The physiotherapy interventions were placed into one of the six categories (general physiotherapy, exercise, treadmill training, cueing, dance and martial arts) according to the type of treatment administered. However, the content and delivery of the interventions within each category were diverse and varied substantially. Further, a wide variety of validated and customised outcome measures were used to assess the effectiveness of the physiotherapy interventions. Consequently, it was inappropriate to combine the results of studies or perform any statistical analysis.</P>
<P>Nevertheless, results of the most regularly used outcome measures could be examined on a trial by trial basis. The most frequently reported physiotherapy outcome measures were gait speed and timed up and go. The motor subscales of the UPDRS and PDQ-39 were the most commonly reported clinician-rated disability and patient-rated quality of life outcome measures respectively. Falls data were also considered to be an important outcome in PD. Even in the case of these more widely reported outcome measures, quantitative meta-analysis could not be performed due to the wide variety of interventions employed by the included studies such that no two studies with comparable interventions assessed the same outcome measure.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Gait speed (m/s)</I>
</HEADING>
<P>Gait speed was measured in 19 studies with data available from 15 studies; data were inadequately or not reported for four trials (<LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Khallaf-2011" TYPE="STUDY">Khallaf 2011</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Shen-2011" TYPE="STUDY">Shen 2011</LINK>). Nine (<LINK REF="STD-Almeida-2012" TYPE="STUDY">Almeida 2012</LINK>; <LINK REF="STD-Chaiwanichsiri-2011" TYPE="STUDY">Chaiwanichsiri 2011</LINK>; <LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>; <LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>; <LINK REF="STD-Hass-2006" TYPE="STUDY">Hass 2006</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-Miyai-2000" TYPE="STUDY">Miyai 2000</LINK>; <LINK REF="STD-Vivas-2011" TYPE="STUDY">Vivas 2011</LINK>; <LINK REF="STD-Werner-2010" TYPE="STUDY">Werner 2010</LINK>) of the 15 studies reported no difference between the two intervention arms. In five studies (<LINK REF="STD-Dias-2005" TYPE="STUDY">Dias 2005</LINK> (mean difference between arms 0.34 m/s); <LINK REF="STD-Frazzitta-2009" TYPE="STUDY">Frazzitta 2009</LINK> (mean difference between arms 0.1 m/s); <LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK> (mean difference between arms 0.16 m/s); <LINK REF="STD-Thaut-1996" TYPE="STUDY">Thaut 1996</LINK> (mean difference between arms 0.093 m/s); <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK> (mean difference between arms 0.15 m/s)) the gait speed was significantly increased in the novel experimental arm compared to the comparator arm. The remaining study (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>) was a three-arm trial. Hackney (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>) recorded significantly greater gait speed in the tango arm compared to the waltz/foxtrot arm (mean difference between arms 0.06m/s), but not the Tai Chi arm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Timed up and go (s)</I>
</HEADING>
<P>The timed up and go test was reported in 15 studies with data available from 14 studies; data were inadequately or not reported for one study (<LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>). There was no difference between the two intervention arms for 12 studies (<LINK REF="STD-Almeida-2012" TYPE="STUDY">Almeida 2012</LINK>; <LINK REF="STD-Braun-2011" TYPE="STUDY">Braun 2011</LINK>; <LINK REF="STD-Chaiwanichsiri-2011" TYPE="STUDY">Chaiwanichsiri 2011</LINK>; <LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>; <LINK REF="STD-Hackney-2010" TYPE="STUDY">Hackney 2010</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-Loureiro-2010" TYPE="STUDY">Loureiro 2010</LINK>; <LINK REF="STD-Morris-2009" TYPE="STUDY">Morris 2009</LINK>; <LINK REF="STD-Pelosin-2010" TYPE="STUDY">Pelosin 2010</LINK>; <LINK REF="STD-Robichaud-2012" TYPE="STUDY">Robichaud 2012</LINK>; <LINK REF="STD-Sigurgeirsson-2009" TYPE="STUDY">Sigurgeirsson 2009</LINK>; <LINK REF="STD-Vivas-2011" TYPE="STUDY">Vivas 2011</LINK>). In the Ebersbach (<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>) study, the time taken to complete the timed up and go test was significantly improved (that is reduced) with the Lee Silverman voice treatment (LSVT) BIG arm compared to the Nordic walking and home exercise arms. In the Hackney (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>) study, the timed up and go test was significantly improved in the tango arm compared to the waltz or foxtrot and Tai Chi arms.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Falls</I>
</HEADING>
<P>Outcome measures that report data on falls are important and pertinent in PD studies. However, only five trials reported data on falls (11%) (<LINK REF="STD-Hirsch-1996" TYPE="STUDY">Hirsch 1996</LINK>; <LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Smania-2010" TYPE="STUDY">Smania 2010</LINK>). </P>
<P>
<LINK REF="STD-Hirsch-1996" TYPE="STUDY">Hirsch 1996</LINK> reported the effect of training on mean latency to fall (average number of seconds participants swayed before stepping or falling, touching the surrounding panels with hands, or needing assistance from the technician to keep from sitting in the harness) and the proportion of falls (number of trials resulting in falls). There were no significant differences between the combined balance and resistance arm and balance only arm for either outcome.</P>
<P>
<LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK> was published in abstract form. There was insufficient information on the falls data collected to allow a description of the manner in which falls were analysed or to give any indication of the result.</P>
<P>
<LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK> monitored falls using daily &#8216;falls calendars&#8217; that were maintained by study participants. There were no differences between the Tai Chi and resistance training arms.</P>
<P>
<LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK> measured the number of fallers, the number of multiple fallers and falls rate. The number of falls during the intervention phase (eight weeks) was significantly lower in the progressive strength training arm compared to the movement strategy training arm (n = 10 versus n = 24; P = 0.006), with the frequency of falls varying markedly. However, the time to first fall did not differ significantly between groups (P = 0.4).</P>
<P>
<LINK REF="STD-Smania-2010" TYPE="STUDY">Smania 2010</LINK> reported the number of falls by means of a falls diary. A diary of the number of falls, their circumstances, and the consequences for the patient&#8217;s health were kept for one month prior to each evaluation session. There was no significant difference between the balance training experimental arm and the general physical exercises arm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Clinician-rated disability</I>
</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">UPDRS motor subscale</HEADING>
<P>The motor subscale of the UPDRS was reported in 23 studies with data and information available from 17; data were inadequately or not reported for six studies (<LINK REF="STD-Joudoux-2011" TYPE="STUDY">Joudoux 2011</LINK>; <LINK REF="STD-Khallaf-2011" TYPE="STUDY">Khallaf 2011</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>; <LINK REF="STD-Shen-2011" TYPE="STUDY">Shen 2011</LINK>; <LINK REF="STD-Toole-2005" TYPE="STUDY">Toole 2005</LINK>). There was no difference between the two intervention arms for 14 studies (<LINK REF="STD-Almeida-2012" TYPE="STUDY">Almeida 2012</LINK>; <LINK REF="STD-Burini-2006" TYPE="STUDY">Burini 2006</LINK>; <LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>; <LINK REF="STD-Frazzitta-2009" TYPE="STUDY">Frazzitta 2009</LINK>; <LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>; <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>; <LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Miyai-2000" TYPE="STUDY">Miyai 2000</LINK>; <LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK>; <LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>; <LINK REF="STD-Robichaud-2012" TYPE="STUDY">Robichaud 2012</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>). In the <LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK> study, the UPDRS motor score was significantly improved in the LSVT BIG arm compared to the Nordic walking and home exercise arms. In the <LINK REF="STD-Ridgel-2009" TYPE="STUDY">Ridgel 2009</LINK> study, UPDRS motor scores showed a significantly greater improvement in the forced exercise arm compared to the voluntary exercise arm. In the <LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK> study, partial weight supported (-20%) treadmill training had a significantly greater improvement in UPDRS motor score compared to conventional gait training (no data in publication).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Patient-rated quality of life</I>
</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">PDQ-39 (Summary Index)</HEADING>
<P>A total of 13 studies described using data from the PDQ-39 but the data were only available from eight studies; data were inadequately or not reported in five studies (<LINK REF="STD-Joudoux-2011" TYPE="STUDY">Joudoux 2011</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>; <LINK REF="STD-Sigurgeirsson-2009" TYPE="STUDY">Sigurgeirsson 2009</LINK>). Seven studies (<LINK REF="STD-Burini-2006" TYPE="STUDY">Burini 2006</LINK>; <LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>; <LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>; <LINK REF="STD-Morris-2009" TYPE="STUDY">Morris 2009</LINK>; <LINK REF="STD-Pelosin-2010" TYPE="STUDY">Pelosin 2010</LINK>; <LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>) reported no difference between the intervention arms. Only the <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK> trial reported a significant difference, with quality of life scores significantly improved in the tango arm compared to the waltz or foxtrot and Tai Chi arms.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Adverse events</I>
</HEADING>
<P>Nine trials recorded adverse event data (<LINK REF="STD-Chaiwanichsiri-2011" TYPE="STUDY">Chaiwanichsiri 2011</LINK>; <LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Picelli-2012" TYPE="STUDY">Picelli 2012</LINK>; <LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>; <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>). Minor adverse events such as muscle soreness, falls and dizziness were reported, with none of these trials reporting events significant enough to cause concern over the safety of the intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Compliance</I>
</HEADING>
<P>Only 18 of the 43 trials discussed participant compliance, with 13 (<LINK REF="STD-Burini-2006" TYPE="STUDY">Burini 2006</LINK>; <LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>; <LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>; <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>; <LINK REF="STD-Hirsch-1996" TYPE="STUDY">Hirsch 1996</LINK>; <LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>; <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>; <LINK REF="STD-Miyai-2000" TYPE="STUDY">Miyai 2000</LINK>; <LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK>; <LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>; <LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>; <LINK REF="STD-Thaut-1996" TYPE="STUDY">Thaut 1996</LINK>; <LINK REF="STD-Toole-2005" TYPE="STUDY">Toole 2005</LINK>) quantifying it in some form; however this was difficult to analyse.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Health economics</I>
</HEADING>
<P>Only one trial (<LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>) intended to look at health economics. Watts 2008 (See <LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>) published a protocol for economic analysis alongside the McGinley trial. They proposed to evaluate cost-effectiveness using a three-way comparison of the cost per fall averted and the cost per quality adjusted life year saved across two physical therapy interventions and a control group.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Summary of main results</HEADING>
<P>This review updates the previous Cochrane review published in 2001 (<LINK REF="REF-Deane-2001b" TYPE="REFERENCE">Deane 2001b</LINK>) comparing the effectiveness of one approach of physiotherapy intervention versus a second approach of physiotherapy intervention for the treatment of PD. The review now includes 43 randomised trials and 1693 participants (compared with seven trials and 142 participants in the 2001 review). Many recent systematic reviews have focused on specific areas of physiotherapy such as exercise, cueing and treadmill training (<LINK REF="REF-Allen-2011" TYPE="REFERENCE">Allen 2011</LINK>; <LINK REF="REF-Crizzle-2006" TYPE="REFERENCE">Crizzle 2006</LINK>; <LINK REF="REF-Goodwin-2008" TYPE="REFERENCE">Goodwin 2008</LINK>; <LINK REF="REF-Lim-2005" TYPE="REFERENCE">Lim 2005</LINK>; <LINK REF="REF-Mehrholz-2010" TYPE="REFERENCE">Mehrholz 2010</LINK>; <LINK REF="REF-Nieuwboer-2008" TYPE="REFERENCE">Nieuwboer 2008</LINK>). Physiotherapy for PD encompasses a wide range of methods and techniques ranging from standard UK National Health Service (NHS) physiotherapy to exercise regimens and martial arts (<LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>). Therefore, it is important that all approaches of physiotherapy intervention are included. Physiotherapy interventions were placed into six categories according to the type of treatment administered. However, the content and delivery of the interventions within each category varied substantially. In view of the disparate study designs, variety of interventions, and the array of outcome measures used the results of individual studies could not be combined using quantitative meta-analysis methods.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparison of different physiotherapy interventions</HEADING>
<P>A recent Cochrane review provided evidence on the short-term benefit of physiotherapy in the treatment of PD (<LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>). However, it did not identify whether any specific type of physiotherapy intervention provides greater benefit. This review aimed to assess this by comparing the effectiveness of one approach of physiotherapy intervention with a second approach of physiotherapy intervention. The various physiotherapy interventions used in the trials included in this review were categorised according to the type of treatment administered to aid comparisons (general physiotherapy, exercise, treadmill training, cueing, dance, martial arts). However, despite categorisation, the techniques employed within each category were diverse. Therefore, it was not possible or appropriate to combine the results by meta-analysis as any such analysis would be difficult to interpret. It is also difficult to summarise such large amounts of heterogeneous data using a qualitative approach. Consequently, we conclude that there is no robust trial evidence to support any one approach of physiotherapy over another in the treatment of PD.</P>
<P>The content and delivery of the interventions used in the trials included within this review were diverse in nature. Although attempts were made to compare trials that were 'like for like' through the creation of different categories, the interventions delivered varied substantially within these categories. In the future it may be useful to further subcategorise by the primary aim of the trial. For example, categories for the primary aim might be to improve gait or improve a specific problem such as gait freezing or balance, or improve overall PD performance or function. The variation in the therapy delivered is unsurprising. Physiotherapy is an autonomous profession. Physiotherapists use different sets of skills and work within their own scope of practice (<LINK REF="REF-Chartered-Society-of-Physiotherapy" TYPE="REFERENCE">Chartered Society of Physiotherapy</LINK>), and so this variation in the interventions delivered within clinical trials may reflect the diversity of clinical practice. Over the past decade, steps have been taken to try and provide best practice consensus in the form of the Dutch <I>KNGF guidelines for physical therapy in patients with Parkinson&#8217;s disease</I> (<LINK REF="REF-Keus-2004" TYPE="REFERENCE">Keus 2004</LINK>). However, this publication provides a guidance framework rather than a 'recipe' for treatment. It is therefore important that physiotherapy interventions are compared against each other within rigorous trial designs to determine which are the most effective. This will provide therapists with a menu of treatment strategies that are known to be effective, from which they can devise individualised interventions. However, given the complexity of physiotherapy interventions, it is important that such trials follow the Medical Research Council guidelines for developing and evaluating complex interventions (<LINK REF="REF-MRC-2008" TYPE="REFERENCE">MRC 2008</LINK>), which will help standardise interventions. In addition, many of the trials included in this review had interventions that were intensive and for long durations, which may not be feasible in main stream care. Therefore, future trials should be designed such that the interventions are transferable and cost-effective in main stream care.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Outcome measures</HEADING>
<P>There was a large variety of outcome measures utilised in the different studies included in this review. The majority of the outcomes were standard physiotherapy and PD outcomes. Gait speed, timed up and go, UPDRS motor score and quality of life measured using the PDQ-39 were the most frequently reported outcome measures within their respective categories. PD is a multidimensional disease and several important outcomes were either poorly or not reported; this includes data on the number of the falls, depression and anxiety and adverse events. Further, many of the outcomes measured were not relevant to the PD patient or carer. There is a need for the use of functional gait outcomes in future trials which look at the impact on the patient during everyday living rather than in a laboratory environment. Further, only one trial intended to look at a health economics analysis of physiotherapy intervention, therefore little is known about the cost-effectiveness and economic value of this therapy. Future trials should include these outcomes.</P>
<SUBSECTION>
<HEADING LEVEL="6">Gait speed</HEADING>
<P>Six trials (<LINK REF="STD-Dias-2005" TYPE="STUDY">Dias 2005</LINK>; <LINK REF="STD-Frazzitta-2009" TYPE="STUDY">Frazzitta 2009</LINK>; <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>; <LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK>; <LINK REF="STD-Thaut-1996" TYPE="STUDY">Thaut 1996</LINK>; <LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>) reported significant differences between the treatment arms for gait speed. The observed differences between treatment arms ranged from 0.06 to 0.34 m/s. In all these trials, with the exception of Hackney 2009, the intervention arm that used cueing or treadmill training methods, or both, was the better treatment arm. The Hackney trial (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>) examined dance with the tango arm outperforming the waltz or foxtrot arm. The possible relevance and benefit of these significant differences to patients with PD must be put into context in terms of what is considered a minimally clinically important change (MCIC). Data on what is considered an MCIC are lacking for PD patients, but some data have been reported in stroke patients. In one study, it was reported that an increase in speed of just 0.03 and 0.13 m/s could translate into a change from a limited household to an unlimited household walker, and from an unlimited household walker to a most-limited community walker, respectively (<LINK REF="REF-Perry-1995" TYPE="REFERENCE">Perry 1995</LINK>). Therefore, these differences in gait speed between arms are consistent with the findings reported by Perry (<LINK REF="REF-Perry-1995" TYPE="REFERENCE">Perry 1995</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Timed up and go</HEADING>
<P>The MCIC in PD patients is thought to be 11 seconds (<LINK REF="REF-Steffen-2008" TYPE="REFERENCE">Steffen 2008</LINK>). The differences seen between treatment arms in the Ebersbach (<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>) and Hackney trials (<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>) were much smaller than this (the mean difference between arms ranged from 1.1 to 2 seconds).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">UPDRS motor <I>s</I>ubscale</HEADING>
<P>Three trials reported a significant benefit of one treatment arm in improving UPDRS motor over the other arms. The UPDRS motor score in the LSVT BIG arm in the Ebersbach (<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>) trial improved by 5.05 points, which was significantly different from the two other arms in which the score increased (that is got worse) by 0.53 and 1.68 points in the Nordic walking and home exercise arms, respectively. Ridgel (<LINK REF="STD-Ridgel-2009" TYPE="STUDY">Ridgel 2009</LINK>) reported a significant difference in UPDRS motor score between the forced exercise arm (-16.6 points) and the voluntary exercise arm (3.6 points). Additionally, Talakkad (<LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK>) reported a significantly greater improvement of the UPDRS motor score in the partial weight supported (-20%) treadmill training compared to conventional gait training, although there were no data in the abstract publication. The MCIC for the UPDRS motor score has been reported in two studies. One analysed data from two independent randomised controlled trials and concluded that the MCIC was five points for the motor score (<LINK REF="REF-Schrag-2006" TYPE="REFERENCE">Schrag 2006</LINK>). The second study performed a cross-sectional analysis on 653 PD participants and reported a MCIC of 2.3 to 2.7 points for the motor score (<LINK REF="REF-Shulman-2010" TYPE="REFERENCE">Shulman 2010</LINK>). Considering the recommendations of both Schrag (<LINK REF="REF-Schrag-2006" TYPE="REFERENCE">Schrag 2006</LINK>) and Shulman et al (<LINK REF="REF-Shulman-2010" TYPE="REFERENCE">Shulman 2010</LINK>) the improvements seen in the Ebersbach (<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>) and Ridgel (<LINK REF="STD-Ridgel-2009" TYPE="STUDY">Ridgel 2009</LINK>) trials may reflect a MCIC. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Patient-rated quality of life</HEADING>
<P>A study performed by Peto et al (<LINK REF="REF-Peto-2001" TYPE="REFERENCE">Peto 2001</LINK>) to determine the MCIC for the PDQ-39 Parkinson&#8217;s questionnaire reported that a difference of 1.6 on the summary index was a meaningful change. Only the <LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK> trial reported a significant difference, with quality of life scores significantly improved by 7.10 points in the tango arm, which was significantly different from the waltz or foxtrot arm that improved by 0.68 points and the Tai Chi arm which had an increased score of 1.55 points (that is got worse). This improvement in quality of life that was seen in the tango arm is therefore meaningful to patients.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of the evidence</HEADING>
<P>There has been an improvement in the trial methodological quality and reporting since the last Cochrane review (<LINK REF="REF-Deane-2001b" TYPE="REFERENCE">Deane 2001b</LINK>). The use of more robust randomisation methods, blinding and intention-to-treat analyses has increased since the previous review, although it was still inadequate. Of the 43 trials, only 24 trials provided information on the randomisation method (of which eight were considered low risk) and only four used a central independent randomisation procedure to ensure concealment of treatment allocation; 23 trials used blinded assessors and only 10 stated that they used intention-to-treat analysis methods. The lack of information in many trial reports may not necessarily indicate lack of implementation within the trial, but without this information provided in the trial publications the level of bias within the individual trials is difficult to assess. The need for further improvement in the methodological quality of trials in physiotherapy for PD was noted recently (<LINK REF="REF-Kwakkel-2007" TYPE="REFERENCE">Kwakkel 2007</LINK>; <LINK REF="REF-Tomlinson-2012" TYPE="REFERENCE">Tomlinson 2012</LINK>). Future trials must be methodologically sound, large, randomised, and controlled with reporting following CONSORT guidelines (<LINK REF="REF-Boutron-2008a" TYPE="REFERENCE">Boutron 2008a</LINK>; <LINK REF="REF-Boutron-2008b" TYPE="REFERENCE">Boutron 2008b</LINK>).</P>
<P>The trials included in the review were relatively small, with the majority assessing the effect of one approach of physiotherapy intervention versus a second approach of physiotherapy intervention over a short period of time, with limited follow-up. The overall size of trials has increased (with an average of 39 participants per trial in this review compared to 20 in the previous review), but the number of small and underpowered trials remains a problem. Small trials may be subject to &#8216;random error&#8217; (<LINK REF="REF-Doll-1980" TYPE="REFERENCE">Doll 1980</LINK>) and consequently may give rise to false negative or positive results. Further, it must be noted that the mean age of onset of PD in the participants in the trials was 60 years. This is relatively young as the average age of onset in the PD MED trial is 67 to 69 years (<LINK REF="REF-Patel-2010" TYPE="REFERENCE">Patel 2010</LINK>), therefore the results of the trials may not be relevant to the general PD population, in particular older PD patients.</P>
<P>It should also be noted that only 18 of the 43 trials discussed participant compliance. This is surprising as compliance can be an important determinant of the outcomes measured and the acceptability of the interventions being assessed in the trials. Therefore, it would be beneficial if the level of compliance is measured in future trials.</P>
<P>Another limitation is that the follow-up period in the trials included in this review was relatively short. Outcome measures were assessed in all trials at baseline and immediately or shortly after the intervention had ceased (one or two weeks, with one trial (<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>) assessing at 12 weeks post-intervention). PD is a long-term neurodegenerative disease, so it is important that the long-term effect of treatment is assessed. Only half of the 43 trials followed-up participants and reported further data during the post-treatment period (but this could have been only two weeks or up to 12 months post-treatment). The previous review&#8217;s recommendations were for participants to be followed-up for at least six months. Only two trials did this, reporting follow-up data at 12 months (<LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>) and at both 6 and 12 months (<LINK REF="STD-Werner-2010" TYPE="STUDY">Werner 2010</LINK>) post-treatment. Long-term data will provide valuable information about the duration of any improvement following therapy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Reporting biases</HEADING>
<P>Many trials used multiple outcome measures, and in the majority of trials the primary outcome measure was not explicitly stated. Therefore, it was difficult to assess and identify if studies were free of selective outcome reporting. </P>
<P>In order to minimise the risk of publication bias, a comprehensive search was performed of multiple databases, including searching of unpublished and ongoing studies, without any language restrictions. Also, where necessary, authors were contacted to request additional information. However, as with any systematic review, publication bias should still be taken into consideration.</P>
<P>In summary, large, well-designed randomised trials with improved specific treatment strategies and a follow-up of at least 12 months that assess the impact of treatment on all aspects of a patient's PD, alongside a health economics assessment, are needed.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-01-26 23:47:45 +0000" MODIFIED_BY="[Empty name]">
<P>Considering the small number of participants, the methodological flaws in many of the studies, the wide variety of physiotherapy interventions and outcome measures used, there is insufficient evidence to support the use of one approach of physiotherapy intervention over another for the treatment of PD.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>The majority of the studies included in this review were small and had a short follow-up period. It is clear that larger randomised controlled trials with longer-term follow-up are required, particularly focusing on improving trial methodology and reporting. Rigorous methods of randomisation should be used and the allocation should be adequately concealed. Data should be analysed according to intention-to-treat principles and trials should be reported according to the guidelines set out in the CONSORT statement (<LINK REF="REF-Boutron-2008a" TYPE="REFERENCE">Boutron 2008a</LINK>; <LINK REF="REF-Boutron-2008b" TYPE="REFERENCE">Boutron 2008b</LINK>).</LI>
</UL>
<UL>
<LI>This review highlights the variety of physiotherapy interventions being tested for the treatment of PD. There is a need for more specific trials with improved treatment strategies to underpin the most appropriate choice of physiotherapy intervention and the outcomes measured. This review also reinforces the need for the universal employment of clinically relevant, reliable and sensitive outcome measures with a predefined outcome in each trial. </LI>
<LI>Future trials should, where appropriate, try to follow the Medical Research Council guidelines for developing and evaluating complex interventions (<LINK REF="REF-MRC-2008" TYPE="REFERENCE">MRC 2008</LINK>).</LI>
<LI>Future trials should be designed such that the interventions are transferable and cost-effective in main stream care.</LI>
</UL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>We recognise the contributions of all the original trialists and the individuals who performed the trials that contributed to this systematic review, and thank the participants who agreed to help improve the assessment of PD treatment by taking part in these trials.</P>
<P>We acknowledge Parkinson&#8217;s UK for funding and the Department of Health whose core support for BCTU made this review possible.</P>
<P>We would also like to thank Ana Verissimo who provided a translation for the <LINK REF="STD-Dias-2005" TYPE="STUDY">Dias 2005</LINK> paper.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Carl Clarke, Natalie Ives, Charmaine Meek, Smitaa Patel, Catherine Sackley and Keith Wheatley are either recruiting for or involved in the running of the UK PD REHAB trial.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-01-26 23:59:58 +0000" MODIFIED_BY="[Empty name]">
<P>Claire Tomlinson was involved in searching and selection of studies, data extraction, analysis and interpretation of the review.</P>
<P>Clare Herd was involved in searching and selection of studies, data extraction, analysis and interpretation of the review.</P>
<P>Smitaa Patel was involved in selection of studies, data extraction.</P>
<P>Charmaine Meek was involved in selection of studies, data extraction and provided expert physiotherapy input into the interpretation of the review.</P>
<P>Carl Clarke contributed to the design of the protocol and was involved in the interpretation of the review providing clinical input.</P>
<P>Rebecca Stowe contributed to the design of the protocol and was involved in searching and selection of studies and interpretation of the review.</P>
<P>Laila Shah was involved in searching and selection of studies for the review.</P>
<P>Catherine Sackley contributed to the design of the protocol and provided expert physiotherapy input into the interpretation of the review.</P>
<P>Katherine Deane undertook the 2001 Cochrane Review, and was involved in the interpretation of this review.</P>
<P>Keith Wheatley contributed to the design of the protocol and was involved in the interpretation of the review.</P>
<P>Natalie Ives contributed to the design of the protocol and was involved in the analysis and interpretation of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-05-07 09:58:18 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-05-07 09:56:02 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-05-07 09:50:28 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Almeida-2012" MODIFIED="2013-01-31 15:09:53 +0000" MODIFIED_BY="[Empty name]" NAME="Almeida 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-01-31 15:09:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20110923&lt;br&gt;IS - 2042-0080 (Electronic)&lt;br&gt;IS - 2042-0080 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Journal Article&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:09:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Almeida QJ, Bhatt H</AU>
<TI>A manipulation of visual feedback during gait training in Parkinson's disease</TI>
<SO>Parkinsons Disease</SO>
<YR>2012</YR>
<PG>508720</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Braun-2011" MODIFIED="2012-12-03 16:07:53 +0000" MODIFIED_BY="[Empty name]" NAME="Braun 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-08-24 14:44:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21402327&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;DC - 20110315&lt;/p&gt;" NOTES_MODIFIED="2012-08-24 14:44:59 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Braun S, Beurskens A, Kleynen M, Schols J, Wade D</AU>
<TI>Rehabilitation with mental practice has similar effects on mobility as rehabilitation with relaxation in people with Parkinson's disease: a multicentre randomised trial</TI>
<SO>Journal of Physiotherapy</SO>
<YR>2011</YR>
<VL>57</VL>
<NO>1</NO>
<PG>27-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Burini-2006" MODIFIED="2012-12-03 16:02:45 +0000" MODIFIED_BY="[Empty name]" NAME="Burini 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-11-30 15:26:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burini D, Farabollini B, Iacucci S, Rimatori C, Riccardi G, Capecci M, et al</AU>
<TI>A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease</TI>
<SO>Europa Medicophysica</SO>
<YR>2006</YR>
<VL>42</VL>
<NO>3</NO>
<PG>231-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chaiwanichsiri-2011" MODIFIED="2012-12-04 10:01:21 +0000" MODIFIED_BY="[Empty name]" NAME="Chaiwanichsiri 2011" YEAR="2009">
<REFERENCE MODIFIED="2012-08-24 14:46:22 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;English&lt;br&gt;Article&lt;br&gt;Chaiwanichsiri, D (reprint author), Chulalongkorn Univ, Fac Med, Dept Rehabil Med, Bangkok 10330, Thailand&lt;br&gt;dootchai@gmail.com&lt;br&gt;27&lt;br&gt;0&lt;br&gt;CHULALONGKORN UNIV, FAC MED&lt;br&gt;BANGKOK&lt;br&gt;CHULALONGKORN UNIV, FAC MED, 1873, RAMA 4, BANGKOK, 10330, THAILAND&lt;br&gt;ASIAN BIOMED&lt;br&gt;OCT&lt;br&gt;Discipline: Research &amp;amp; Experimental Medicine&lt;br&gt;860PQ&lt;/p&gt;" NOTES_MODIFIED="2012-08-24 14:46:22 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chaiwanichsiri D, Wangno W, Kitisomprayoonkul W, Bhidayasiri R</AU>
<TI>Treadmill training with music cueing: a new approach for Parkinson's gait facilitation</TI>
<SO>Asian Biomedicine</SO>
<YR>2011</YR>
<VL>5</VL>
<NO>5</NO>
<PG>649-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-24 14:47:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Chaiwanichsiri D</AU>
<TI>Treadmill and music cueing for gait training in mild to moderate Parkinson's disease</TI>
<SO>clinicaltrials.gov</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dias-2005" MODIFIED="2012-12-04 10:01:05 +0000" MODIFIED_BY="[Empty name]" NAME="Dias 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-12-01 16:26:55 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Article in portuguese, http://www2.pucpr.br/reol/index.php/RFM?dd1=24&lt;/p&gt;" NOTES_MODIFIED="2011-12-01 16:26:55 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dias NP, Fraga DA, Cacho EWA, Oberg TD</AU>
<TI>Training of gait with visual cues in the patient with Parkinson's disease</TI>
<SO>Fisioterapia em Movimento</SO>
<YR>2005</YR>
<VL>18</VL>
<NO>4</NO>
<PG>43-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Diehl-2011" MODIFIED="2014-04-12 14:38:32 +0100" MODIFIED_BY="[Empty name]" NAME="Diehl 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-04-12 14:38:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diehl D, Combs S, Staples B</AU>
<TI>Comparison of boxing training and traditional exercise on balance and quality of life outcomes in persons with Parkinson's disease: a pilot study</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<PG>S124</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ebersbach-2010" MODIFIED="2013-01-31 15:10:24 +0000" MODIFIED_BY="[Empty name]" NAME="Ebersbach 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:10:24 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;SEP 15&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:10:24 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M, Kupsch A, et al</AU>
<TI>Comparing exercise in Parkinson's disease - The Berlin LSVT (R) BIG study</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>12</NO>
<PG>1902-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fisher-2008" MODIFIED="2011-12-07 13:35:21 +0000" MODIFIED_BY="[Empty name]" NAME="Fisher 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-12-07 13:35:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;JUL&lt;/p&gt;" NOTES_MODIFIED="2011-12-07 13:35:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisher BE, Wu AD, Salem GJ, Song J, Lin CH, Yip J, et al</AU>
<TI>The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2008</YR>
<VL>89</VL>
<NO>7</NO>
<PG>1221-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frazzitta-2009" MODIFIED="2011-12-08 09:47:23 +0000" MODIFIED_BY="[Empty name]" NAME="Frazzitta 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-12-08 09:28:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frazzitta G, Maestri R, Uccellini D, Bertotti G, Abelli P</AU>
<TI>Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: A comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1139-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hackney-2007" MODIFIED="2012-12-04 10:16:02 +0000" MODIFIED_BY="[Empty name]" NAME="Hackney 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-12-08 13:27:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackney ME, Kantorovich S, Levin R, Earhart GM</AU>
<TI>Effects of tango on functional mobility in Parkinson's disease: A preliminary study</TI>
<SO>Journal of Neurologic Physical Therapy</SO>
<YR>2007</YR>
<VL>31</VL>
<NO>4</NO>
<PG>173-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hackney-2009" MODIFIED="2012-12-04 10:16:08 +0000" MODIFIED_BY="[Empty name]" NAME="Hackney 2009" YEAR="2008">
<REFERENCE MODIFIED="2011-12-08 15:32:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;0&lt;/p&gt;" NOTES_MODIFIED="2011-12-08 15:32:27 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackney ME, Earhart GM</AU>
<TI>Effects of Dance on Movement Control in Parkinson's Disease: A Comparison of Argentine Tango and American Ballroom</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>6</NO>
<PG>475-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-27 15:39:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hackney ME, Earhart GM</AU>
<TI>Health-related quality of life and alternative forms of exercise in Parkinson disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>9</NO>
<PG>644-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-12-08 15:34:22 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;OCT&lt;/p&gt;" NOTES_MODIFIED="2011-12-08 15:34:22 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackney ME, Earhart GM</AU>
<TI>Tai Chi improves balance and mobility in people with Parkinson disease</TI>
<SO>Gait &amp; Posture</SO>
<YR>2008</YR>
<VL>28</VL>
<NO>3</NO>
<PG>456-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hackney-2010" MODIFIED="2013-01-31 15:12:29 +0000" MODIFIED_BY="[Empty name]" NAME="Hackney 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:12:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackney ME, Earhart GM</AU>
<TI>Effects of dance on gait and balance in Parkinson's disease: A comparison of partnered and nonpartnered dance movement</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2010</YR>
<VL>24</VL>
<NO>4</NO>
<PG>384-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hass-2006" MODIFIED="2013-01-27 10:33:29 +0000" MODIFIED_BY="[Empty name]" NAME="Hass 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-01-27 10:33:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hass CJ, Waddell DE, Wolf SL, Juncos JL, Gregor RJ</AU>
<TI>The influence of tai chi training on locomotor ability in Parkinson's disease</TI>
<SO>American Society of Biomechanics (www.asbweb.org/conferences/2006/pdfs/154.pdf)</SO>
<YR>2006</YR>
<PG>154</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hirsch-1996" MODIFIED="2014-05-07 09:46:02 +0100" MODIFIED_BY="[Empty name]" NAME="Hirsch 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-01-31 15:12:40 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;57&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:12:40 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hirsch MA, Toole T, Maitland CG, Rider RA</AU>
<TI>The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2003</YR>
<VL>84</VL>
<NO>8</NO>
<PG>1109-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:46:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hirsch MA</AU>
<TI>Activity dependent enhancement of balance following strength and balance training</TI>
<SO>PhD Thesis, Florida State University</SO>
<YR>1996</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="UMI Number: 9622856"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joudoux-2011" MODIFIED="2013-01-27 10:41:21 +0000" MODIFIED_BY="[Empty name]" NAME="Joudoux 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-27 10:41:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Embase&lt;br&gt;UI - 70538284&lt;/p&gt;" NOTES_MODIFIED="2013-01-27 10:41:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joudoux S, Santiago T, Hutin E, Bayle N, Gracies JM</AU>
<TI>Randomised controlled single-blind trial comparing two rehabilitation programs in Parkinson's disease at a moderate stage: Methodology</TI>
<SO>Annals of Physical and Rehabilitation Medicine. Conference proceeding</SO>
<YR>2011</YR>
<VL>54</VL>
<PG>e104</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Juncos-2006" MODIFIED="2013-05-15 22:23:49 +0100" MODIFIED_BY="[Empty name]" NAME="Juncos 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-05-15 22:23:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract S43.006&lt;/p&gt;" NOTES_MODIFIED="2013-05-15 22:23:49 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Juncos JL, Haber M, Waddell D, Gregor R, Wohl SL</AU>
<TI>A controlled study of aerobic exercise and Chinese exercise modalities in Parkinson disease</TI>
<SO>Neurology</SO>
<YR>2006</YR>
<VL>66</VL>
<NO>5 Suppl 2</NO>
<PG>A314</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-26 14:45:20 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;NCT00029809&lt;/p&gt;" NOTES_MODIFIED="2012-11-26 14:45:20 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Juncos JL</AU>
<TI>Chinese exercise modalities in Parkinson's disease</TI>
<SO>controlled-trials.com</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khallaf-2011" MODIFIED="2013-01-27 10:43:16 +0000" MODIFIED_BY="[Empty name]" NAME="Khallaf 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-27 10:43:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Embase&lt;br&gt;UI - 70603145&lt;/p&gt;" NOTES_MODIFIED="2013-01-27 10:43:16 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khallaf MES, Fathy H</AU>
<TI>Influence of moderate aerobic exercises on activities of daily living and depression in patients with Parkinson's disease</TI>
<SO>European Journal of Neurology. Conference proceeding</SO>
<YR>2011</YR>
<VL>18</VL>
<PG>439</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2012" MODIFIED="2014-05-07 09:46:14 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-26 15:35:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Li F, Fitzgerald K</AU>
<TI>Postural stability in Parkinson's disease patients after Tai Chi training: A randomised controlled trial</TI>
<SO>WFN XIX World Congress on Parkinson's Disease and Related Disorders</SO>
<YR>2012</YR>
<VL>18</VL>
<PG>s155</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:46:14 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20120209&lt;br&gt;IS - 1533-4406 (Electronic)&lt;br&gt;IS - 0028-4793 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SB - AIM&lt;br&gt;SB - IM&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:46:14 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, et al</AU>
<TI>Tai chi and postural stability in patients with Parkinson's disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>2012</YR>
<VL>366</VL>
<NO>6</NO>
<PG>511-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-26 15:34:29 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CRISP/Report database - ongoing trial&lt;/p&gt;" NOTES_MODIFIED="2012-11-26 15:34:29 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sieber B, Fuzhong L</AU>
<TI>Tai Chi and Parkinson's disease</TI>
<SO>Report Database</SO>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loureiro-2010" MODIFIED="2014-05-07 09:46:31 +0100" MODIFIED_BY="[Empty name]" NAME="Loureiro 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-07 09:46:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Loureiro APC, Stori FR, Chen R, Ribas CG, Loureiro CC</AU>
<TI>Comparative study of conventional physiotherapy and virtual rehabilitation using Wii Fit for improvement of balance in Parkinson's disease patients</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25 Suppl 3</VL>
<PG>S714</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mak-2008" MODIFIED="2014-05-07 09:46:44 +0100" MODIFIED_BY="[Empty name]" NAME="Mak 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-05-07 09:46:44 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 10&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:46:44 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mak MK, Hui-Chan CW</AU>
<TI>Effect of 4-week training with audio-visual cues on sit-to-stand in Parkinsonian patients</TI>
<SO>Movement Disorders</SO>
<YR>2005</YR>
<VL>20 Suppl 10</VL>
<PG>388</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:14:07 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;MAR 15&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:14:07 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mak MKY, Hui-Chan CWY</AU>
<TI>Cued task-specific training is better than exercise in improving sit-to-stand in patients with Parkinson's disease: A randomized controlled trial</TI>
<SO>Movement Disorders</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>4</NO>
<PG>501-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-McGinley-2012" MODIFIED="2013-05-15 22:23:27 +0100" MODIFIED_BY="[Empty name]" NAME="McGinley 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-15 22:23:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Embase&lt;br&gt;UI - 2012021790&lt;/p&gt;" NOTES_MODIFIED="2013-05-15 22:23:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McGinley JL, Martin C, Huxham FE, Menz HB, Danoudis M, Murphy AT, et al</AU>
<TI>Feasibility, safety, and compliance in a randomized controlled trial of physical therapy for Parkinson's disease</TI>
<SO>Parkinson's Disease</SO>
<YR>2012</YR>
<PG>795294</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-27 10:37:57 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21801451&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;DC - 20110825&lt;/p&gt;" NOTES_MODIFIED="2013-01-27 10:37:57 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morris ME, Menz HB, McGinley JL, Huxham FE, Murphy AT, Iansek R, et al</AU>
<TI>Falls and mobility in Parkinson's disease: protocol for a randomised controlled clinical trial</TI>
<SO>BMC Neurology</SO>
<YR>2011</YR>
<VL>11</VL>
<PG>93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-06 17:06:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watts JJ, McGinley JL, Huxham F, Menz HB, Iansek R, Murphy AT, et al</AU>
<TI>Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial</TI>
<SO>BMC Geriatrics</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Miyai-2000" MODIFIED="2012-12-04 10:46:39 +0000" MODIFIED_BY="[Empty name]" NAME="Miyai 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-12-20 10:05:00 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;57&lt;/p&gt;" NOTES_MODIFIED="2011-12-20 10:05:00 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyai I, Fujimoto Y, Ueda Y, Yamamoto H, Nozaki S, Saito T, et al</AU>
<TI>Treadmill training with body weight support: Its effect on Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2000</YR>
<VL>81</VL>
<NO>7</NO>
<PG>849-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Miyai-2002" MODIFIED="2012-12-04 10:46:48 +0000" MODIFIED_BY="[Empty name]" NAME="Miyai 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-12-20 10:05:11 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;OCT&lt;/p&gt;" NOTES_MODIFIED="2011-12-20 10:05:11 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyai I, Fujimoto Y, Yamamoto H, Ueda Y, Saito T, Nozaki S, et al</AU>
<TI>Long-term effect of body weight-supported treadmill training in Parkinson's disease: A randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2002</YR>
<VL>83</VL>
<NO>10</NO>
<PG>1370-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morris-2009" MODIFIED="2014-05-07 09:47:13 +0100" MODIFIED_BY="[Empty name]" NAME="Morris 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:47:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 1&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:47:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin CL, Morris ME, Iansek R</AU>
<TI>Carry-over effects of inpatient rehabilitation in Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2008</YR>
<VL>23 Suppl 1</VL>
<PG>675</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:47:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morris ME, Iansek R, Kirkwood B, Danoudis M, Martin CL</AU>
<TI>Carry-over effects of movement strategy training in Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S270</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:16:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;JAN 15&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:16:31 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Morris ME, Iansek R, Kirkwood B</AU>
<TI>A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>1</NO>
<PG>64-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-12-21 12:08:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 15&lt;/p&gt;" NOTES_MODIFIED="2011-12-21 12:08:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morris ME, Iansek R</AU>
<TI>Effects of strategy training compared to exercises for gait rehabilitation in Parkinson disease: A randomized controlled trial</TI>
<SO>Movement Disorders</SO>
<YR>2006</YR>
<VL>21</VL>
<PG>688</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:16:03 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Letter - Link with Morris ME; Ref ID:72 (Mov Dis 2009,24:64-71)&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:16:03 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schenkman M</AU>
<TI>Reply: A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>4</NO>
<PG>524</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Palmer-1986" MODIFIED="2013-01-31 15:17:21 +0000" MODIFIED_BY="[Empty name]" NAME="Palmer 1986" YEAR="1984">
<REFERENCE MODIFIED="2013-01-31 15:17:05 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:17:05 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Palmer SS, Mortimer JA, Webster DD, Bistevins R, Dickinson GL</AU>
<TI>Comparison of stretch exercises and karate training as therapy for Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1984</YR>
<VL>65</VL>
<NO>10</NO>
<PG>626</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:17:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;OCT&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:17:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Palmer SS, Mortimer JA, Webster DD, Bistevins R, Dickinson GL</AU>
<TI>Exercise therapy for Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1986</YR>
<VL>67</VL>
<NO>10</NO>
<PG>741-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pelosin-2010" MODIFIED="2013-01-31 15:17:53 +0000" MODIFIED_BY="[Empty name]" NAME="Pelosin 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:17:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;OCT&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:17:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pelosin E, Avanzino L, Bove M, Stramesi P, Nieuwboer A, Abbruzzese G</AU>
<TI>Action observation improves freezing of gait in patients with Parkinson's disease</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2010</YR>
<VL>24</VL>
<NO>8</NO>
<PG>746-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Picelli-2012" MODIFIED="2014-05-07 09:47:29 +0100" MODIFIED_BY="[Empty name]" NAME="Picelli 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 09:47:29 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20120119&lt;br&gt;IS - 1552-6844 (Electronic)&lt;br&gt;IS - 1545-9683 (Linking)&lt;br&gt;LA - ENG&lt;br&gt;PT - JOURNAL ARTICLE&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:47:29 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Picelli A, Melotti C, Origano F, Waldner A, Fiaschi A, Santilli V, et al</AU>
<TI>Robot-assisted gait training in patients with Parkinson's disease: A randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>4</NO>
<PG>353-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Poliakoff-2009" MODIFIED="2014-05-07 09:47:40 +0100" MODIFIED_BY="[Empty name]" NAME="Poliakoff 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:47:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poliakoff E, Galpin A, McDonald K, Dick J, Kellett M, Hayes S, et al</AU>
<TI>The effect of gym training on multiple outcomes in Parkinson's disease: A pilot randomised waiting-list controlled trial</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S374</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reuter-2011" MODIFIED="2014-05-07 09:47:49 +0100" MODIFIED_BY="[Empty name]" NAME="Reuter 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-07 09:47:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20110523&lt;br&gt;IS - 2090-2212 (Electronic)&lt;br&gt;IS - 2090-2204 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Journal Article&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:47:49 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reuter I, Mehnert S, Leone P, Kaps M, Oechsner M, Engelhardt M</AU>
<TI>Effects of a flexibility and relaxation programme, walking, and nordic walking on Parkinson's disease</TI>
<SO>Journal of Aging Research</SO>
<YR>2011</YR>
<VL>2011</VL>
<PG>232473</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ridgel-2009" MODIFIED="2013-01-31 15:19:01 +0000" MODIFIED_BY="[Empty name]" NAME="Ridgel 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-01-31 15:19:01 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;JUL&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:19:01 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ridgel AL, Vitek JL, Alberts JL</AU>
<TI>Forced, not voluntary, exercise improves motor function in Parkinson's disease patients</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>6</NO>
<PG>600-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Robichaud-2012" MODIFIED="2014-05-07 09:48:11 +0100" MODIFIED_BY="[Empty name]" NAME="Robichaud 2012" YEAR="2009">
<REFERENCE MODIFIED="2012-10-12 10:13:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Chen D, Corcos DM</AU>
<TI>Motor deficits - Experimental and clinical correlates</TI>
<SO>Report Database</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-27 10:30:52 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract S02.003&lt;/p&gt;" NOTES_MODIFIED="2013-01-27 10:30:52 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corcos D, Robichaud JA, David FJ, Vaillancourt DE, Poon C, Rafferty M, et al</AU>
<TI>24 months of exercise improves the motor symptoms in Parkinson's disease</TI>
<SO>Neurology</SO>
<YR>2012</YR>
<VL>78</VL>
<PG>S02.003</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:48:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract 422&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:48:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rafferty MR, Robichaud JA, David FJ, Poon C, Vaillancourt DE, Comella CL, et al</AU>
<TI>Long-term exercise improves and maintains physical function in people with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2012</YR>
<VL>27 Suppl 1</VL>
<PG>S135</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-23 11:20:28 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Start date: October 2007&lt;/p&gt;" NOTES_MODIFIED="2012-11-23 11:20:28 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Robichaud JA, Corcos D</AU>
<TI>The effect of exercise on individuals with Parkinson's disease</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-23 11:17:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Start date: October 2007&lt;/p&gt;" NOTES_MODIFIED="2012-11-23 11:17:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Robichaud JA, Corcos D</AU>
<TI>The effect of exercise on individuals with Parkinson's disease</TI>
<SO>controlled-trials.gov</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:48:11 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract 425&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:48:11 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Robichaud JA, David FJ, Poon C, Rafferty M, Vaillancourt DE, Comella CL, et al</AU>
<TI>Long-term progressive exercise improves bradykinesia and muscle weakness</TI>
<SO>Movement Disorders</SO>
<YR>2012</YR>
<VL>27 Suppl 1</VL>
<PG>S136</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schenkman-2012a" MODIFIED="2013-01-31 15:21:54 +0000" MODIFIED_BY="[Empty name]" NAME="Schenkman 2012a" YEAR="2012">
<REFERENCE MODIFIED="2013-01-31 15:21:54 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22822237&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Phys Ther. 92(11):1395-410, 2012 Nov&lt;br&gt;JC - 0022623, p6w&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20121105&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:21:54 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schenkman M, Hall DA, Baron AE, Schwartz RS, Mettler P, Kohrt WM</AU>
<TI>Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial</TI>
<SO>Physical Therapy</SO>
<YR>2012</YR>
<VL>92</VL>
<NO>11</NO>
<PG>1395-410</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-23 10:15:47 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Start date: 11.04.03 End date: 31.03.11&lt;/p&gt;" NOTES_MODIFIED="2012-11-23 10:15:47 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Schenkman M, Shinowara N</AU>
<TI>Exercise, physical function and Parkinson's disease</TI>
<SO>Report Database</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-27 15:01:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Shinowara N</AU>
<TI>Gait and step training to prevent fall in Parkinson's disease</TI>
<SO>Report Database</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shankar-2009" MODIFIED="2014-05-07 09:48:22 +0100" MODIFIED_BY="[Empty name]" NAME="Shankar 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:48:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shankar A, Labelle N, Derwent L, Bonfield S, Eliasziw M, Hu B, et al</AU>
<TI>Treadmill-walking with music shows a synergistic improvement in gait and balance in patients with Parkinson's disease: A randomized controlled trial</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S281-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Shen-2011" MODIFIED="2012-12-04 10:48:38 +0000" MODIFIED_BY="[Empty name]" NAME="Shen 2011" YEAR="2010">
<REFERENCE MODIFIED="2012-11-23 14:33:20 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Accession Number: 2011351648. Language: English. Entry Date: 20120127. Revision Date: 20120127. Publication Type: journal article; abstract; randomized controlled trial; research. Journal Subset: Allied Health; Asia; Double Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed. Special Interest: Physical Therapy. Instrumentation: Limit of Stability Test; One Leg Stance (OLS); Activities Specific Balance Confidence (ABC) Scale. NLM UID: 100908968&lt;/p&gt;" NOTES_MODIFIED="2012-11-23 14:33:20 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Shen X, Mak MKY</AU>
<TI>Effects of 12-week strategy-focused balance training on balance performance and balance confidence in patients with Parkinson's disease</TI>
<SO>Hong Kong Physiotherapy Journal</SO>
<YR>2011</YR>
<VL>29</VL>
<NO>2</NO>
<PG>100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shiba-1999" MODIFIED="2014-05-07 09:48:34 +0100" MODIFIED_BY="[Empty name]" NAME="Shiba 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-05-07 09:48:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Shiba Y, Obuchi S, Toshima H, Yamakita H</AU>
<TI>Comparison between visual and auditory stimulation in gait training of patients with idiopathic Parkinson's disease</TI>
<SO>World Congress of Physical Therapy Conference</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sigurgeirsson-2009" MODIFIED="2014-05-07 09:48:44 +0100" MODIFIED_BY="[Empty name]" NAME="Sigurgeirsson 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:48:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sigurgeirsson AT, Bjarnadottir OH, Thorsteinsdottir MH, Ingvarsson PE</AU>
<TI>The effect of high-volume walking with visual cues on gait in Parkinson's patients. A randomised controlled trial</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2009</YR>
<VL>15 Suppl 2</VL>
<PG>S192</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smania-2010" MODIFIED="2013-01-31 15:22:37 +0000" MODIFIED_BY="[Empty name]" NAME="Smania 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:22:37 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;NOV-DEC&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:22:37 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smania N, Corato E, Tinazzi M, Stanzani C, Fiaschi A, Girardi P, et al</AU>
<TI>Effect of balance training on postural instability in patients with idiopathic Parkinson's disease</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2010</YR>
<VL>24</VL>
<NO>9</NO>
<PG>826-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Talakkad-2011" MODIFIED="2014-05-07 09:50:03 +0100" MODIFIED_BY="[Empty name]" NAME="Talakkad 2011" YEAR="">
<REFERENCE MODIFIED="2014-05-07 09:49:52 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Embase&lt;br&gt;UI - 70608961&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:49:52 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gupta A, Ganesan M, Pal P, Talakkad S</AU>
<TI>Effect of partial weight-supported treadmill gait training on balance in patients with Parkinson disease</TI>
<SO>2011 Annual Assembly of the American Academy of Physical Medicine and Rehabilitation</SO>
<YR>2011</YR>
<VL>3</VL>
<NO>10</NO>
<PG>S163-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:50:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Talakkad S, Ganesan M, Gupta A, Pal PK, Trichur R</AU>
<TI>Effect of partial weight supported treadmill gait training on cardiovascular dynamics in patients with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26 Suppl 2</VL>
<PG>s173</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Thaut-1996" MODIFIED="2014-05-07 09:50:15 +0100" MODIFIED_BY="[Empty name]" NAME="Thaut 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-05-07 09:50:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Thaut MH, McIntosh GC, Rice RR, Miller RA, Rathbun J, Brault JM</AU>
<TI>Rhythmic auditory stimulation in gait training for Parkinson's disease patients</TI>
<SO>Movement Disorders</SO>
<YR>1996</YR>
<VL>11</VL>
<NO>2</NO>
<PG>193-200</PG>
<IDENTIFIERS MODIFIED="2013-01-31 15:23:16 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toole-2005" MODIFIED="2014-05-07 09:50:28 +0100" MODIFIED_BY="[Empty name]" NAME="Toole 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-01-24 11:39:54 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract 35&lt;/p&gt;" NOTES_MODIFIED="2012-01-24 11:39:54 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maitland CG, Toole T, Warren E, Hubmann MF</AU>
<TI>The effects of loading and unloading on gait and balance control in Parkinsonism</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2004</YR>
<VL>85</VL>
<PG>E13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:50:28 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:50:28 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Toole T, Maitland CG, Warren E, Hubmann MF, Panton L</AU>
<TI>The effects of loading and unloading treadmill walking on balance, gait, fall risk, and daily function in Parkinsonism</TI>
<SO>NeuroRehabilitation</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>4</NO>
<PG>307-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vivas-2011" MODIFIED="2012-08-24 14:39:42 +0100" MODIFIED_BY="[Empty name]" NAME="Vivas 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-08-24 14:39:42 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21807139&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;DC - 20110802&lt;/p&gt;" NOTES_MODIFIED="2012-08-24 14:39:42 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vivas J, Arias P, Cudeiro J</AU>
<TI>Aquatic therapy versus conventional land-based therapy for Parkinson's disease: an open-label pilot study</TI>
<SO>Archives of Physical Medicine &amp; Rehabilitation</SO>
<YR>2011</YR>
<VL>92</VL>
<NO>8</NO>
<PG>1202-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Werner-2010" MODIFIED="2012-12-04 10:56:43 +0000" MODIFIED_BY="[Empty name]" NAME="Werner 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-08 10:43:38 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;English&lt;br&gt;Article&lt;br&gt;Werner, WG (reprint author), New York Inst Technol, Dept Phys Therapy, POB 8000, Old Westbury, NY 11568 USA&lt;br&gt;wwerner@nyit.edu&lt;br&gt;27&lt;br&gt;3&lt;br&gt;SPRINGER HEIDELBERG&lt;br&gt;HEIDELBERG&lt;br&gt;TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY&lt;br&gt;J NEUROL&lt;br&gt;NOV&lt;br&gt;Discipline: Neurosciences &amp;amp; Neurology&lt;br&gt;690CO&lt;/p&gt;" NOTES_MODIFIED="2012-11-08 10:43:38 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Werner WG, Gentile AM</AU>
<TI>Improving gait and promoting retention in individuals with Parkinson's disease: a pilot study</TI>
<SO>Journal of Neurology</SO>
<YR>2010</YR>
<VL>257</VL>
<NO>11</NO>
<PG>1841-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2010" MODIFIED="2013-01-31 15:24:07 +0000" MODIFIED_BY="[Empty name]" NAME="Yang 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:24:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang YR, Lee YY, Cheng SJ, Wang RY</AU>
<TI>Downhill walking training in individuals with Parkinson's disease: A randomized controlled trial</TI>
<SO>American Journal of Physical Medicine &amp; Rehabilitation</SO>
<YR>2010</YR>
<VL>89</VL>
<NO>9</NO>
<PG>706-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-05-07 09:55:01 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Byl-2009" MODIFIED="2014-05-07 09:50:41 +0100" MODIFIED_BY="[Empty name]" NAME="Byl 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:50:41 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract No. P2.121&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:50:41 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Byl N</AU>
<TI>Enhancing safe mobility in patients with Parkinson's disease: effect of dual task training during aerobic and moderate exercise</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2009</YR>
<VL>15 Suppl 2</VL>
<PG>S122</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheon-2012" MODIFIED="2014-04-12 14:55:15 +0100" MODIFIED_BY="[Empty name]" NAME="Cheon 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-04-12 14:55:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheon SM, Sung HR, Chae BK, Kim JW</AU>
<TI>Effects of different exercises in the patients with Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2012</YR>
<VL>18</VL>
<PG>s154</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chouza-2011" MODIFIED="2014-05-07 09:50:53 +0100" MODIFIED_BY="[Empty name]" NAME="Chouza 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-07 09:50:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chouza M, Arias P, Vinas S, Cudeiro J</AU>
<TI>Acute effects of whole-body vibration at 3, 6, and 9 hz on balance and gait in patients with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<PG>920-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cianci-2010" MODIFIED="2014-05-07 09:51:09 +0100" MODIFIED_BY="[Empty name]" NAME="Cianci 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-07 09:51:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Cianci H, Robinson K, Bunting-Perry L, Sollenberger J, Nooregian J, Duda J</AU>
<TI>Are wheeled walkers with visual cues efficacious to treat freezing of gait in Parkinson's disease?</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2010</YR>
<VL>16 Suppl 1</VL>
<PG>S64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Donovan-2011" MODIFIED="2012-10-24 11:18:43 +0100" MODIFIED_BY="[Empty name]" NAME="Donovan 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-10-24 11:18:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;English&lt;br&gt;Article&lt;br&gt;Simon, DK (reprint author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS-638, Boston, MA 02215 USA&lt;br&gt;donovask@gmail.com chen.lim@gmail.com NDiaz2@neuro.columbia.edu brownern@neurology.unc.edu peggy@peggyrose.com LSudarsky@partners.org dtarsy@bidmc.harvard.edu fahn@neuro.columbia.edu dsimon1@bidmc.harvard.edu&lt;br&gt;24&lt;br&gt;1&lt;br&gt;ELSEVIER SCI LTD&lt;br&gt;OXFORD&lt;br&gt;THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND&lt;br&gt;PARKINSONISM RELAT D&lt;br&gt;MAY&lt;br&gt;Discipline: Neurosciences &amp;amp; Neurology&lt;br&gt;770FV&lt;/p&gt;" NOTES_MODIFIED="2012-10-24 11:18:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donovan S, Lim C, Diaz N, Browner N, Rose P, Sudarsky LR, et al</AU>
<TI>Laserlight cues for gait freezing in Parkinson's disease: An open-label study</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2011</YR>
<VL>17</VL>
<NO>4</NO>
<PG>240-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farley-2005" MODIFIED="2014-05-07 09:51:19 +0100" MODIFIED_BY="[Empty name]" NAME="Farley 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-05-07 09:51:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 10&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:51:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farley BG, Koshland GF</AU>
<TI>Learning Big (TM): Efficacy of a large-amplitude exercise approach for patients with Parkinson's disease-bradykinesia to balance</TI>
<SO>Movement Disorders</SO>
<YR>2005</YR>
<VL>20 Suppl 10</VL>
<PG>466</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Filippin-2010" MODIFIED="2012-10-24 09:26:46 +0100" MODIFIED_BY="[Empty name]" NAME="Filippin 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-10-24 09:26:46 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;JUL-AUG&lt;/p&gt;" NOTES_MODIFIED="2012-10-24 09:26:46 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Filippin NT, da Costa PHL, Mattioli R</AU>
<TI>Effects of treadmill-walking training with additional body load on quality of life in subjects with Parkinson's disease</TI>
<SO>Revista Brasileira de Fisioterapia</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>4</NO>
<PG>344-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frazzitta-2012" MODIFIED="2014-05-07 09:51:29 +0100" MODIFIED_BY="[Empty name]" NAME="Frazzitta 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-04-12 14:56:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, et al</AU>
<TI>A new approach to rehabilitation of Parkinsonian patients: The intensive rehabilitation treatment</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<PG>s127</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:51:29 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20120119&lt;br&gt;IS - 1552-6844 (Electronic)&lt;br&gt;IS - 1545-9683 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Journal Article&lt;br&gt;SB - IM&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:51:29 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, et al</AU>
<TI>Effectiveness of intensive inpatient rehabilitation treatment on disease progression in Parkinsonian patients: A randomized controlled trial with 1-year follow-up</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>2</NO>
<PG>144-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gobbi-2009" MODIFIED="2014-05-07 09:52:20 +0100" MODIFIED_BY="[Empty name]" NAME="Gobbi 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:51:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gobbi L, Oliveira-Ferreira M, Aetano MJ, irani-Silva E, Arbieri F, Tella F, et al</AU>
<TI>Exercise programs improve mobility and balance in people with Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2009</YR>
<VL>15 Suppl 2</VL>
<PG>S6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:52:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gobbi LTB, Oliveira-Ferreira MDT, Caetano MJD, Lirani-Silva E, Barbieri FA, Stella F, et al</AU>
<TI>Exercise programs improve mobility and balance in people with Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2009</YR>
<VL>15 Suppl 3</VL>
<PG>S49-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haase-2011" MODIFIED="2013-01-31 14:15:42 +0000" MODIFIED_BY="[Empty name]" NAME="Haase 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 14:15:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Haase M</AU>
<TI>The immediate effects of rhythmic arm swing and finger tapping exercises on gait of Parkinson's patients</TI>
<SO>ProQuest</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamsma-1995" MODIFIED="2013-05-15 22:22:02 +0100" MODIFIED_BY="[Empty name]" NAME="Kamsma 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-05-15 22:22:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamsma YPT, Brouwer WH, Lakke JPWF</AU>
<TI>Training of compensational strategies for impaired gross motor skills in Parkinson' disease</TI>
<SO>Physiotherapy Theory and Practice</SO>
<YR>1995</YR>
<VL>11</VL>
<NO>4</NO>
<PG>209-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klassen-2007" MODIFIED="2014-05-07 09:52:32 +0100" MODIFIED_BY="[Empty name]" NAME="Klassen 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-05-07 09:52:32 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract 2778&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:52:32 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klassen L, Dal Bello-Haas V, Sheppard M, Metcalfe A</AU>
<TI>Evaluating the benefits of group exercise and group exercise and education programs for individuals with Parksinson's disease (PD)</TI>
<SO>Physiotherapy</SO>
<YR>2007</YR>
<VL>93 Suppl 1</VL>
<PG>S91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knobl-2011" MODIFIED="2014-05-07 09:52:41 +0100" MODIFIED_BY="[Empty name]" NAME="Knobl 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-07 09:52:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Knobl PE, Almeida QJ</AU>
<TI>Rehabilitation for Parkinson's disease: Is it the sensory or attention focus that improves disease severity in sensory-attention focused interventions?</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26 Suppl 2</VL>
<PG>s153</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-24 11:14:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Knobl PE</AU>
<TI>An evaluation of motor imagery and exercise interventions in Parkinson's disease</TI>
<SO>ProQuest</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2011" MODIFIED="2012-09-26 14:19:31 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-09-26 14:19:31 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21389845&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;DC - 20110718&lt;/p&gt;" NOTES_MODIFIED="2012-09-26 14:19:31 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee KS, Lee WH, Hwang S</AU>
<TI>Modified constraint-induced movement therapy improves fine and gross motor performance of the upper limb in Parkinson disease</TI>
<SO>American Journal of Physical Medicine &amp; Rehabilitation</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>5</NO>
<PG>380-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2009" MODIFIED="2012-10-24 09:50:35 +0100" MODIFIED_BY="[Empty name]" NAME="Ma 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-10-24 09:50:35 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;MAR&lt;/p&gt;" NOTES_MODIFIED="2012-10-24 09:50:35 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ma HI, Hwang WJ, Lin KC</AU>
<TI>The effects of two different auditory stimuli on functional arm movement in persons with Parkinson's disease: a dual-task paradigm</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>3</NO>
<PG>229-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marchese-2000" MODIFIED="2014-05-07 09:53:11 +0100" MODIFIED_BY="[Empty name]" NAME="Marchese 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-05-07 09:52:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abbruzzese G, Diverio M, Zucchi F, Marchese R</AU>
<TI>Comparison of two physical therapy approaches in the rehabilitation of parkinsonian patients</TI>
<SO>Parkinsonism and Related Disorders</SO>
<YR>1999</YR>
<VL>5 Suppl</VL>
<PG>S49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:53:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marchese R, Diverio M, Zucchi F, Lentino C, Abbruzzese G</AU>
<TI>Comparison of two physical therapy approaches in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols</TI>
<SO>Movement Disorders</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>5</NO>
<PG>879-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Modugno-2010" MODIFIED="2014-05-07 09:53:42 +0100" MODIFIED_BY="[Empty name]" NAME="Modugno 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:27:49 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:27:49 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Modugno N, Iaconelli S, Fiorilli M, Lena F, Kusch I, Mirabella G</AU>
<TI>Active theater as a complementary therapy for Parkinson's disease rehabilitation: A pilot study</TI>
<SO>The Scientific World Journal</SO>
<YR>2010</YR>
<VL>10</VL>
<PG>2301-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:53:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Modugno N</AU>
<TI>Long-term program of social theatre for the management of motor and motor symptoms of Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25 Suppl 3</VL>
<PG>S721</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Munneke-2010" MODIFIED="2014-05-07 09:54:05 +0100" MODIFIED_BY="[Empty name]" NAME="Munneke 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-26 14:19:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 13&lt;/p&gt;" NOTES_MODIFIED="2012-09-26 14:19:59 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keus SH, Bloem BR, Nijkrake M, Lim LI, Munneke M</AU>
<TI>The ParkNet trial: Implementation of an evidence-based guideline for physical therapy in Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2006</YR>
<VL>21</VL>
<PG>S122</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:28:25 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ParkinsonNet Trial&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:28:25 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keus SHJ, Nijkrake MJ, Borm GF, Kwakkel G, Roos RAC, Berendse HW, et al</AU>
<TI>The ParkinsonNet trial: design and baseline characteristics</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>7</NO>
<PG>830-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:53:53 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 1&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:53:53 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munneke M, Kens S, Nijkrake M, Kwakkel G, Berendse H, Roos R, et al</AU>
<TI>Efficiency of evidence-based physiotherapy for Parkinson's disease: the ParkinsonNet Trial</TI>
<SO>Movement Disorders</SO>
<YR>2008</YR>
<VL>23 Suppl 1</VL>
<PG>669</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-26 14:19:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Published online December 2, 2009&lt;/p&gt;" NOTES_MODIFIED="2012-09-26 14:19:59 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Munneke M, Nijkrake M, Keus SHJ, Kwakkel G, Berendse HW, Roos RAC, et al</AU>
<TI>Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial</TI>
<SO>Lancet Neurology</SO>
<YR>2010</YR>
<VL>9</VL>
<NO>1</NO>
<PG>46-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:54:05 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;C&lt;br&gt;Suppl. 16&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:54:05 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munneke M, Nijkrake MJ, Keus SHJ, Lim IIK, Borm GF, van der Wilt GJ, et al</AU>
<TI>Efficiency of physiotherapy in Parkinson's disease: The ParkNet trial</TI>
<SO>Movement Disorders</SO>
<YR>2007</YR>
<VL>22 Suppl 16</VL>
<PG>629</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:28:49 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ParkinsonNet Trial&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:28:49 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nijkrake MJ, Keus SHJ, Overeem S, Oostendorp RAB, Vlieland TPMV, Mulleners W, et al</AU>
<TI>The ParkinsonNet concept: development, implementation and initial experience</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>7</NO>
<PG>823-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pacchetti-2000" MODIFIED="2012-09-26 14:21:48 +0100" MODIFIED_BY="[Empty name]" NAME="Pacchetti 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-26 14:21:48 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;MAY-JUN&lt;/p&gt;" NOTES_MODIFIED="2012-09-26 14:21:48 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G</AU>
<TI>Active music therapy in Parkinson's disease: An integrative method for motor and emotional rehabilitation</TI>
<SO>Psychosomatic Medicine</SO>
<YR>2000</YR>
<VL>62</VL>
<NO>3</NO>
<PG>386-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pohl-2003" MODIFIED="2012-10-24 10:00:30 +0100" MODIFIED_BY="[Empty name]" NAME="Pohl 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-10-24 10:00:30 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;25&lt;/p&gt;" NOTES_MODIFIED="2012-10-24 10:00:30 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pohl M, Rockstroh G, Ruckriem S, Mrass G, Mehrholz J</AU>
<TI>Immediate effects of speed-dependent treadmill training on gait parameters in early Parkinson's disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2003</YR>
<VL>84</VL>
<NO>12</NO>
<PG>1760-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rochester-2011" MODIFIED="2012-10-24 11:14:54 +0100" MODIFIED_BY="[Empty name]" NAME="Rochester 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-10-24 11:14:54 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21462258&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;DC - 20110404&lt;/p&gt;" NOTES_MODIFIED="2012-10-24 11:14:54 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rochester L, Baker K, Nieuwboer A, Burn D</AU>
<TI>Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>3</NO>
<PG>430-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sage-2009a" MODIFIED="2012-10-24 10:02:09 +0100" MODIFIED_BY="[Empty name]" NAME="Sage 2009a" YEAR="2009">
<REFERENCE MODIFIED="2012-10-10 13:37:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sage MD, Almeida QJ</AU>
<TI>Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1132-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Sage-2009b" MODIFIED="2014-05-07 09:54:19 +0100" MODIFIED_BY="[Empty name]" NAME="Sage 2009b" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:54:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sage MD, Almeida QJ</AU>
<TI>A Canadian approach to exercise rehabilitation: a systematic evaluation of strategies to reduce the symptoms of Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S276-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sage-2010" MODIFIED="2014-05-07 09:54:29 +0100" MODIFIED_BY="[Empty name]" NAME="Sage 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-07 09:54:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sage MD, Almeida QJ</AU>
<TI>A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>1</NO>
<PG>64-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stallibrass-2001" MODIFIED="2014-05-07 09:54:43 +0100" MODIFIED_BY="[Empty name]" NAME="Stallibrass 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-05-07 09:54:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Stallibrass C</AU>
<TI>Controlled trial to evaluate the effects of lessons in the Alexander Technique on the management of disability by people with Parkinson's disease</TI>
<SO>National Research Register</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tamir-2007" MODIFIED="2012-10-03 15:24:02 +0100" MODIFIED_BY="[Empty name]" NAME="Tamir 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-10-03 15:24:02 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;JAN-FEB&lt;/p&gt;" NOTES_MODIFIED="2012-10-03 15:24:02 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tamir R, Dickstein R, Huberman M</AU>
<TI>Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>1</NO>
<PG>68-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tickle_x002d_Degnen-2010" MODIFIED="2014-05-07 09:54:51 +0100" MODIFIED_BY="[Empty name]" NAME="Tickle-Degnen 2010" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 09:54:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tickle-Degnen L, Ellis T, Saint-Hilaire M, Thomas CA, Wagenaar RC</AU>
<TI>Efficacy of self-management rehabilitation on quality of life outcomes in Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S377-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-24 10:07:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tickle-Degnen L, Ellis T, Saint-Hilaire M, Thomas CA, Wagenaar RC</AU>
<TI>Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>2</NO>
<PG>194-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-24 10:07:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White DK, Wagenaar RC, Ellis TD, Tickle-Degnen L</AU>
<TI>Changes in walking activity and endurance following rehabilitation for people with Parkinson disease</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2009</YR>
<VL>90</VL>
<NO>1</NO>
<PG>43-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wulf-2009" MODIFIED="2013-01-31 15:29:54 +0000" MODIFIED_BY="[Empty name]" NAME="Wulf 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-01-31 15:29:54 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;FEB&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:29:54 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wulf G, Landers M, Lewthwaite R, Tollner T</AU>
<TI>External focus instructions reduce postural instability in individuals with Parkinson's disease</TI>
<SO>Physical Therapy</SO>
<YR>2009</YR>
<VL>89</VL>
<NO>2</NO>
<PG>162-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yen-2011" MODIFIED="2014-05-07 09:55:01 +0100" MODIFIED_BY="[Empty name]" NAME="Yen 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-07 09:55:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Accession Number: 2011184109. Language: English. Entry Date: 20110722. Revision Date: 20120106. Publication Type: journal article; pictorial; randomized controlled trial; research; tables/charts. Journal Subset: Allied Health; Peer Reviewed; USA. Special Interest: Physical Therapy. Instrumentation: Mini-Mental Status Examination (MMSE) (Folstein et al); Sensory Organization Test (SOT); Hoehn and Yahr Scale; Unified Parkinson Disease Rating Scale (UPDRS). Grant Information: The study was partly supported by the National Science Council, Taipei, Taiwan (NSC 97-2314-B-002-009-MY3).. NLM UID: 0022623&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:55:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yen CY, Lin KH, Hu MH, Wu RM, Lu TW, Lin CH, et al</AU>
<TI>Effects of virtual reality-augmented balance training on sensory organization and attentional demand for postural control in people with Parkinson disease: a randomized controlled trial</TI>
<SO>Physical Therapy</SO>
<YR>2011</YR>
<VL>91</VL>
<NO>6</NO>
<PG>862-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES MODIFIED="2014-05-07 09:56:02 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Brauer-2011" MODIFIED="2013-01-31 14:20:35 +0000" MODIFIED_BY="[Empty name]" NAME="Brauer 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 14:20:35 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21791117&lt;br&gt;ST - MEDLINE&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;DC - 20110815&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 14:20:35 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brauer SG, Woollacott MH, Lamont R, Clewett S, O'Sullivan J, Silburn P, et al</AU>
<TI>Single and dual task gait training in people with Parkinson's disease: a protocol for a randomised controlled trial</TI>
<SO>BMC Neurology</SO>
<YR>2011</YR>
<VL>11</VL>
<PG>90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Protas-2005" MODIFIED="2014-05-07 09:55:13 +0100" MODIFIED_BY="[Empty name]" NAME="Protas 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-05-07 09:55:13 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:55:13 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC</AU>
<TI>Gait and step training to reduce falls in Parkinson's disease</TI>
<SO>NeuroRehabilitation</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>3</NO>
<PG>183-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schenkman-2012b" MODIFIED="2013-01-31 15:00:30 +0000" MODIFIED_BY="[Empty name]" NAME="Schenkman 2012b" YEAR="2012">
<REFERENCE MODIFIED="2013-01-31 15:00:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;controlled_trials.com&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:00:27 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Schenkman M</AU>
<TI>Endurance exercise in Parkinson's disease</TI>
<SO>controlled_trials.com</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 15:00:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Schenkman M</AU>
<TI>Study in Parkinson's disease of exercise (SPARX)</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2009" MODIFIED="2013-01-31 15:33:32 +0000" MODIFIED_BY="[Empty name]" NAME="Smith 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-01-31 15:33:32 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Start date: August 2007&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:33:32 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Smith S, Dibble L</AU>
<TI>High force resistance training and dopamine replacement effects on hypokinesia in Parkinson disease</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uc-2010" MODIFIED="2013-01-31 15:33:42 +0000" MODIFIED_BY="[Empty name]" NAME="Uc 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 15:33:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Start date: Feb 2009&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 15:33:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Uc EY, Newman SR</AU>
<TI>Effects of aerobic exercise in Parkinson's disease</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-van-Nimwegen-2010" MODIFIED="2014-05-07 09:56:02 +0100" MODIFIED_BY="[Empty name]" NAME="van Nimwegen 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-07 09:55:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Speelman AD, van Nimwegan M, Smulders K, Overeem S, Borm G, Backx F, et al</AU>
<TI>Rationale and design of the Parkfit study: a randomized controlled trial to increase physical activity in patients with Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2010</YR>
<VL>16 Suppl 1</VL>
<PG>S58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:55:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Speelman AD, van Nimwegen ML, Smulders K, Overeem S, Borm GF, Backx FJG, et al</AU>
<TI>Design of a randomized controlled trial evaluating the effectiveness of a multifaceted program to increase physical activity in Parkinson patients</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25 Suppl 3</VL>
<PG>S679</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:55:51 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Abstract Th-194&lt;/p&gt;" NOTES_MODIFIED="2014-05-07 09:55:51 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Nimwegen M, Speelman A, Smulders S, Overeem S, Borm G, Backx F, et al</AU>
<TI>Rationale and design of the ParkFit study: A randomized controlled trial to increase physical activity in patient with Parkinson's disease</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24 Suppl 1</VL>
<PG>S284</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-12 15:12:17 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;J&lt;br&gt;AUG 19&lt;/p&gt;" NOTES_MODIFIED="2014-04-12 15:12:17 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>van Nimwegen M, Speelman AD, Smulders K, Overeem S, Borm GF, Backx FJG, et al</AU>
<TI>Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients</TI>
<SO>BMC Neurology</SO>
<YR>2010</YR>
<VL>10</VL>
<NO>

</NO>
<PG>
70
</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 09:56:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>van Nimwegen ML, Speelman AD, Gerrits MS, Bloem BR, Munneke M</AU>
<TI>Monitoring treatment fidelity in the ParkFit Study, a multifaceted behavioral program to increase physical activity in Parkinson patients</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25 Suppl 3</VL>
<PG>S678</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-05-07 09:58:18 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-05-07 09:58:18 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Allen-2011" MODIFIED="2013-01-27 10:09:58 +0000" MODIFIED_BY="[Empty name]" NAME="Allen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Allen NE, Sherrington C, Paul SS, Canning CG</AU>
<TI>Balance and falls in Parkinson's disease: a meta-analysis of the effect of exercise and motor training</TI>
<SO>Movement Disorders</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>9</NO>
<PG>1605-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berg-1992" MODIFIED="2013-01-31 14:21:43 +0000" MODIFIED_BY="[Empty name]" NAME="Berg 1992" TYPE="JOURNAL_ARTICLE">
<AU>Berg KO, Wooddauphinee SL, Williams JI</AU>
<TI>Measuring balance in the elderly - validation of an instrument</TI>
<SO>Canadian Journal of Public Health-Revue Canadienne de Sante Publique</SO>
<YR>1992</YR>
<VL>83</VL>
<PG>S7-S11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boutron-2008a" MODIFIED="2014-05-07 09:56:15 +0100" MODIFIED_BY="[Empty name]" NAME="Boutron 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, for the CONSORT group</AU>
<TI>Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2008</YR>
<VL>148</VL>
<NO>4</NO>
<PG>W60-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boutron-2008b" MODIFIED="2014-05-07 09:56:28 +0100" MODIFIED_BY="[Empty name]" NAME="Boutron 2008b" TYPE="JOURNAL_ARTICLE">
<AU>Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, for the CONSORT group</AU>
<TI>Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2008</YR>
<VL>148</VL>
<NO>4</NO>
<PG>295-309</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chartered-Society-of-Physiotherapy" MODIFIED="2013-01-27 09:53:53 +0000" MODIFIED_BY="[Empty name]" NAME="Chartered Society of Physiotherapy" TYPE="BOOK">
<AU>The Chartered Society of Physiotherapy</AU>
<SO>Rules of professional conduct</SO>
<YR>2002</YR>
<EN>2nd</EN>
<ED>The Chartered Society of Physiotherapy</ED>
<PB>The Chartered Society of Physiotherapy</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crizzle-2006" MODIFIED="2013-01-27 09:51:17 +0000" MODIFIED_BY="[Empty name]" NAME="Crizzle 2006" TYPE="JOURNAL_ARTICLE">
<AU>Crizzle AM, Newhouse IJ</AU>
<TI>Is physical exercise beneficial for persons with Parkinson's disease?</TI>
<SO>Clinical Journal of Sports Medicine</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>5</NO>
<PG>422-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deane-2001a" MODIFIED="2013-01-27 08:07:00 +0000" MODIFIED_BY="[Empty name]" NAME="Deane 2001a" TYPE="JOURNAL_ARTICLE">
<AU>Deane K, Jones DE, Playford ED, Ben-Shlomo Y, Clarke CE</AU>
<TI>Physiotherapy versus placebo or no intervention in Parkinson's disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>3</NO>
<PG>CD002817</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deboer-1996" MODIFIED="2014-04-12 15:15:15 +0100" MODIFIED_BY="[Empty name]" NAME="Deboer 1996" TYPE="JOURNAL_ARTICLE">
<AU>Deboer AGEM, Wijker W, Speelman JD, Dehaes JCJM</AU>
<TI>Quality of life in patients with Parkinson's disease: Development of a questionnaire</TI>
<SO>Journal of Neurology, Neurosurgery, and Psychiatry</SO>
<YR>1996</YR>
<VL>61</VL>
<NO>1</NO>
<PG>70-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Doll-1980" MODIFIED="2013-01-31 14:22:20 +0000" MODIFIED_BY="[Empty name]" NAME="Doll 1980" TYPE="JOURNAL_ARTICLE">
<AU>Doll R, Peto R</AU>
<TI>Randomized controlled trials and retrospective controls</TI>
<SO>British Medical Journal</SO>
<YR>1980</YR>
<VL>280</VL>
<NO>6206</NO>
<PG>44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duncan-1990" MODIFIED="2013-01-31 14:22:46 +0000" MODIFIED_BY="[Empty name]" NAME="Duncan 1990" TYPE="JOURNAL_ARTICLE">
<AU>Duncan PW, Weiner DK, Chandler J, Studenski S</AU>
<TI>Functional Reach - A new clinical measure of balance</TI>
<SO>Journals of Gerontology</SO>
<YR>1990</YR>
<VL>45</VL>
<NO>6</NO>
<PG>M192-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fahn-1987" MODIFIED="2013-01-27 08:29:36 +0000" MODIFIED_BY="[Empty name]" NAME="Fahn 1987" TYPE="BOOK_SECTION">
<AU>Fahn S, Elton RL</AU>
<TI>UPDRS Development Committee. Unified Parkinson's Disease Rating Scale</TI>
<SO>Recent developments in Parkinson's disease</SO>
<YR>1987</YR>
<PG>153-63</PG>
<ED>Fahn S, Marsden CD, Calne DB, Goldestein M</ED>
<PB>Macmillan Health Care Information</PB>
<CY>Florham Park, NJ</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gage-2004" MODIFIED="2013-01-27 10:19:31 +0000" MODIFIED_BY="[Empty name]" NAME="Gage 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gage H, Storey L</AU>
<TI>Rehabilitation for Parkinson's disease: a systematic review of available evidence</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>5</NO>
<PG>463-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibb-1988" MODIFIED="2014-04-12 15:16:08 +0100" MODIFIED_BY="[Empty name]" NAME="Gibb 1988" TYPE="JOURNAL_ARTICLE">
<AU>Gibb WRG, Lees AJ</AU>
<TI>The relevance of the Lewy Body to the pathogenesis of idiopathic Parkinsons disease</TI>
<SO>Journal of Neurology, Neurosurgery, and Psychiatry</SO>
<YR>1988</YR>
<VL>51</VL>
<NO>6</NO>
<PG>745-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giladi-2000" MODIFIED="2013-01-27 10:19:34 +0000" MODIFIED_BY="[Empty name]" NAME="Giladi 2000" TYPE="JOURNAL_ARTICLE">
<AU>Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD</AU>
<TI>Construction of freezing of gait questionnaire for patients with Parkinsonism</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2000</YR>
<VL>6</VL>
<NO>3</NO>
<PG>165-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goodwin-2008" MODIFIED="2013-01-27 10:19:37 +0000" MODIFIED_BY="[Empty name]" NAME="Goodwin 2008" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL</AU>
<TI>The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta-analysis</TI>
<SO>Movement Disorders</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>5</NO>
<PG>631-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hoehn-1967" MODIFIED="2013-01-31 14:24:47 +0000" MODIFIED_BY="[Empty name]" NAME="Hoehn 1967" TYPE="JOURNAL_ARTICLE">
<AU>Hoehn MM, Yahr MD</AU>
<TI>Parkinsonism - onset, progression and mortality</TI>
<SO>Neurology</SO>
<YR>1967</YR>
<VL>17</VL>
<NO>5</NO>
<PG>427-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jenkinson-1997" MODIFIED="2013-01-27 10:19:43 +0000" MODIFIED_BY="[Empty name]" NAME="Jenkinson 1997" TYPE="JOURNAL_ARTICLE">
<AU>Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N</AU>
<TI>The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score</TI>
<SO>Age and Ageing</SO>
<YR>1997</YR>
<VL>26</VL>
<NO>5</NO>
<PG>353-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kersten-2004" MODIFIED="2013-01-27 08:40:02 +0000" MODIFIED_BY="[Empty name]" NAME="Kersten 2004" TYPE="BOOK_SECTION">
<AU>Kersten P</AU>
<TI>Principles of physiotherapy assessment and outcome measures</TI>
<SO>Physical management in neurological rehabilitation</SO>
<YR>2004</YR>
<PG>29-46</PG>
<EN>2nd</EN>
<ED>Stokes M</ED>
<PB>Elsevier Mosby</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keus-2004" MODIFIED="2014-05-07 09:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Keus 2004" TYPE="JOURNAL_ARTICLE">
<AU>Keus S, Hendriks HJ, Bloem BR, Bredero-Cohen AB, De Goede CJ, van Haaren M, et al</AU>
<TI>Clinical practice guidelines for physical therapy in patients with Parkinsons disease</TI>
<SO>Dutch Journal of Physiotherapy</SO>
<YR>2004</YR>
<VL>114 Suppl 3</VL>
<PG>1-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keus-2007" MODIFIED="2013-01-27 10:19:50 +0000" MODIFIED_BY="[Empty name]" NAME="Keus 2007" TYPE="JOURNAL_ARTICLE">
<AU>Keus SHJ, Bloem BR, Hendriks EJM, Bredero-Cohen AB, Munneke M</AU>
<TI>Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research</TI>
<SO>Movement Disorders</SO>
<YR>2007</YR>
<VL>22</VL>
<NO>4</NO>
<PG>451-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keus-2009" MODIFIED="2013-01-31 14:25:14 +0000" MODIFIED_BY="[Empty name]" NAME="Keus 2009" TYPE="JOURNAL_ARTICLE">
<AU>Keus SHJ, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR</AU>
<TI>Physical therapy in Parkinson's disease: Evolution and future challenges</TI>
<SO>Movement Disorders</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>1</NO>
<PG>1-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kwakkel-2007" MODIFIED="2013-01-27 10:19:54 +0000" MODIFIED_BY="[Empty name]" NAME="Kwakkel 2007" TYPE="JOURNAL_ARTICLE">
<AU>Kwakkel G, de Goede CJT, van Wegen EEH</AU>
<TI>Impact of physical therapy for Parkinson's disease: A critical review of the literature</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2007</YR>
<VL>13</VL>
<PG>S478-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lim-2005" MODIFIED="2013-01-27 10:19:56 +0000" MODIFIED_BY="[Empty name]" NAME="Lim 2005" TYPE="JOURNAL_ARTICLE">
<AU>Lim I, van Wegen E, de Goede C, Deutekom M, Nieuwboer A, Willems A, et al</AU>
<TI>Effects of external rhythmical cueing on gait in patients with Parkinson's disease: a systematic review</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>7</NO>
<PG>695-713</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2010" MODIFIED="2013-01-27 10:53:04 +0000" MODIFIED_BY="[Empty name]" NAME="Mehrholz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M</AU>
<TI>Treadmill training for patients with Parkinson's disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<PG>CD007830</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MRC-2008" MODIFIED="2014-05-07 09:56:53 +0100" MODIFIED_BY="[Empty name]" NAME="MRC 2008" TYPE="OTHER">
<AU>Medical Research Council</AU>
<TI>Developing and evaluating complex interventions: new guidance</TI>
<SO>http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871</SO>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mutch-1986" MODIFIED="2013-01-31 14:26:14 +0000" MODIFIED_BY="[Empty name]" NAME="Mutch 1986" TYPE="JOURNAL_ARTICLE">
<AU>Mutch WJ, Strudwick A, Roy SK, Downie AW</AU>
<TI>Parkinson's Disease - disability, review and management</TI>
<SO>British Medical Journal</SO>
<YR>1986</YR>
<VL>293</VL>
<NO>6548</NO>
<PG>675-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NICE-CG35-2006" MODIFIED="2013-04-30 13:13:55 +0100" MODIFIED_BY="[Empty name]" NAME="NICE CG35 2006" TYPE="OTHER">
<AU>National Institute for Health and Clinical Excellence</AU>
<TI>NICE clinical guideline 35. Parkinson's disease: diagnosis and management in primary and secondary care</TI>
<SO>www.nice.org.uk</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nieuwboer-2008" MODIFIED="2013-01-27 10:20:05 +0000" MODIFIED_BY="[Empty name]" NAME="Nieuwboer 2008" TYPE="JOURNAL_ARTICLE">
<AU>Nieuwboer A, Rochester L, Jones D</AU>
<TI>Cueing gait and gait-related mobility in patients with Parkinson's disease - Developing a therapeutic method based on the international classification of functioning, disability, and health</TI>
<SO>Topics in Geriatric Rehabilitation</SO>
<YR>2008</YR>
<VL>24</VL>
<NO>2</NO>
<PG>151-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nijkrake-2007" MODIFIED="2014-05-07 09:57:03 +0100" MODIFIED_BY="[Empty name]" NAME="Nijkrake 2007" TYPE="JOURNAL_ARTICLE">
<AU>Nijkrake MJ, Keus SH, Kalf JG, Sturkenboom IH, Munneke M, Kappelle AC, Bloem BR</AU>
<TI>Allied health care interventions and complementary therapies in Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2007</YR>
<VL>13 Suppl 3</VL>
<PG>S488-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Patel-2010" MODIFIED="2014-05-07 09:57:14 +0100" MODIFIED_BY="[Empty name]" NAME="Patel 2010" TYPE="JOURNAL_ARTICLE">
<AU>Patel S, Cheed V, Ives N, Clarke C, Rick C, Wheatley K, Gray R, on behalf of the PD MED Collaborators</AU>
<TI>A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson's disease (PD MED Trial)</TI>
<SO>Movement Disorders</SO>
<YR>2010</YR>
<VL>25 Suppl 3</VL>
<PG>S681</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-PDS-2008" MODIFIED="2013-01-27 09:01:39 +0000" MODIFIED_BY="[Empty name]" NAME="PDS 2008" TYPE="OTHER">
<AU>PDS</AU>
<TI>Life with Parkinson's today - room for improvement</TI>
<SO>Parkinson's Disease Society, London</SO>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perry-1995" MODIFIED="2013-05-08 12:11:48 +0100" MODIFIED_BY="[Empty name]" NAME="Perry 1995" TYPE="JOURNAL_ARTICLE">
<AU>Perry J, Garrett M, Gronley JK, Mulroy SJ</AU>
<TI>Classification of walking handicap in the stroke population</TI>
<SO>Stroke</SO>
<YR>1995</YR>
<VL>26</VL>
<NO>6</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peto-1995" MODIFIED="2013-01-31 14:27:07 +0000" MODIFIED_BY="[Empty name]" NAME="Peto 1995" TYPE="JOURNAL_ARTICLE">
<AU>Peto V, Jenkinson C, Fitzpatrick R, Greenhall R</AU>
<TI>The development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease</TI>
<SO>Quality of Life Research</SO>
<YR>1995</YR>
<VL>4</VL>
<NO>3</NO>
<PG>241-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peto-2001" MODIFIED="2014-05-07 09:57:25 +0100" MODIFIED_BY="[Empty name]" NAME="Peto 2001" TYPE="JOURNAL_ARTICLE">
<AU>Peto V, Jenkinson C, Fitzpatrick R</AU>
<TI>Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire</TI>
<SO>Age and Ageing</SO>
<YR>2001</YR>
<VL>30</VL>
<PG>299-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Plant-2000" MODIFIED="2013-01-27 09:00:42 +0000" MODIFIED_BY="[Empty name]" NAME="Plant 2000" TYPE="OTHER">
<AU>Plant R, Jones D, Walton G, Ashburn A, Lovgreen B, Handford F, Kinnear E</AU>
<TI>Physiotherapy for people with Parkinson's disease: UK best practice short report</TI>
<SO>Institution of Rehabilitation, University of Northumbria</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Podsiadlo-1991" MODIFIED="2013-01-31 14:27:37 +0000" MODIFIED_BY="[Empty name]" NAME="Podsiadlo 1991" TYPE="JOURNAL_ARTICLE">
<AU>Podsiadlo D, Richardson S</AU>
<TI>The Timed Up and Go - A test of basic functional mobility for frail elderly persons</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>1991</YR>
<VL>39</VL>
<NO>2</NO>
<PG>142-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Powell-1995" MODIFIED="2013-01-31 14:28:46 +0000" MODIFIED_BY="[Empty name]" NAME="Powell 1995" TYPE="JOURNAL_ARTICLE">
<AU>Powell LE, Myers AM</AU>
<TI>The Activities-Specific Balance Confidence (Abc) Scale</TI>
<SO>Journals of Gerontology Series A, Biological Sciences and Medical Sciences</SO>
<YR>1995</YR>
<VL>50</VL>
<NO>1</NO>
<PG>M28-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Qutubuddin-2005" MODIFIED="2013-01-27 10:20:20 +0000" MODIFIED_BY="[Empty name]" NAME="Qutubuddin 2005" TYPE="JOURNAL_ARTICLE">
<AU>Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W</AU>
<TI>Validating the Berg Balance Scale for patients with Parkinson's disease: A key to rehabilitation evaluation</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2005</YR>
<VL>86</VL>
<NO>4</NO>
<PG>789-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rascol-2002" MODIFIED="2013-01-27 08:57:50 +0000" MODIFIED_BY="[Empty name]" NAME="Rascol 2002" TYPE="JOURNAL_ARTICLE">
<AU>Rascol O, Payoux P, Ferreira J, Brefel-Courbon C</AU>
<TI>The management of patients with early Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2002</YR>
<VL>9</VL>
<NO>1</NO>
<PG>61-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Robertson-2003" MODIFIED="2013-01-27 08:55:50 +0000" MODIFIED_BY="[Empty name]" NAME="Robertson 2003" TYPE="BOOK_SECTION">
<AU>Robertson D</AU>
<TI>Developing and delivering services</TI>
<SO>Neurological Rehabilitation of Parkinson's Disease</SO>
<YR>2003</YR>
<ED>Playford D, Thompson AJ</ED>
<PB>Martin Dunitz</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Robertson-2008" MODIFIED="2013-01-27 08:58:03 +0000" MODIFIED_BY="[Empty name]" NAME="Robertson 2008" TYPE="BOOK_SECTION">
<AU>Robertson D, Aragon A, Moore G, Whelan L</AU>
<TI>Rehabilitation and the interdisciplinary team</TI>
<SO>Parkinson's Disease in the Older Patient</SO>
<YR>2008</YR>
<EN>2nd</EN>
<ED>Playfer J, Hindle J</ED>
<PB>Radcliffe Publishing Ltd</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rubenis-2007" MODIFIED="2014-05-07 09:57:39 +0100" MODIFIED_BY="[Empty name]" NAME="Rubenis 2007" TYPE="JOURNAL_ARTICLE">
<AU>Rubenis J</AU>
<TI>A rehabilitational approach to the management of Parkinson's disease</TI>
<SO>Parkinsonism &amp; Related Disorders</SO>
<YR>2007</YR>
<VL>13 Suppl 3</VL>
<PG>S495-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schrag-2000" MODIFIED="2013-01-27 08:57:57 +0000" MODIFIED_BY="[Empty name]" NAME="Schrag 2000" TYPE="JOURNAL_ARTICLE">
<AU>Schrag A, Jahanshahi M, Quinn N</AU>
<TI>How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population</TI>
<SO>Movement Disorders</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>6</NO>
<PG>1112-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schrag-2006" MODIFIED="2013-05-08 12:12:50 +0100" MODIFIED_BY="[Empty name]" NAME="Schrag 2006" TYPE="JOURNAL_ARTICLE">
<AU>Schrag A, Sampaio C, Counsell N, Poewe W</AU>
<TI>Minimal clinically important change on the Unified Parkinson's Disease Rating Scale</TI>
<SO>Movement Disorders</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1200-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shulman-2010" MODIFIED="2013-05-08 12:13:10 +0100" MODIFIED_BY="[Empty name]" NAME="Shulman 2010" TYPE="JOURNAL_ARTICLE">
<AU>Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ</AU>
<TI>The clinically important difference on the Unified Parkinson's Disease Rating Scale</TI>
<SO>Archives of Neurology</SO>
<YR>2010</YR>
<VL>67</VL>
<NO>1</NO>
<PG>64-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steffen-2008" MODIFIED="2013-05-08 12:12:25 +0100" MODIFIED_BY="[Empty name]" NAME="Steffen 2008" TYPE="JOURNAL_ARTICLE">
<AU>Steffen T, Seney M</AU>
<TI>Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-Item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in people with parkinsonism</TI>
<SO>Physical Therapy</SO>
<YR>2008</YR>
<VL>88</VL>
<NO>6</NO>
<PG>733-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Talley-2008" MODIFIED="2013-01-27 10:20:30 +0000" MODIFIED_BY="[Empty name]" NAME="Talley 2008" TYPE="JOURNAL_ARTICLE">
<AU>Talley KMC, Wyman JF, Gross CR</AU>
<TI>Psychometric properties of the activities-specific balance confidence scale and the survey of activities and fear of falling in older women</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2008</YR>
<VL>56</VL>
<NO>2</NO>
<PG>328-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tinetti-1990" MODIFIED="2014-05-07 09:57:56 +0100" MODIFIED_BY="[Empty name]" NAME="Tinetti 1990" TYPE="JOURNAL_ARTICLE">
<AU>Tinetti ME, Richman D, Powell L</AU>
<TI>Falls efficacy as a measure of fear of falling</TI>
<SO>Journals of Gerontology</SO>
<YR>1990</YR>
<VL>45</VL>
<NO>6</NO>
<PG>239-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tomlinson-2012" MODIFIED="2014-05-07 09:58:07 +0100" MODIFIED_BY="[Empty name]" NAME="Tomlinson 2012" TYPE="JOURNAL_ARTICLE">
<AU>Tomlinson CL, Patel S, Meek C, Clarke CE, Stowe R, Shah L, et al</AU>
<TI>Physiotherapy versus placebo or no intervention in Parkinson's disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>8</NO>
<PG>CD002817</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trew-2005" MODIFIED="2013-01-27 08:24:43 +0000" MODIFIED_BY="[Empty name]" NAME="Trew 2005" TYPE="BOOK">
<AU>Trew M, Everett T</AU>
<SO>Human movement: an introductory text</SO>
<YR>2005</YR>
<EN>5th</EN>
<PB>Churchill Livingstone</PB>
<CY>Edinburgh</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1992" MODIFIED="2013-01-31 14:31:20 +0000" MODIFIED_BY="[Empty name]" NAME="Ware 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ware JE, Sherbourne CD</AU>
<TI>The MOS 36-Item Short-Form Health Survey (Sf-36) .1. Conceptual framework and item selection</TI>
<SO>Medical Care</SO>
<YR>1992</YR>
<VL>30</VL>
<NO>6</NO>
<PG>473-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Webster-1968" MODIFIED="2014-05-07 09:58:18 +0100" MODIFIED_BY="[Empty name]" NAME="Webster 1968" TYPE="JOURNAL_ARTICLE">
<AU>Webster DD</AU>
<TI>Critical analysis of disability in Parkinson's disease</TI>
<SO>Modern Treatment</SO>
<YR>1968</YR>
<VL>5</VL>
<NO>2</NO>
<PG>257-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Welsh-2003" MODIFIED="2013-01-27 10:20:45 +0000" MODIFIED_BY="[Empty name]" NAME="Welsh 2003" TYPE="JOURNAL_ARTICLE">
<AU>Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, et al</AU>
<TI>Development and testing of the Parkinson's disease quality of life scale</TI>
<SO>Movement Disorders</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>6</NO>
<PG>637-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whittle-1996" MODIFIED="2013-01-27 08:25:39 +0000" MODIFIED_BY="[Empty name]" NAME="Whittle 1996" TYPE="BOOK">
<AU>Whittle M</AU>
<SO>Gait analysis: an introduction</SO>
<YR>1996</YR>
<EN>2nd</EN>
<PB>Butterworth-Heinemann</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yahr-1969" MODIFIED="2013-01-31 14:32:26 +0000" MODIFIED_BY="[Empty name]" NAME="Yahr 1969" TYPE="JOURNAL_ARTICLE">
<AU>Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM</AU>
<TI>Treatment of Parkinsonism with levodopa</TI>
<SO>Archives of Neurology</SO>
<YR>1969</YR>
<VL>21</VL>
<NO>4</NO>
<PG>343-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yardley-2005" MODIFIED="2013-01-27 10:20:50 +0000" MODIFIED_BY="[Empty name]" NAME="Yardley 2005" TYPE="JOURNAL_ARTICLE">
<AU>Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C</AU>
<TI>Development and initial validation of the Falls Efficacy Scale-International (FES-I)</TI>
<SO>Age and Ageing</SO>
<YR>2005</YR>
<VL>34</VL>
<NO>6</NO>
<PG>614-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yarrow-1999" MODIFIED="2013-01-27 08:13:27 +0000" MODIFIED_BY="[Empty name]" NAME="Yarrow 1999" TYPE="BOOK_SECTION">
<AU>Yarrow S</AU>
<TI>Members' 1998 survey of the Parkinson's Disease Society of the United Kingdom</TI>
<SO>Parkinson's disease: Studies in psychological and social care</SO>
<YR>1999</YR>
<PG>79-92</PG>
<ED>Percival R, Hobson P</ED>
<PB>BPS Books</PB>
<CY>Leicester</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-01-27 08:06:51 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Deane-2001b" MODIFIED="2013-01-27 08:06:51 +0000" MODIFIED_BY="[Empty name]" NAME="Deane 2001b" TYPE="JOURNAL_ARTICLE">
<AU>Deane K, Jones DE, Ellis-Hill C, Clarke CE, Playford ED, Ben-Shlomo Y</AU>
<TI>Physiotherapy for Parkinson's disease: a comparison of techniques</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<PG>CD002815</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-01-27 10:22:00 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Almeida-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by pulling allocation out of a hat</P>
<P>Analysed on a per protocol basis</P>
<P>Treated as outpatients for 9 hours over 6 weeks</P>
<P>Assessed at baseline, 6 weeks and 12 weeks</P>
<P>Assessors were blinded for UPDRS III evaluation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>14 participants in the Overground walking group (OG), 14 in the Treadmill walking group (TM) and 14 in the control group (CL). 2 dropouts in TM group, 1 dropout in CL group.</P>
<P>Participants' mean age 73.9 years (OG), 63.9 years (TM), 67.4 years (CL); male/female 12/2 (OG), 8/6 (TM), 11/3 (CL); Hoehn and Yahr stage not stated; duration of PD not stated.</P>
<P>Inclusion criteria: Confirmed as having clinically typical Parkinson's disease by at least one movement disorders neurologist. Exclusion criteria: Past history of neurological conditions other than Parkinson's disease, orthopaedic or visual disturbances that severely impaired walking ability, unable to independently walk down an 8 metre GAITRite carpet for a total of 10 trials.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-18 13:36:03 +0100" MODIFIED_BY="[Empty name]">
<P>OG: Walk down equally spaced transverse lines presented on a 16m carpet. The cues were white lines of tape. Participants asked to walk across the lines, turn and continue back. Spacings were set at 8% greater than the initial step length of any of the groups (70 cm). 30 minute session with mandatory 2 min break every 8 mins, additional rest allowed if necessary but a total of 24 mins walking was required to consider gait session complete.</P>
<P>TM: Walk on a treadmill presented with equally distributed standardised transverse white lines. Spacings were set at 8% greater than the initial step length of any of the groups (70 cm). 30 minute session with mandatory 2 min break every 8 mins, additional rest allowed if necessary but a total of 24 mins walking was required to consider gait session complete.</P>
<P>CL: Instructed to continue their usual activities.</P>
<P>Participants were optimally medicated at time of all training and testing sessions and remained on stable regimen throughout trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Step length</P>
<P>UPDRS III</P>
<P>Timed up and go</P>
<P>Gait speed</P>
<P>Cadence</P>
<P>Double support time</P>
<P>Step time</P>
<P>Step-to-step variability, step time variability</P>
<P>30 second chair stand</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>CL arm not included in review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Braun-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Random allocation list used for each site with block sizes of 4</P>
<P>Both intention-to-treat and per protocol analysis were carried out</P>
<P>Treated as outpatients for either 1 hour per week (groups) or 30 mins per week (individuals) over 6 weeks</P>
<P>Assessed at baseline (week 0-1), at 7-8 weeks and at 3 months (12-13 weeks)</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>25 participants in the physiotherapy with mental practice group (PT+MP) and 22 in the physiotherapy and relaxation group (PT+R). There were 3 dropouts PT+MP group and 4 in the PT+R group prior to the post-intervention assessment, and a further 4 dropouts in the PT-MP group and 3 in the PT-R group prior to the 3 month follow-up assessment.</P>
<P>Participants' mean age 70 years (PT-MP), 69 years (PT-R); Male/female ratio, 17/8 (PT-MP), 15/7 (PT-R); Mean Hoehn and Yahr not given; Mean duration of PD 5.2 years (PT-MP), 6.6 years (PT-R).</P>
<P>Inclusion criteria: Clinically diagnosed adults with PD, sufficient cognitive level and communication skills to engage mental practice. Exclusion criteria: Other conditions such as stroke, rheumatic disease or dementia prior to onset of PD and sufficient to cause persistent premorbid disability.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 13:37:15 +0000" MODIFIED_BY="[Empty name]">
<P>Participants entering the trial were already receiving physiotherapy. This pre-existing treatment was continued. The randomly allocated new treatment was incorporated into the participants existing program.</P>
<P>PT-MP: In half hour sessions 10 mins were spent on mental practice, in group sessions of 1 hour, 20 mins were spent on mental practice. Therapy was recorded in pre-structured files which detailed content and duration. As soon as possible therapists encouraged unguided mental practice. Logs were given to participants to record unguided mental practice behaviour. The main goal of mental practice was to improve locomotor tasks like walking, standing up from a chair or the floor. This was achieved through four steps, explaining the concept, developing imagery techniques, applying mental practice and consolidating. During therapy imagery attempts and overt movements were combined. This information was embedded in the imagery attempts to make them as vivid as possible.  The proportions of actual movements and imagery attempts were based on individual preferences.</P>
<P>PT-R: In half hour sessions 10 mins were spent on relaxation, in group sessions of 1 hour, 20 mins were spent on relaxation. Therapy was recorded in pre-structured files. As soon as possible therapists encouraged unguided relaxation. Logs were given to participants to record unguided practice. Used to control for attention and consisted of treatment according to the national Dutch guidelines with relaxation therapy being incorporated into each session. The amount of relaxation incorporated matched the amount of mental practice in the experimental group. Relaxation followed the principles of progressive muscle relaxation.</P>
<P>It was not stated whether drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Patient and therapist perceived effect on walking performance using visual analogue scale</P>
<P>Timed up and go</P>
<P>10 m walk test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-03 11:46:15 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burini-2006">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Cross-over design</P>
<P>Participants coupled consecutively with list of random numbers. Numbers correspond to a sealed envelope containing group allocation</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered to groups in 45-50 minute sessions, 3 times per week up to a total of 20 sessions</P>
<P>Assessed at Baseline, after 7 weeks of first treatment, after 8 weeks wash-out period, after 7 weeks of second treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>13 participants in the aerobic training group and 13 in the Qi-gong group. There were 2 dropouts in each group.</P>
<P>Participants' mean age 65.7 years (aerobic training), 62.7 years (Qi-gong); Male/female ratio, 5/8 (aerobic training), 4/9 (Qi-gong); Mean Hoehn and Yahr 2.8 (aerobic training), 2.7 (Qi-gong); Mean duration of PD 11.2 years (aerobic training), 10.6 years (Qi-gong).</P>
<P>Inclusion criteria: PD subjects, stable medication, Hoehn and Yahr stage II to III. Exclusion criteria: Severe cognitive impairment (MMSE &lt; 24), concomitant severe neurologic cardiopulmonary or orthopaedic disorders, specific contraindication to the execution of a cardiopulmonary test or aerobic training, recent participation in any physiotherapy/rehabilitation program during 2 months prior to start of trial.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-04 12:24:31 +0100" MODIFIED_BY="[Empty name]">
<P>Aerobic training: Cycle ergometer used with warm-up, endurance and cool-down phases in each 45 min session occurring 3 times per week.</P>
<P>Qi-gong: Breathing exercises, stretches, neck and trunk rotation exercises and balance training in the upright position, 50 minute sessions 3 times per week.</P>
<P>Drug regimen remained constant throughout trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS III</P>
<P>UPDRS II</P>
<P>Brown's disability scale (BDS)</P>
<P>6-minute walk test</P>
<P>Borg scale for breathlessness</P>
<P>Beck depression inventory (BDI)</P>
<P>PDQ-39</P>
<P>Spirometry test</P>
<P>Maximum cardiopulmonary exercise test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chaiwanichsiri-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treated as outpatients for 3 sessions per week and using home practice for 3 sessions per week each lasting 30 minutes over 4 weeks plus 4 week home program</P>
<P>Assessed at baseline, immediately after treatment (4 weeks), and after home program at 8 weeks</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>10 participants in the treadmill + music + home-walking (TMH) group, 10 participants in the treadmill and home-walking (TH) group, 10 participants in the home-walking group (H). No dropouts described.</P>
<P>Participants' mean age 67.1 years (TMH group), 67.9 years (TH group), 68.6 years (H group); Male/female ratio 10/0 (TMH group), 10/0 (TH group), 10/0 (H group); Mean Hoehn and Yahr score 2.3 (TMH group), 2.5 (TH group), 2.1 (H group); Mean duration of PD 3.7 years (TMH group), 7.4 years (TH group), 4.4 years (H group).</P>
<P>Inclusion criteria: Male, 60-80 years old, PD as diagnosed by attending neurologists, Thai Mental State Examination &gt; 23, stable medications without freezing, no exercise program in last 2 months, no contraindication for exercise, H&amp;Y II-III, independent walking without use of gait aids. Exclusion criteria: Medication change during study, inability to walk on treadmill, cannot complete 80% of prescribed program.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-14 13:26:26 +0100" MODIFIED_BY="[Empty name]">
<P>TMH: 10 minutes of stretching followed by 20 minutes of treadmill training with cueing (music) delivered 3 days per week and home-walking practised 3 days per week. After treadmill speed was set, the step frequency would be identified by adjustable electrical metronome. The prepared music with the same rhythmic frequency was chosen. Then the participants were training to walk synchronised with the matched music rhythm on the treadmill. This music would be recorded in MP3 for the participants to take home and listen during home practice. Home program consisted of 10 minutes of stretching and 20 minutes walking. After 4 weeks treadmill training ceased but home program was continued for a further 4 weeks.</P>
<P>TH: 10 minutes of stretching followed by 20 minutes of treadmill training without cueing delivered 3 days per week and home-walking, as described above, practised 3 days per week. After 4 weeks treadmill training ceased but home program was continued for a further 4 weeks.</P>
<P>H: Home-walking practised 6 days per week.</P>
<P>Patients were excluded if medication was changed during trial period. Patients did not participate in training in 2 months prior to study start.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Timed up and go</P>
<P>Walking speed</P>
<P>Step length</P>
<P>Cadence</P>
<P>Stride length</P>
<P>6-minute walk test</P>
<P>6 metre walk time</P>
<P>Single leg stance</P>
<P>UPDRS I, II, III</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dias-2005">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in a total of 20 hour long sessions</P>
<P>Assessed at baseline, immediately after treatment and 30 days after end of treatment</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>8 participants in the physiotherapy and cardiovascular exercise with visual cues (PTCV) group and 8 in the physiotherapy only (PT) group. No dropouts described.</P>
<P>Participants mean age 61.5 years (PTCV group), 64.3 years (PT group); Male/female ratio 4/4 (PTCV group), 7/1 (PT group); Mean Hoehn and Yahr 1.6 (PTCV group), 1.7 (PT group); Mean duration of PD 7.4 years (PTCV group), 8.4 years (PT group).</P>
<P>Inclusion criteria: Hoehn and Yahr stage &#8804;3. Exclusion criteria: Any degree of dementia, joint deformations, arthritis, severe pain, other neurological disturbance, submitted to neurological surgery, severe associated pathologies that would impair physiotherapy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-06-08 13:59:11 +0100" MODIFIED_BY="[Empty name]">
<P>PTCV: 20 sessions of physiotherapy following a protocol that included 15 mins muscular stretching, 30 mins gait training on stable ground with visual cues, 15 mins cardiovascular exercise using ergometric bicycle.</P>
<P>PT: Conventional physiotherapy.</P>
<P>It was not stated whether drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS</P>
<P>Functional independence measurement scale</P>
<P>Berg balance scale</P>
<P>Hoehn and Yahr scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Article in Portuguese</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diehl-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treated for 24-36 sessions, lasting 90 mins each over 12 weeks</P>
<P>Assessed at baseline and immediately after treatment</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>20 participants were recruited, group split not stated. Dropouts not stated.</P>
<P>Baseline characteristics not stated but it was reported that no significant differences were found between groups in pre-test demographic variables.</P>
<P>Inclusion and exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-06 15:51:33 +0100" MODIFIED_BY="[Empty name]">
<P>Group box training: Stretching, lateral foot work, punching various targets, resistance exercises and aerobic training.</P>
<P>Traditional group exercises:Stretching, resistance exercises, aerobic and balance activities.</P>
<P>It was not stated whether drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Berg balance scale</P>
<P>Activities-specific balance confidence scale</P>
<P>Functional reach test</P>
<P>Parkinson's disease quality of life scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ebersbach-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomly allocated by drawing lots</P>
<P>Analysed on a per protocol basis</P>
<P>Treatment took place for 1 hour sessions 4 times per week for 4 weeks</P>
<P>Assessed at baseline and at 16 weeks</P>
<P>Assessors blinded for UPDRS III, not stated for other outcomes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>20 participants in LSVT BIG (BIG) group, 19 participants in Nordic walking (WALK) group and 19 participants in the Home exercise (HOME) group. 1 dropout in WALK group and 1 in HOME group.</P>
<P>Participants mean age 67.1 years (LSVT BIG group), 65.5 years (WALK group), 69.3 years (HOME group); Male/female ratio 7/13 (LSVT-BIG group), 7/12 (WALK group), 8/11 (HOME group); Mean Hoehn and Yahr 2.8 (LSVT BIG group), 2.6 (WALK group), 2.5 (HOME group); Mean duration of PD 6.1 years (LSVT-BIG group), 7.8 years (WALK group), 7.4 years (HOME group).</P>
<P>Inclusion criteria: Fulfil diagnostic criteria for IPD, Hoehn &amp; Yahr stage I-III outpatient treatment, stable medication 4 weeks prior to inclusion. Exclusion criteria: Dementia (MMSE&lt;25), severe depression, disabling dyskinesias, comorbidity affecting mobility or ability to exercise.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>LSVT BIG: 50% of exercises consisted of standardized whole-body movements with maximal amplitude, repetitive multidirectional movements and stretching. 50% of exercise included goal-directed ADL according to individual needs and preferences. ADL were performed using high amplitude LSVT BIG movements. LSVT BIG was delivered one-to-one with intensive motivation and feedback. Participants were constantly encouraged to work with at least &#8216;80% of their maximal energy&#8217; on every repetition and taught to use bigger movements in routine activities to provide continuous exercise in everyday movements. Participants in all groups were encouraged to exercise regularly at home. Diaries were used to document type and duration of exercise performed in addition to supervised LSVT BIG.</P>
<P>WALK: Each session consisted of a standardized protocol for beginners including warming up, practicing Nordic walking and finally a cooling down. Sessions were performed in a local park in groups of 4 or 6 and constantly supervised by the therapist. Participants in all groups were encouraged to exercise regularly at home. Diaries were used to document type and duration of exercise performed in addition to supervised WALK sessions.</P>
<P>HOME: 1 hours instruction of domestic training with practical demonstration and training. Exercises included stretching, high-amplitude movements, as well as active workouts for muscular power and posture. Participants in all groups were encouraged to exercise regularly at home. They received a diary to document type and duration of exercise performed.</P>
<P>Changes in medication occurred in 6 patients from each group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS III</P>
<P>PDQ-39</P>
<P>Timed up and go</P>
<P>Time to walk 10 m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fisher-2008">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Subjects closed their eyes and selected a card corresponding to 1 of the 3 groups</P>
<P>Analysis method not stated</P>
<P>Treated as outpatients for 24 sessions over 8 weeks for both treatment arms, 6 sessions over 8 weeks for control group</P>
<P>Assessed at baseline and immediately post-treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>10 participants in treadmill group, 10 participants in physiotherapy group and 10 in the control arm. No dropouts.</P>
<P>Participants' mean age, 64.0 years (treadmill), 61.5 years (physiotherapy), 63.1 years (control). Male/female ratio, 6/4 (treadmill), 5/5 (physiotherapy), 8/2 (control). Mean Hoehn and Yahr 1.9 in all 3 groups. Mean duration of PD 1.2 years (treadmill), 0.7 years (physiotherapy), 1.5 years (control).</P>
<P>Inclusion criteria: Early stage PD, diagnosis of PD within 3 years of study participation, Hoehn and Yahr stage 1 or 2, 18 years or older, medical clearance from primary care physician to participate in exercise programme, ability to walk. Exclusion criteria: Medical or physical screening examination showed a score of less than 24 on the MMSE, there were physician determined major medical problems such as cardiac dysfunction that would interfere with participation, they had musculoskeletal impairments or excessive pain in any joint that could limit participation in an exercise programme, had insufficient endurance and stamina to participate in exercise 3 times per week for a 1 hour session.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Treadmill: Level of intensity was defined by metabolic equivalents (MET). High intensity exercise greater than 3 METs. Body weight supported (BWS) treadmill training. Goal of each session was to reach and maintain a MET &gt; 3. Exercise progressed by decreasing BWS (initially 10% of participants' bodyweight) and physical assistance, increasing the treadmill speed and time on the treadmill, with the end goal for each participant to walk on the treadmill continuously for 45 min within the MET range.</P>
<P>Physiotherapy: Less than 3 METs. This group was representative of general or traditional physical therapy. Each 45 min session was individualised and consisted of activities from 6 categories 1) passive range of motion and stretching 2) active range of motion 3) balance activities 4) gait 5) resistance training 6) practice of functional activities and transitional movements.</P>
<P>Control: Zero intensity group. Six 1 hour education classes taken over an 8 week period.</P>
<P>All participants were allowed to continue their customary exercise routines and filled out a daily exercise diary.</P>
<P>Drug therapy was constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS (Total, I, II and III subscores)</P>
<P>Hoehn and Yahr</P>
<P>Functional assessments</P>
<P>Walking tests: average gait velocity, step length, stride length, cadence, double limb support time, ankle, knee, hip rotation</P>
<P>Sit-to-stand test</P>
<P>Transcranial magnetic stimulation (subset)</P>
<P>All participants took their customary medications at the same time relative to each assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Control arm not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frazzitta-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treatment was delivered over 4 weeks in 28 sessions lasting 20 mins each</P>
<P>Assessed at baseline and immediately after treatment</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>20 participants in treadmill with cues group, 20 in Auditory and visual cues group. No dropouts.</P>
<P>Participants mean age 71 years for both groups; Male/female ratio not stated; Mean Hoehn and Yahr 3 for both groups; Mean duration of condition 13.2 years (treadmill group), 12.9 years (cued group).</P>
<P>Inclusion criteria: Clinically probable IPD, ability to walk without assistance, visual and hearing capacity sufficient to perceive the cues, freezing of gait at the time of peak medication, stable pharmacological treatment, Hoehn &amp; Yahr stage III, no cognitive impairment, MMSE &gt; 26. Exclusion criteria: Neurological condition other than IPD, postural hypertension, cardiovascular disorders, musculoskeletal disorders, vestibular dysfunction limiting locomotion or balance.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-16 15:14:35 +0100" MODIFIED_BY="[Empty name]">
<P>Treadmill: Rehabilitation protocol for gait disturbance &amp; freezing that used treadmill training associated with auditory &amp; visual cues. Maximum tolerated walking speed -40% used for 2 day warm-up, then increased by 0.05 stride cycles/second. Visual cue of target on screen that participant had to reach with stride, auditory cue of music at matched frequency.</P>
<P>Cued: Visual cue of lines spaced according to individual stride length for gait training coupled with auditory cue of music at frequency matching that used in Treadmill group.</P>
<P>It was not stated whether drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS III</P>
<P>Gait speed</P>
<P>Freezing of gait questionnaire</P>
<P>Stride length</P>
<P>6 minute walking test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-04 15:16:12 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hackney-2007">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not given</P>
<P>Treated as outpatients for 20 sessions each lasting 1 hour delivered over 13 weeks</P>
<P>Assessed 1 week prior to treatment and 1 week after treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>9 participants in Tango group, 10 in Exercise group. No dropouts were reported.</P>
<P>Participants mean age 72.6 years (Tango), 69.6 years (exercise); Male/female ratio 6/3 (Tango), 6/4 (exercise); Hoehn and Yahr 2.3 (Tango), 2.2 (exercise); Mean duration of condition 6.2 years (Tango), 3.3 years (exercise).</P>
<P>Inclusion criteria: Diagnosed with clinically defined IPD, clear benefit from PD medications.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 14:05:07 +0000" MODIFIED_BY="[Empty name]">
<P>Tango: Progressive Tango dance lessons with postural stretches, balance exercises, Tango-style, footwork patterns and experimentation with timing of steps to music with and without partner.</P>
<P>Exercise: Structured flexibility exercise classes designed for people with PD and/or elderly individuals. Breathing and stretching exercises progressed to resistance and dexterity exercises sometimes using water bottles or yard sticks to provide resistance or leverage. Some exercises done standing or using chair for support and last 10 minutes consisted of core strengthening exercises using floor matts or modified exercises in chair.</P>
<P>Drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS III</P>
<P>Berg balance scale</P>
<P>Freezing of gait</P>
<P>Timed up and go</P>
<P>Velocity of walking and dual-task walking</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hackney-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by selecting allocation from a hat, carried out by trial investigator</P>
<P>Method of analysis not given</P>
<P>Treatment delivered in 1 hour sessions twice weekly for a total of 20 sessions</P>
<P>Assessed at baseline and within 1 week of completing 20 classes</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>19 participants in tango group, 19 in Waltz/Foxtrot group , 17 in Tai Chi and 20 in control. 5 dropouts in Tango group, 2 dropouts in Waltz/Foxtrot, 4 dropouts in Tai Chi and 3 in control group.</P>
<P>Participants mean age 68.2 years (Tango group), 66.8 years (Waltz/Foxtrot group), 64.9 (Tai Chi), 66.5 (control); Male/female ratio 11/3 (Tango group), 11/6 (Waltz/Foxtrot), 11/2 (Tai Chi),12/5 (control); Hoehn &amp; Yahr 2.1 (Tango), 2.0 (Waltz/Foxtrot), 2.0 (Tai Chi), 2.2 (control); Mean duration of condition 6.9 years (Tango), 9.2 years (Waltz/Foxtrot), 8.7 (Tai Chi), 5.9 (control).</P>
<P>Inclusion criteria: At least 40 years of age, could stand for at least 30 min, could walk independently 3 or more metres with or without assistive device, diagnosis of IPD using diagnostic criteria for critically defined "definite PD" based upon published standards, patients demonstrated clear benefit from L-dopa, Hoehn &amp; Yahr I-III. Exclusion criteria: History of neurological deficit other than PD, patients had been previously screened for dementia by their neurologists and none were diagnosed with dementia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Waltz/Foxtrot and Progressive Tango: Experience professional ballroom dancer taught progressive Tango, Waltz/Foxtrot lessons. Instructor, equally versed in both dances, attempted to give all students equal time in leading and following dance roles. All steps done in closed practice position, participants maintain contact through upper extremities and face one another.</P>
<P>Tai Chi: Progressive lessons on Tai Chi's 1st and 2nd circles of the Yang short style of Cheng Manching taught by experienced instructor.</P>
<P>Control: No intervention.</P>
<P>Drug therapy was constant during the trial or patients were excluded.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>PDQ-39</P>
<P>UPDRS III</P>
<P>Berg balance scale</P>
<P>Tandem stance test</P>
<P>Timed up and go test</P>
<P>One leg stance test</P>
<P>6 minute walk test</P>
<P>Gait</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Control arm not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hackney-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by selecting allocation from a hat</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treatment was delivered in 1 hour classes twice a week for 10 weeks</P>
<P>Assessed in the week prior to start of treatment, the week following completion of 10 week treatment and 4 weeks after completion of treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>19 participants in the partnered tango group, 20 in the non-partnered tango group. 7 dropouts in partnered group, 5 in non-partnered group.</P>
<P>Participants mean age 69.6 years in both groups; Male/female ratio 13/6 (partnered), 15/5 (non-partnered); Mean Hoehn and Yahr 2.5 (partnered) 2.0 (non-partnered); Duration of condition 9.5 years (partnered), 7.9 years (non-partnered).</P>
<P>Inclusion criteria: PD without a history of other neurological deficits, at least 40 years of age, able to stand for at least 30 minutes and walk independently for 3 or more metres with or without an assistive device, diagnosis of IPD Hoehn and Yahr stages I-III using diagnostic criteria for clinically defined 'definite PD' and demonstrated clear benefit from L-dopa. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Both partnered and non-partnered groups began with identical warm-ups to upbeat latin music. After warm-up both classes listened to and danced to identical commercial tango music selections in the same order of presentation.</P>
<P>Partnered: both sexes spent equal time leading and following dance steps, performed in a &#8216;closed practice&#8217; position, an adaptation of the traditional ballroom frame. Participants with PD always danced with individuals without PD. These individuals included caregivers and loved ones who elected to participate in classes as well as young adult volunteers.</P>
<P>Non-partnered: learned the same Argentine &#8216;leading&#8217; and &#8216;following&#8217; tango-based steps as the partner group but performed them without a partner. Caregivers, loved ones and volunteers participated in the nonpartner class also.</P>
<P>Participants remained on a steady drug regimen throughout the study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Tandem stance</P>
<P>One leg stance</P>
<P>Timed up and go</P>
<P>6 minute walk test</P>
<P>Gait velocity</P>
<P>Cadence</P>
<P>Stride length</P>
<P>Swing percentage</P>
<P>Double support percentage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hass-2006">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treatment delivered in 1 hour sessions twice a week for a total of 32 sessions</P>
<P>Assessment intervals not stated</P>
<P>Investigators were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>23 participants were recruited into the study. Number of dropouts was not stated.</P>
<P>Baseline characteristics for groups not stated. Total mean age 67 years; Hoehn Yahr 2.2.</P>
<P>Inclusion criteria: IPD. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-12-09 12:16:11 +0000" MODIFIED_BY="[Empty name]">
<P>Tai Chi: Emphasised physical movements, mind/body coordination &amp; meditation. 8 forms of Tai Chi performed in sessions.</P>
<P>Qi-gong: Emphasised prolonged intense contemplative or deep meditation in 2 postures, seated or lying supine on floor mats.</P>
<P>It was not stated whether drug therapy was kept constant during the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Gait initiation</P>
<P>Gait velocity</P>
<P>Stride length</P>
<P>Stance</P>
<P>Double limb support</P>
<P>Step duration</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirsch-1996">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design<BR/>Randomised according to a computer generated random number list but concealment of allocation not stated</P>
<P>Analysed on a per protocol basis<BR/>Treated as outpatients for an unspecified period of time (3 days/week) for 10 weeks<BR/>Assessed at baseline, immediately after treatment and 4 weeks later</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>6 patients in novel combined balance and resistance training group and 9 patients in balance training group. No dropouts stated.<BR/>Patients mean age 70.8 years (combined), 75.7 years (balance); Male/female ratio not stated; Hoehn and Yahr 1.8 (combined), 1.9 (balance); Duration of condition 5.5 years (combined), 8.3 years (balance).<BR/>Inclusion criteria: Diagnosed with IPD by neurologist, not participated in any organised balance or muscle strengthening activities before being pre-tested, ambulatory, not acutely ill, able to follow simple commands, not suffering from unstable cardiovascular disease.<BR/>Exclusion criteria: Uncontrolled chronic conditions that would interfere with safety and conduct of the training and testing.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-04 11:25:59 +0100" MODIFIED_BY="[Empty name]">
<P>Combined: Group training in strengthening and balance exercises. Resistance exercises used Nautilus leg extension and side-lying leg-flexion machines and therabands. Balance training consisting of gentle sternal or dorsal perturbation and leaning movements designed to enhance limit of stability whilst standing on a firm or a compliant surface.<BR/>Balance: 'standard' group balance therapy as described above.<BR/>Medications kept stable throughout trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Balance</P>
<P>Muscle strength (subset) : knee extensors, knee flexors, ankle plantar flexors</P>
<P>Latency to fall</P>
<P>% of trials resulting on falls</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation violation; 1 patient who was allocated to the combined therapy group was reassigned to the balance group after 2 weeks of training due to an inguinal hernia making it impossible for him to carry out the strength training</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Joudoux-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treated for 3 weekly 1 hour sessions for 8 weeks</P>
<P>Assessed at baseline, after treatment and after 3 months follow-up</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>50 participants recruited, group split not stated. Dropouts not stated.</P>
<P>Patients baseline characteristics not stated.<BR/>Inclusion criteria: Mild to moderate PD (Hoehn and Yahr II-III). Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-12 10:54:12 +0100" MODIFIED_BY="[Empty name]">
<P>Assymmetric motor training Program: Designed to enhance only the agonist activity of the 'body openers' i.e. extension/supination/abduction/external rotation - which is more reduced than their antagonist activity of flexion/protonation/adduction/internal rotation in PD - aiming at re-balancing forces around joints.</P>
<P>Broad program: Standard techniques of passive and active joint mobilisations, balance and gait training, relaxation techniques and respiratory techniques and respiratory work.</P>
<P>Not stated whether drug regimen remained constant throughout trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS III</P>
<P>GMT score</P>
<P>Rapid alternating movements</P>
<P>Hand writing and spiralography</P>
<P>PDQ-39</P>
<P>Dpression (GDS-15)</P>
<P>Video recording of 8 activities of daily living and biomechanical evaluations</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Juncos-2006">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Method of randomisation not stated</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treated for 6 months</P>
<P>Assessed at baseline then monthly and after last training session</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>56 participants were randomised into Aerobic exercise (AE), Tai Chi Chung (TCC) or Qi Gong (QG) groups. 16 dropouts in total. Group splits not stated.</P>
<P>Baseline characteristics for groups not stated. Total mean age 65 years.</P>
<P>Inclusion criteria: Ambulatory subjects with IPD, stable medication regimen, MMSE &gt; 24/30. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-12 10:55:34 +0100" MODIFIED_BY="[Empty name]">
<P>AE: Moderate intensity walk-run program with moderate caloric expenditure.</P>
<P>TCC: Intermediate intensity to that of AE, low caloric expenditure.</P>
<P>QG: Meditation in stillness, minimal caloric expenditure.</P>
<P>Drugs stable during therapy.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS total</P>
<P>UPDRS motor</P>
<P>UPDRS ADL</P>
<P>PDQ-39</P>
<P>Clinical global impression</P>
<P>Walking speed</P>
<P>Falls</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract and trial registration only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khallaf-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treatment dose not stated</P>
<P>Assessment intervals not stated</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>15 participants in Physiotherapy and treadmill group (PT + T) and 15 in Physiotherapy only group (PT). Dropouts not described.</P>
<P>Participant baseline characteristics not stated.</P>
<P>Inclusion/exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-05 15:57:14 +0100" MODIFIED_BY="[Empty name]">
<P>PT + T: Designed physiotherapy program in addition to 20 min of treadmill training.</P>
<P>PT: Designed physiotherapy program only.</P>
<P>Not stated whether drug therapies were kept constant throughout trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS II and III</P>
<P>Hamilton rating scale of depression</P>
<P>Walking speed</P>
<P>Walking distance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only, no contact details found for author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by permuted blocks, allocation delivered in sealed envelopes</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treatment delivered in 2 sessions per week each lasting an hour over 24 weeks</P>
<P>Assessed at baseline and post intervention (at 6 months) and at 3 months follow-up</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>65 participants in Tai Chi group, 65 in resistance group, 65 in the stretching group. 9 dropouts in Tai Chi group, 6 in resistance group, 4 in stretching group.</P>
<P>Participants mean age 68 years (Tai Chi), 69 years (resistance), 69 years (stretching); Male/female ratio 45/20 (Tai Chi), 38/27 (resistance), 39/26 (stretching); Mean Hoehn and Yahr not given; Duration of condition 8 years (Tai Chi), 8 years (resistance), 6 years (stretching).</P>
<P>Inclusion criteria: Clinical diagnosis of PD, aged 40 - 85 years, Hoehn and Yahr stage I - IV, at least one score of at least 2 or more for at least one limb for the tremor, rigidity, postural stability or bradykinesia items in the motor section of the UPDRS, stable medication use, ability to stand unaided and walk with or without an assistive device, medical clearance for participation and willingness to be assigned to any of the three interventions. Exclusion criteria: Current participation in any other behavioural or pharmacologic study or instructor led exercise program, a MMSE score lower than 24, debilitating conditions or vision impairment that would impede full participation in the study, unavailability during the study period.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 14:37:13 +0000" MODIFIED_BY="[Empty name]">
<P>Tai Chi: Six Tai Chi movements integrated into an eight-form routine.  The protocol was specifically designed to tax balance and gait by having participants perform symmetric and diagonal movements, such as weight shifting, controlled displacement of the centre of mass over the base of support, ankle sways an anterior &#8211;posterior and lateral stepping. The first 10 weeks emphasized the mastery of single forms through multiple repetitions; later weeks focused on repetitions to enhance balance and increase locomotion. Natural breathing was integrated into the training routine.</P>
<P>Resistance: Focused on strengthening the muscles that are important for posture, balance and gait.  Resistance (with weighted vests and ankle weights) was introduced at week 10. Weight vest resistance was initially set at 1% of body weight and was increased by approx. 1 to 2% of body weight, depending on each participants tolerance, every fifth week until 5% of body weight was achieved. Ankle weights started at 0.45 Kg per limb and were gradually increased to 1.36 Kg. the routine involved 8 to 10 exercises, including forward and side steps, squats, forward and side lunges, and heel and toe raises, performed in 1 to 3 sets of 10 to 15 repetitions. Progression was modified for participants with physical limitations. Natural breathing was emphasized during the training routine.</P>
<P>Stretching: This control condition was designed to provide a low intensity exercise program with the social interaction and enjoyment inherent in the two other interventions but without similar training benefits in lower-extremity weight bearing, strength or balance.  The core activities encompassed a variety of seated and standing stretches involving the upper body (neck, upper back, shoulders, chest and arms) and lower extremities (quadriceps, hamstrings, calves and hips) with the use of gentle joint extension and flexion and trunk rotation. Abdominal breathing with an emphasis on inhaling and exhaling to maximum capacity and relaxation of major muscle were also included.</P>
<P>There were no significant changes reported in outside physical activity or use of anti-parkinsonian medication.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Two indicators of postural stability: maximum excursion and directional control</P>
<P>Stride length</P>
<P>Walking velocity</P>
<P>Strength of bilateral knee extensors and flexors</P>
<P>Functional reach test</P>
<P>Timed up and go</P>
<P>UPDRS III</P>
<P>Number of falls</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>122/195 participants continued with their exercise out to 3 month follow-up so this is not a clean follow up comparison</P>
<P>Stretching arm classed as attention control and not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loureiro-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Analysis method not stated</P>
<P>Treatment delivered in 2 sessions per week over 6 weeks</P>
<P>Assessment intervals not stated</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>6 participants in conventional physiotherapy (Physio) group, 6 in complimentary activities (CA) group.</P>
<P>Mean age 57 (Physio group), 65 (CA group).</P>
<P>Inclusion criteria: Hoehn and Yahr II-III. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Physio: Conventional physiotherapy.</P>
<P>CA: Wii fit in addition to conventional physiotherapy.</P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Timed up and go</P>
<P>Anterior functional reach</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mak-2008">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel-group design</P>
<P>Participants randomly allocated to groups by drawing lots</P>
<P>Method of analysis not described</P>
<P>Treated as outpatients for 4 hours (audio-visual), 6 hours (exercise) over 4 weeks</P>
<P>Assessed at baseline, at 2 weeks, immediately after and 2 weeks after treatment had ended</P>
<P>Assessor was blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>21 participants in the cueing group, 21 participants in the exercise group and 18 in the control group. 2 dropouts from the cueing group, 2 from the exercise group and 4 from the control group.</P>
<P>No baseline characteristics given for drop-outs. Participants' mean age 63 (cueing), 66 (exercise), 63 (control). No data given for the sex of participants. Hoehn and Yahr stage 2.8 (cueing), 2.7 (exercise) and 2.7 (control). Duration of PD 5.9 years (cueing), 6.1 years (exercise), 5.9 years (control).</P>
<P>Inclusion criteria: diagnosed with PD according to Quinn, stable on anti-PD medications without dyskinesia, orthopaedic, arthritic or heart problems, aged between 50-75 years old, perform sit to stand independently, can follow instructions. No exclusion criteria stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-12-12 16:29:45 +0000" MODIFIED_BY="[Empty name]">
<P>Cueing: Audio-visual cued task-specific training for 20 min three times per week. Received cued sit-to-stand training using Equitest-Balance Master. Visual cue was given on a computer screen with verbal command as auditory cue. Each task lasted 2 min, repeated once with a 30 second rests in between.</P>
<P>Exercise: 45 min of conventional exercise twice a week. Conventional mobility and strengthening exercises for flexors and extensors of trunk, hips, knees and ankles followed by sit-to-stand practice.</P>
<P>Control: No treatment.</P>
<P>Drugs stable during therapy.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Peak horizontal velocity</P>
<P>Peak vertical velocity</P>
<P>Movement time</P>
<P>3D Kinematics data of sit-to-stand</P>
<P>Not stated when during the day tests took place</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Control group not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McGinley-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Method of randomisation not stated</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treated as outpatients for a 2 hour session once per week for 8 weeks plus home practice</P>
<P>Assessed at baseline, one week after intervention, at 3 months and 12 months after intervention</P>
<P>Assessors blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>69 participants in Movement strategy training group (MST), 70 in Progressive strength training group (PST), 71 in Life-skills control group (LS). 14 dropouts prior to post-intervention time point.</P>
<P>Baseline characteristics not split by group. Participants mean age 67.9 years; Male/female ratio 140/70; Hoehn and Yahr mean score not stated; Duration of condition 6.7 years.</P>
<P>Inclusion criteria: Confirmed Idiopathic Parkinson's disease, Hoehn &amp; Yahr stages 0-4, able to participate in an outpatient exercise program including strength training, willing to complete a falls calendar for 12 months after therapy, able to walk, willing and able to attend the therapy and assessment program. Exclusion criteria: Score less than 24 on mini-mental state examination, rating greater than 4 on the modified Hoehn &amp; Yahr scale, on major tranquillisers, other medical conditions that could limit or prevent exercising safely at the required intensity, other prior neurological conditions affecting and dementia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 15:01:25 +0000" MODIFIED_BY="[Empty name]">
<P>MST: Movement strategies emphasise task specific practice of everyday functional actions such as rolling over, standing up, walking, crossing obstacles and turning. These tasks are practised with strategies such as visual or auditory cues, mental rehearsal and movement planning, conscious attention during the task and breaking the task into a sequence of smaller components. The program is tailored to movement impairments, activity limitations, and cognitive status and learning ability.</P>
<P>An individualised home practice session of strategies to practice within the home or community will be completed once a week. Structured falls risk education will also be provided each week. A single home visit will be conducted by a trained therapist or nurse to check compliance with the therapy program.</P>
<P>PST: Strengthening exercises for quadriceps, hip and trunk extensor muscles, hip abductors, calf, and ankle dorsiflexors, tailored to individual&#8217;s strength and functional ability. Where possible training is performed in functional tasks such as standing up from a chair, stepping up onto a step etc, using body weight, weighted vests and Thera-band<SUP>®</SUP> to progress the resistance. Structured falls risk education will be provided each week. An individualised home practice session of strengthening exercises will also be completed once a week. A single home visit will be conducted by a trained therapist or nurse to check compliance with the therapy program.</P>
<P>LS: Equivalent duration to the MST and PST groups. Each session led by OTs, PTs, Speech pathologists or social workers and included content such as relaxation, games, or communication activities. Guided discussion. Guided discussion will also include topics such as the impact of PD on the individual and family, support and resources available and fatigue management. None of the content will relate to walking, balance or falls risk education. A home session of reflection activities and relaxation practice will also be completed once per week.</P>
<P>Not stated whether the drug therapy was constant during treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Falls: no. of fallers per group, no. of multiple fallers per group, falls rate over 12 months in each group</P>
<P>Number of injurious falls</P>
<P>Walking speed</P>
<P>6 minute walk test</P>
<P>Timed up and go</P>
<P>UPDRS II and III</P>
<P>PDQ-39</P>
<P>EuroQol-5D</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>LS arm not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyai-2000">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Cross-over design</P>
<P>Randomisation using the envelope method</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Inpatients treated for 12 sessions, each lasting 45 minutes, over 4 weeks</P>
<P>Assessed at baseline, after first set of treatment at 4 weeks and after second set of treatment at 8 weeks</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>5 participants in body-weight supported treadmill training (BWSTT) and 5 in conventional physiotherapy (PT). No dropouts described.</P>
<P>Participants mean age 66 years (BWSTT), 69.3 years (PT); Male/female ratio 2/3 (BWSTT), 3/2 (PT); Hoehn and Yahr 2.8 (BWSTT), 2.9 (PT); Duration of condition 4.9 years (BWSTT), 3.6 years (PT).</P>
<P>Inclusion criteria: Hoehn and Yahr stage 2.5 or 3 Parkinson's disease, no dementia MMSE &gt;27. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-19 08:56:24 +0100" MODIFIED_BY="[Empty name]">
<P>BWSTT: Walking with 20% bodyweight support (BWS) for 12 minutes, then 4.5 minutes rest, followed by 10% BWS for 12 minutes, another 4.5 minutes rest and finally 12 minutes walking with 0% BWS. Walking speed started at 0.5 km/hr and was ramped up in 0.5 km/hr increments to 3.0 km/hr as tolerated.</P>
<P>PT: General conditioning, range of motion exercise, activities of daily living training and gait training.</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS</P>
<P>UPDRS subscales (mental, ADL, motor and complications)</P>
<P>Overground ambulation endurance</P>
<P>Gait speed</P>
<P>No. steps taken for 10 metre walk</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Pre-crossover data only used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyai-2002">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation was the envelope method</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treatment delivered for 12 sessions over 1 month, sessions lasted 45 minutes</P>
<P>Assessed at baseline, at 1 month, 2 months, 3 months, 4 months, 5 months and 6 months</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>11 participants in body-weight supported treadmill training (BWSTT) group and 9 in conventional physiotherapy (PT) group. 4 participants not analysed due to changes in their medication.</P>
<P>Participants mean age 69.5 years (BWSTT), 69.8 years (PT); Male/female ratio 5/6 (BWSTT), 5/4 (PT); Hoehn and Yahr 2.9 (BWSTT), 2.8 (PT); Duration of condition 4.1 years (BWSTT), 4.5 years (PT).<BR/>Inclusion criteria: Diagnosis of Parkinson's disease based on the presence of rest tremor, bradykinesia, rigidity, positive response to l-dopa and no evidence of vascular lesions on MRI. Hoehn and Yahr stage 2.5 or 3. Exclusion criteria: Dementia, MMSE &lt;27.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>BWSTT: Walking with 20% bodyweight support (BWS) for 12 minutes, then 4.5 minutes rest, followed by 10% BWS for 12 minutes, another 4.5 minutes rest and finally 12 minutes walking with 0% BWS. Walking speed started at 0.5 km/hr and was ramped up in 0.5 km/hr increments to 3.0 km/hr as tolerated.</P>
<P>PT: General conditioning, range of motion exercise, activities of daily living training and gait training.</P>
<P>Changes in medication not allowed. Participants who changed their medication were excluded.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS</P>
<P>UPDRS subscales (mental, ADL, motor and complications)</P>
<P>Gait speed</P>
<P>No. steps taken for 10 metre walk</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-12-20 12:04:08 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morris-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised using generated random number sequences by an independent university source</P>
<P>Method of analysis not stated</P>
<P>Treated as inpatients for 2 weeks in 16 sessions each lasting 45 minutes</P>
<P>Assessed at baseline, immediately after treatment and at 3 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-26 15:16:23 +0000" MODIFIED_BY="[Empty name]">
<P>14 participants in movement strategies (MS) group and 14 in exercise (Ex) group. 2 participants missing from follow-up in exercise group.</P>
<P>Participants mean age 68 years (MS), 66 years (Ex); Male/female ratio, disease severity and duration for groups were not stated.</P>
<P>Inclusion criteria: Aged 21 -80 years, medically stable, diagnosis of IPD confirmed by a neurologist, &gt;23 MMSE with a minimum of 2 out of 3 on the recall question, Hoehn &amp; Yahr II or III, able to walk 10 metres 3 times without assistance. Exclusion criteria: Unsafe to participate in the therapy programs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-17 12:40:41 +0100" MODIFIED_BY="[Empty name]">
<P>MS: Learn how to use cognitive strategies such as focusing their attention on movement and responding to external cues to enhance walking, turning, standing up from a chair and obstacle negotiation. Based on principles of Victorian comprehensive Parkinson's disease program.</P>
<P>Ex: Lower limb and trunk strengthening exercises, spinal and lower limb flexibility exercises and receiving feedback on optimal postural alignment for a range positions.</P>
<P>Not stated whether the drug therapy was constant during treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS Motor</P>
<P>UPDRS ADL</P>
<P>10 m walk test</P>
<P>Timed up and go</P>
<P>2 min walk test</P>
<P>Balance-shoulder tug</P>
<P>PDQ-39</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-05 15:16:55 +0000" MODIFIED_BY="[Empty name]">
<P> </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Palmer-1986">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised in pairs matched for stage of disease, sex and age, method not stated</P>
<P>Method of analysis not stated</P>
<P>Treated as outpatients for 12 weeks in 1 hour sessions 3 times per week</P>
<P>Assessed at baseline and immediately after therapy</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>7 participants in United Parkinson Foundation (UPF) exercise program, 7 in upper body karate (UBK) training program. No dropouts were described.</P>
<P>Participants mean age 63.9 years (UPF), 65.9 years (UBK); Male/female ratio not stated; Hoehn and Yahr 2.4 (UPF), 2.4 (UBK); Duration of condition not stated.</P>
<P>Inclusion criteria: IPD, stabilization on a regimen of pharmacologic therapy, ability to attend the scheduled evaluation and exercise sessions. Exclusion criteria: Physical problems that might cause them to risk injury during exercises.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-11 09:59:41 +0000" MODIFIED_BY="[Empty name]">
<P>UPF: Stretch exercises from the UPF exercise program led by a corrective therapist.</P>
<P>UBK: Trained in upper body Karate techniques by a rehabilitation nursing student who had a black belt in karate. All karate was done in a seated position. Each session consisted of approximately 15 mins warm-up stretching exercises, 35 mins karate training and 10 mins cool down stretching exercises.</P>
<P>Drug therapy was stable during therapy period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Forearm pronation/supination rate</P>
<P>Pursuit score walk index</P>
<P>Degree of activated rigidity</P>
<P>Degree of arm tremor</P>
<P>Activated rigidity</P>
<P>Grip strength</P>
<P>9-hole peg test</P>
<P>Minnesota placing and turning test</P>
<P>Arm swings test</P>
<P>Rapid alternating arm movement test</P>
<P>Button board</P>
<P>Putting shirt on and off</P>
<P>Putting shoes and socks on and off</P>
<P>Getting up from chair</P>
<P>Long latency stretch response</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-11 09:59:30 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pelosin-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by computerised random-number generator performed by an independent researcher</P>
<P>Method of analysis not stated</P>
<P>Treated as outpatients for 4 weeks with hour long sessions delivered 3 times per week</P>
<P>Assessed at baseline, 2 days after completion of all therapy sessions and 4 weeks later</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>9 participants in action group, 9 in landscape group. 2 additional patients were recruited but excluded due to past history of neurological conditions other than PD. No dropouts described.</P>
<P>Participants mean age 68.8 years (action), 70.2 years (landscape); Male/female ratio not stated; Hoehn &amp; Yahr 2.1 (action), 2.2 (landscape); Duration of condition 11.6 years (action), 9.5 years (landscape).</P>
<P>Inclusion criteria: IPD according to the UK PDS BB criteria. All on stable medication regime. Mobile despite occurrence of freezing at least once a week (minimum score of 2 on item 3 of the FOG questionnaire) and for at least 2s (minimum score of 1 on item 4 of FOG-Q). MMSE &gt; 24. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 15:23:50 +0000" MODIFIED_BY="[Empty name]">
<P>Action: Instructed to carefully watch 6 video clips (each clip lasting 6 mins) showing strategies useful in circumventing FOG episodes. During each training session 2 video clips (with different sequences of actions) were presented twice. The complexity of movements progressively increased from simple actions to more complex movements. All actions shown in the video clips were performed by a physical therapist. To ensure proper attention during the video presentation, patients were explicitly asked to concentrate on how the actions were performed and were not allowed to imitate any movement. After video clip observation, patients were asked to practice (for the remaining time of the session-36 min) the observed actions repetitively and accurately according to the instructions of the physical therapist.</P>
<P>Landscape: Matched the experimental protocol, with the exception that during each training sessions they watched 2 video clips (presented twice) containing sequences of static pictures of mountains and seaside, countryside, and desert scenes without any living (human or animal) representations. During training sessions, patients in the landscape group performed the same movements/ actions used for the Action group following the physical therapist&#8217;s instructions, in the exact order and for the same amount of time.</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>FOG Questionnaire and FOG diary</P>
<P>Timed up and go</P>
<P>10 metre walking test</P>
<P>Tinetti scale part I and II</P>
<P>Berg balance scale</P>
<P>PDQ-39</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Only data for FOG could be extracted from paper</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Picelli-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Participants randomised using list, generated by www.randomisation.com kept in locked desk draw</P>
<P>Analysed on a per protocol basis</P>
<P>Treated as outpatients for 45 minute sessions, 3 times per week for 4 weeks</P>
<P>Assessed at baseline, post intervention, and 1 month after treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>21 participants in Robot assisted gait-training group (RAGT) and 20 participants in physiotherapy group (PT). 3 dropouts in RAGT group and 2 in PT group.</P>
<P>Participants' mean age 68.1 years (RAGT), 68.7 years (PT). Male/female ratio, 10/8 (RAGT), 6/12 (PT). Hoehn and Yahr 2.7 (RAGT), 2.7 (PT). Duration of PD 6.6 years (RAGT), 7.4 years (PT). Baseline data not given for drop-outs.</P>
<P>Inclusion criteria: Confirmed PD, Hoehn and Yahr score 2.5 or 3, MMSE score &gt; 23. Exclusion criteria: Severe dyskinesias of "on-off" phases, change of PD medications during the study, deficits of somatic sensation in the lower limbs, vestibular disorders or paroxysmal vertigo, other neurological orthopaedic conditions involving the lower limbs and cardiovascular comorbidity.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>RAGT: 2 motor driven footplates positioned on 2 bars that provide a Robot assisted propulsion by means of a planetary gear system, simulating stance and swing with a ratio of 60% to 40% between the two phases. A progressive reduction of body weight combined with an increase in gait speed. Each training session consisted of 3 parts (each one lasting 10 minutes), with a 5-minute rest after each of them. Patients were first trained at 20% of body weight supported and at a speed of 1 km/h for 10 minutes; then at 10% of body weight supported and a speed of 1.3 km/hr for 10 mins; and finally, at 0% of body weight supported and a speed of 1.6 km/hr for 10 mins. Patients were instructed to &#8220;help&#8221; the gait trainer (GT1) gait-like movement during training. Any patient unable to maintain the chosen pace was excluded from the study.</P>
<P>PT: Program included active joint mobilization and conventional gait training. Each treatment session consisted of 2 parts with a 5-minute rest between them. First patients performed active joint mobilization of the lower limbs (hip, knee and ankle) in the supine and prone positions (10 repetitions of 6 exercises) for 10 minutes (5 minutes per position). Then they performed conventional gait therapy based on the proprioceptive neuromuscular facilitation (PNF) concept for 30 minutes. Among the PNF techniques we facilitated pelvic motion to improve control of the pelvis as a &#8220;key point of control&#8221; for maintaining a gait pattern. Conventional gait therapy consisted of 10 minutes each of rhythmic initiation, slow reversal and agonistic reversal exercises applied to the pelvic region. The time spent in PNF was equal to that spent in RAGT. The same trained therapist treated all the patients in this group and standardized the duration of each part of the treatment.</P>
<P>No changes in medications as this was a criterion for exclusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>10 m walk test</P>
<P>6 min walk test</P>
<P>Spatiotemporal gait parameters including stride length</P>
<P>Parkinson's fatigue scale</P>
<P>UPDRS Total</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-06 17:05:56 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poliakoff-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method was done by drawing lots and placing allocations in two sets of sealed envelopes for high and low severity of Parkinson's disease</P>
<P>Method of analysis was unclear</P>
<P>Treatment delivered in two 1 hour sessions per week for 10 or 20 weeks</P>
<P>Assessed at baseline, at 10 weeks and 20 weeks</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>16 participants in 20 week gym group (gym), 16 in 10 week gym group (control). 4 dropouts from gym group and 6 dropouts from control group.</P>
<P>Participant mean age 66.6 years (gym), 63.7 years (control); Male/female ratio, 11/5 (gym), 10/6 (control); Hoehn and Yahr not stated; Duration of condition 7.4 years (gym), 4.7 years (control).</P>
<P>Inclusion criteria: mild to moderate PD. Exclusion criteria: diagnosed with dementia, attendance of a group exercise class for Parkinson's disease, other neurodegenerative disease, &gt;2weeks holiday booked during the study period.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-24 09:10:19 +0100" MODIFIED_BY="[Empty name]">
<P>20 Week: 20 week biweekly gym training programme at local leisure complex. 1 hours weekly training in the studio and 1 hour in the gym, each run by gym staff with experience of working with PD. Gym sessions consisted of mainly cardiovascular activity, studio sessions emphasised on gait and agility. The patients used external stimuli (such as music) and team working was encouraged.</P>
<P>10 Week: 10 week programme as above starting 10 weeks after baseline assessment.</P>
<P>Not clear whether the drug therapy was constant during treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Simple, choice and serial reaction time</P>
<P>Videotaped motor performance</P>
<P>PDQ-39</P>
<P>UPDRS III</P>
<P>Illness perceptions (BIPQ)</P>
<P>Questionnaire assessing experiences of programme</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract and manuscript accepted for publication in Neurorehabilitation</P>
<P>Data used from assessments at baseline and 20 weeks</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reuter-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation was conducted using a computer generated sequence</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in 70 minute sessions 3 times per week for 6 months</P>
<P>Assessed at baseline and post-intervention</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>30 participants in Nordic walking group (NW), 30 in walking group (W) and 30 in flexibility and relaxation group (FR). No dropouts from any group.</P>
<P>Participant mean age 62.0 years (NW), 63.0 years (W), 62.1 years (FR); Male/female ratio not stated; Hoehn &amp; Yahr 2.5 (NW), 2.5 (W), 2.4 (FR); Duration of condition 5.3 years (NW), 6.0 years (W), 5.2 years (FR).</P>
<P>Inclusion criteria: PD diagnosed using UKBB criteria assessed by movement disorder specialist, Hoehn and Yahr stage II-III. Exclusion criteria: Severe concomitant disease which limit physical performance, second neurological disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 18:00:26 +0000" MODIFIED_BY="[Empty name]">
<P>NW: Consisted of warming up including some flexibility and strength exercises with and without the poles. One session per week was dedicated to practising NW technique, the other sessions focused on endurance training. Participants were encouraged to increase the intensity of the training by walking faster or uphill and to increase the distance walked. Each training session finished with a cooling down programme. Training sessions took place in a park and a forest near to the university hospital.</P>
<P>W: Consisted of warming up, technique training, endurance training and cooling down. Instructors emphasised on arm swing and coordination of upper and lower limbs. One session per week included walking uphill to improve muscle strength.</P>
<P>FR: Performed flexibility exercises and relaxation training. The training focused on stretching, improving balance and range of movements. The flexibility and relaxation programme did not include aerobic exercises.</P>
<P>Medical treatment was optimised prior to study and minor changes were allowed in 5 patients during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Max walking speed on treadmill</P>
<P>12 m and 24 m walking test</P>
<P>Stride length</P>
<P>Gait variability</P>
<P>UPDRS</P>
<P>PDQ-39</P>
<P>Physical activity in everyday life</P>
<P>Adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ridgel-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in 1 hour sessions, 3 times per week for 8 weeks</P>
<P>Assessed at baseline, immediately after completion of treatment, and four weeks after completion of treatment</P>
<P>Assessors blinded for UPDRS outcome only</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>5 participants in forced exercise group, 5 in voluntary exercise. No dropouts described.</P>
<P>Participants mean age 58 years (forced), 64 years (voluntary); Male/female ratio not stated; Hoehn and Yahr stage not stated; Duration of condition 7.9 years (forced), 4.4 years (voluntary).</P>
<P>Inclusion criteria: IPD. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-18 16:24:24 +0100" MODIFIED_BY="[Empty name]">
<P>Forced: Tandem stationary bicycle with trainer. Lower extremity forced exercise (FE) intervention using a stationary tandem bicycle. Patient&#8217;s pedaling rate was increased to approximately 30% more than their preferred rate.</P>
<P>Voluntary: Exercise on a stationary single bicycle.</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS part III</P>
<P>Manual functional dexterity</P>
<P>Bimanual dexterity</P>
<P>Centre of pressure (CoP)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-26 18:03:08 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robichaud-2012">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Method of randomisation not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment was delivered in 1 hour sessions twice per week for 24 months</P>
<P>Assessed at baseline, 6, 12, 18 and 24 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-12 11:44:18 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised not stated. 48 patients assessed at 6 months, down to 38 at 24 months. Group split not stated.</P>
<P>Group baseline characteristics not stated. Total mean age 59 years, total mean duration of condition 7 years.</P>
<P>Eligibility criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-12 11:37:30 +0100" MODIFIED_BY="[Empty name]">
<P>Progressive resistance exercise: Weight lifting program.</P>
<P>Fitness counts: Flexibility, balance and strengthening program.</P>
<P>Not stated whether the drug therapy was constant during treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>UPDRS motor</P>
<P>Timed up and go</P>
<P>Berg balance scale</P>
<P>Modified physical performance test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstracts and trial registrations only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schenkman-2012a">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised using computer generated assignments kept in opaque, sealed envelopes, unsealed by research assistant after baseline assessment</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treatment was delivered in 1 hour sessions, 3 times per week for the first 4 months then tapered for 1 month to once monthly sessions out to 16 months. Home exercise group received just once monthly supervised sessions throughout</P>
<P>Assessed at baseline, 4 months, 10 months and 16 months</P>
<P>Assessors blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>39 participants in Flexibilty/balance/function exercise group (FBF), 41 in Aerobic exercise group (AE) and 41 in Home exercise group (HE).</P>
<P>Participant mean age 64.5 years (FBF), 63.4 years (AE), 66.3 years (HE); Male/female ratio 24/15 (FBF), 26/15 (AE), 26/15 (HE); Hoehn and Yahr 2.3 (FBF), 2.2 (AE), 2.3 (HE); Duration of condition 4.9 years (FBF), 3.9 years (AE), 4.5 years (HE).</P>
<P>Inclusion criteria: Primary PD diagnosed by a movement disorders specialist using the UKBBC, lived in the community, ambulated independently, Hoehn &amp; Yahr stage II-III. Exclusion criteria: Uncontrolled hypertension, on-state freezing or exercise limitations from other disorders, MMSE&lt;24.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 18:10:12 +0000" MODIFIED_BY="[Empty name]">
<P>FBF: Individualised spinal and extremity flexibility exercises followed by group balance/functional training. 2 months of flexibility training one-on-one with a physical therapist followed by 2 months of small group exercise (up to 6 participants) that included flexibility, balance and functional exercise.</P>
<P>AE: Treadmill, bike and/or elliptical trainer. Included 5-10 min of warm-up, 30 minutes exercise at 65% to 80% HR max and 5-10min of cool down. Participants were encouraged to use a treadmill but were permitted to use a stationary bicycle or elliptical trainer.</P>
<P>HE: Exercised at home using the National PD Foundation &#8216;Fitness counts&#8217; program. Consisted of exercises in the home setting utilizing Fitness Counts with a single monthly group exercise session supervised by a physical therapist. Flexibility and strengthening exercises in sitting and standing. Daily walking (no specific guidelines).</P>
<P>All participants regardless of group assignment were assisted to develop long term exercise habits. After randomisation and before beginning to exercise, participants met with their trainer to discuss motivation to exercise, potential barriers and strategies to develop exercise habits.</P>
<P>Participants were asked to record supervised and home exercise throughout the 16 months.</P>
<P>Drug therapy was kept constant for the first 4 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Overall physical function</P>
<P>Balance - functional reach</P>
<P>Walking economy - VO<SUB>2 </SUB>
</P>
<P>UPDRS ADL</P>
<P>UPDRS Motor</P>
<P>PDQ-39</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shankar-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment was delivered in 30 min sessions, twice a week for 8 weeks</P>
<P>Assessed at baseline and at 2 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>10 participants in Treadmill with Cueing (TwC) group, 9 in Treadmill without Cueing (T) group and 10 in Cueing only (C) group. No dropouts described.</P>
<P>Baseline characteristics not stated for groups.</P>
<P>Inclusion criteria: Moderate Parkinson's disease. No exclusion criteria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-18 13:28:25 +0000" MODIFIED_BY="[Empty name]">
<P>TwC: Walking on the treadmill with music for 30 min twice a week. Music was selected based upon participant input and cadence-matched to the participant's preferred walking speed.</P>
<P>T: Walking on the treadmill without music for 30 min twice a week.</P>
<P>C: Listening to music for 30 min twice a week.</P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Gait and Balance Scale</P>
<P>UPDRS III</P>
<P>PDQ-39</P>
<P>Not stated when examinations took place</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shen-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered over 12 weeks</P>
<P>Assessed at baseline and immediately after training and at 12 weeks follow-up</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>23 participants in balance group, 22 in control group. No dropouts described.</P>
<P>Participants baseline characteristics not stated.</P>
<P>Inclusion criteria: PD patients. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-18 13:28:32 +0000" MODIFIED_BY="[Empty name]">
<P>Balance: Task specific to facilitate reaction time and length of compensatory steps during activities with self-induced perturbation and in response to external perturbation.</P>
<P>Control: Strength training of lower limb muscles with moderate intensity. </P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Limit of stability</P>
<P>Walking speed</P>
<P>One leg stance time</P>
<P>Activities-specific balance confidence scale</P>
<P>UPDRS III</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shiba-1999">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Cross-over group design<BR/>Method of randomisation not stated</P>
<P>Method of analysis of the data not stated</P>
<P>Treated as outpatients for an unknown period of time. 1 week between each training regimen.</P>
<P>Assessed at baseline and immediately after treatment</P>
<P>Not stated whether the assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>8 participants took part in the study. No dropouts described.</P>
<P>Baseline characteristics not stated for groups. Total mean age 65 years; total male/female ratio 3/5.<BR/>Inclusion criteria: Stable mild to moderate Parkinson's disease. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-20 09:23:22 +0100" MODIFIED_BY="[Empty name]">
<P>Visual training: Patients walked over parallel lines at 90 degrees to the direction of travel. Distance apart of lines dependant on patients normal stride length.</P>
<P>Auditory stimulation: Patients walked to a rhythm that was 30% of their comfortable walking rhythm. <BR/>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Stride length</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only. No numerical data available</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sigurgeirsson-2009">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Method of randomisation not stated</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in 30 min sessions, 4 sessions per week for 4 weeks</P>
<P>Assessed at baseline, immediately after treatment and 3 months after treatment</P>
<P>Not stated whether the assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>26 participants randomised, group split not stated. No dropouts described.</P>
<P>Baseline characteristics of groups not stated.Total mean Hoehn Yahr 2.1.</P>
<P>Inclusion and exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-20 11:26:35 +0000" MODIFIED_BY="[Empty name]">
<P>Exercise: Walking with visual cues.</P>
<P>Control: Walking without cues.</P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Timed up and go</P>
<P>PDQ-39</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smania-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation list used</P>
<P>Method of analysis not stated</P>
<P>Treated as outpatients in 50 min sessions, 3 times per week for 7 weeks</P>
<P>Assessed at baseline, immediately post treatment and 1 month post-treatment</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>33 participants in balance group, 31 in control group. 5 dropouts in balance group, 4 in control group.</P>
<P>Participants mean age 67.6 years (balance), 67.3 years (control); Male/female 14/14 (balance), 15/12 (control); Hoehn and Yahr not stated; Duration of condition 10.4 years (balance), 8.6 years (control).</P>
<P>Inclusion criteria: Idiopathic PD and postural instability, Hoehn &amp; Yahr 3-4, did not require assistance to rise from chairs or beds. Exclusion criteria: Unstable cardiovascular disease or other chronic conditions that could interfere with their safety during testing or training procedures, other neurological conditions or mental deterioration (MMSE &lt;23), severe dyskinesias or &#8216;on-off&#8217; phases.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 19:26:55 +0000" MODIFIED_BY="[Empty name]">
<P>Balance: Each patient was submitted to balance training consisting of exercises aimed at improving both feedforward and feedback postural reactions. Patients were required to repeat exercises from 3 different groups. Group 1: self-destabilisation of the centre-of-body mass (feedforward), group 2 : externally induced destabilisation of the centre-of-body mass (feedback), group 3: emphasis of coordination between leg and arm movements during walking as well as locomotor dexterity over an obstacle course and other potentially destabilising activities (continuous feedback and feedforward adjustments). During each session 10 exercises were undertaken, 4 from group 1, 4 from group 2 and 2 from group 3. 5 &#8211; 10 repeats of each for 5 mins. Complexity of exercises was increased with patient&#8217;s ability. Support was provided by therapist at pelvis or chest when required.</P>
<P>Control: Exercises not specifically designed to improve postural reactions. Active joint mobilisation, muscle stretching and motor coordination exercises. During each session 10 exercises were undertaken, 6 in supine position, 2 in the sitting position and 2 in the standing position. 5 &#8211; 10 repeats of each for 5 mins. Complexity of exercises was increased with patient&#8217;s ability.</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Berg balance scale</P>
<P>Activities specific balance confidence</P>
<P>Postural transfer test</P>
<P>Self destabilization of the centre of foot pressure test</P>
<P>Falls diary</P>
<P>UPDRS Total</P>
<P>Modified Hoehn and Yahr</P>
<P>Geriatric depression scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Talakkad-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Method of randomisation not stated</P>
<P>Method of analysis not described</P>
<P>Treated for 8 hours over 4 weeks</P>
<P>Assessed at baseline and after 4 weeks of intervention</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>60 participants were randomised into this trial. Dropouts were not described.</P>
<P>Baseline characteristics of participants were not stated.</P>
<P>Eligibility criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-18 13:39:05 +0100" MODIFIED_BY="[Empty name]">
<P>Conventional gait training (CGT).</P>
<P>Partial weight supported treadmill training: 20% unweighting.</P>
<P>Control: No specific intervention.</P>
<P>Drug therapy not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Dynamic posturography</P>
<P>UPDRS (total and motor subscore)</P>
<P>Beat-to-beat finger blood pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only</P>
<P>Control arm not included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thaut-1996">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design<BR/>Randomised using a computerised random number generator<BR/>Analysed on an intention-to-treat basis<BR/>Treated at home or in the community, for 10.5 hours over 3 weeks. Assessed in laboratory, at baseline and immediately after treatment</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>15 patients in novel rhythmic auditory stimulation group (RAS), 11 in standard self paced training group (SPT) and 11 in no treatment group (NT). No dropouts noted.</P>
<P>Patients mean age 69 years (RAS), 74 years (SPT), 71 (NT); Male/female 10/5 (RAS), 8/3 (SPT), 8/3 (NT); Hoehn and Yahr 2.4 (RAS), 2.5 (SPT), 2.6 (NT); Duration of condition 7.2 years (RAS), 5.4 years (SPT), 8.5 years (NT).<BR/>Inclusion criteria: IPD with significant gait deficits but able to walk without physical assistance. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-01-24 15:31:01 +0000" MODIFIED_BY="[Empty name]">
<P>RAS: Individual. 30 min/day walking to 3 different tempos of music. For 1st week; normal tempo = pretest cadence, quick = 5-10% faster, fast = an additional 5-10% faster. After each week each tempo was increased by 5-10% to a maximum pace of 130 steps/min.<BR/>SPT: Individual. 30 min/day walking at normal, quick and fast speeds.</P>
<P>NT: No treatment.<BR/>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Stride velocity<BR/>Stride cadence<BR/>Stride length<BR/>EMG analysis on leg muscles</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>3 arms to trial; RAS, SPT and no treatment. SPT versus no treatment are compared in 'Physiotherapy for patients with Parkinson's disease' Cochrane review. New correspondence with author on randomisation method</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Toole-2005">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised using table of random numbers</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in 20 mins sessions, 3 times per week for 6 weeks</P>
<P>Assessed at baseline, within 1 week of completing intervention and 4 weeks later</P>
<P>Not stated whether assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>23 participants randomised, group split not stated. No dropouts described.</P>
<P>Participants mean age 75.4 years standard treadmill group (ST), 76.4 years unweighted treadmill group (UT), 72.0 years weighted treadmill group (WT); Male/female ratio not stated; Hoehn &amp; Yahr 4.8 (ST), 3.6 (UT), 3.4 (WT); Duration of condition not stated.</P>
<P>Inclusion criteria: Parkinsonism, Hoehn and Yahr 1-4. Exclusion criteria: Uncompensated cardiovascular disease, uncontrolled high blood pressure, leg claudication, significant dementia, other disorders of comprehension and/or other medical conditions that would interfere with the participants safety and comfort during submaximal exercise.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-30 11:57:50 +0000" MODIFIED_BY="[Empty name]">
<P>ST: Treadmill training with no loading or unloading.</P>
<P>UT: Treadmill training assisted by the biodex unweighting system at a 25% body weight reduction for 15 mins then 5 mins with system removed.</P>
<P>WT: Treadmill training wearing weighted scuba-diving belt which increased normal body weight by 5% for 15 mins then 5 mins without belt.</P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Balance from dynamic posturography</P>
<P>Berg balance scale</P>
<P>UPDRS</P>
<P>Biomechanical assessment of strength and range of motion</P>
<P>Gait</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-14 15:11:25 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vivas-2011">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Method of analysis not stated</P>
<P>Treated as outpatients with twice weekly 45 minute sessions for 4 weeks</P>
<P>Assessed at baseline, after 4 weeks treatment and at 17 days follow-up</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>6 participants in water based exercise group (Water), 6 in land based exercise group (Land). 1 dropout in Water group.</P>
<P>Participant mean age 65.7 years (Water), 68.3 years (Land); Male/female ratio 3/3 (Water), 4/2 (Land); Hoehn and Yahr 2.7 (Water), 2.4 (Land); Duration of condition 4.2 (Water), 7.8 (Land).</P>
<P>Inclusion criteria: IPD, ability to follow a stable medication schedule, Hoehn &amp; Yahr stage II-III (Off medication), lack of dementia (MMSE &#8805; 24). Exclusion criteria: unable to walk independently, undergone surgical treatment for PD.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 19:47:01 +0000" MODIFIED_BY="[Empty name]">
<P>Water: Warm-up exercises, trunk mobility exercises, postural stability exercises, transferring oneself and changing body positions, all carried out in water. Progression was encouraged with introduction of more complex exercises as appropriate.</P>
<P>Land: Warm-up exercises, trunk mobility exercises, postural stability exercises, transferring oneself and changing body positions, all carried out on land. Progression was encouraged with introduction of more complex exercises as appropriate.</P>
<P>Medication withheld for 12 hours before evaluations, for OFF-dose performance.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Functional reach test</P>
<P>Berg balance scale</P>
<P>Gait - turn time, velocity, cadence, step amplitude</P>
<P>Timed up and go</P>
<P>UPDRS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Werner-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by individual not involved in testing or treatment using a computer generated number list for allocation</P>
<P>Analysed on an Intention-to-treat basis</P>
<P>Treatment delivered in 90 min sessions, 2 times per week for 2 weeks</P>
<P>Assessed at baseline (4-5 days prior to start of intervention), 1 week after training and at 3, 6 and 12 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>6 participants in Verbal instruction with augmented feedback group (VIAF), 6 in Verbal instruction only group (VI). 5 dropouts at follow-up time-points, group split not stated.</P>
<P>Participant mean age 72.8 years (VIAF), 69.3 years (VI); Male/female ratio 5/1 (VIAF), 5/1 (VI); Hoehn and Yahr 2.3 (VIAF), 2.5 (VI); Duration of condition not stated.</P>
<P>Inclusion criteria: Adequate vision. Exclusion criteria: MMSE&lt;21, marked dyskinesia or other neurological impairments in addition to PD. Cardiac or musculoskeletal pathology that might impact gait, required an assistive device to walk, had video feedback or gait training previously or had difficulty understanding English.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>VIAB: 15 trials, of walking 7.5 m then returning to starting position with instruction to 'Walk as well as you can', per session. Verbal instruction and augmented feedback before each trial and 3 minutes of seated rest between each trial. Verbal instructions were to 'take big step' prior to each trial, during rest period participants were given 3 viewings of video playback of their walking performance from prior trial. On each viewing they were asked to a) focus on step length and comment on what they observed, b) indicate what they planned to do on next attempt. If subject did not comment accurately after viewing video or did not verbalise what they planned to do next, additional verbal 'knowledge of performance' (KP) or suggestions/corrections ('transitional information' (TI)) were provided by the experimenter.</P>
<P>VI: Trials conducted in same manner as for VIAB group but during rest period the group engaged in discussion or were given something to read.</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Stride length</P>
<P>Cadence</P>
<P>Gait velocity</P>
<P>Shoulder excursion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2010">
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised by independent arbiter who picked out a sealed envelopes 30 mins before the start of the intervention</P>
<P>Method of analysis not stated</P>
<P>Treatment delivered in 30 mins sessions, 3 times per week for 4 weeks</P>
<P>Assessed at baseline, within 7 days of completion of treatment, 1 month after treatment</P>
<P>Assessors were not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>16 participants in downhill walking group (DW), 17 in physiotherapy group (PT). 2 dropouts in DW group, 5 dropouts in PT group.</P>
<P>Participants mean age 68.1 years (DW), 66.3 years (PT); Male/female 9/6 (DW), 7/8 (PT); Hoehn and Yahr 2.2 (DW), 2.2 (PT); Duration of condition 4.8 years (DW), 5.3 years (PT).</P>
<P>Inclusion criteria: Diagnosed with IPD (as defined by the UK Brain Bank Criteria) by a neurologist, Hoehn and Yahr stages I through III, ability to walk independently, stable medication usage, freedom from any other problems that might affect training and ability to understand instructions and follow commands. Exclusion criteria not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-26 19:55:48 +0000" MODIFIED_BY="[Empty name]">
<P>DW: Downhill walking training using a treadmill. Subjects walked on a motorized treadmill with a body weight support (BWS) system under the close supervision of a physical therapist. Initially the downhill grade was set at 3%. If subjects could walk with correct erect posture and large strides without stumbling during the training period, the downhill grade was then increased by 1% per training period. Treadmill speed was set at a level that was comfortable for each participant. A BWS of &lt;40% of the body weight was provided and decreased to the maximum extent possible. Rest periods were provided as needed.</P>
<P>PT:Conventional therapy training program consisted of flexibility exercises (5 mins), strengthening exercises (7 mins), proprioceptive neuromuscular facilitation, coordination training, balance training (8 mins) and overground walking training (10 mins).</P>
<P>Drug therapy was stable during trial period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Speed</P>
<P>Cadence</P>
<P>Stride length</P>
<P>Thoriacic kyphosis</P>
<P>Muscle strength</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Byl-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>After contacting the author it was found that the study was not properly randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheon-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Not stated whether patients were randomised into trial. Author contacted but no response</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chouza-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Whole body vibration technique not usually used by physiotherapists</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cianci-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded as confounded due to use of rolling walker</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Donovan-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi randomised using alternate allocation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farley-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Insufficient information available from abstract for review and no author correspondence was achieved</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Filippin-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Single arm study, so not randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-06 13:48:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frazzitta-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-06 13:48:58 +0000" MODIFIED_BY="[Empty name]">
<P>Comparator arm consists of suggested home exercise and usual care only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gobbi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Insufficient information available from abstract for review and not stated whether randomisation was carried out</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haase-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Single short session of intervention; treatment under one day. Not rehabilitative therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamsma-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Partially randomised with a portion of patients placed in a convenient group based on practical grounds such as availability of transport</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klassen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Difference between the two physiotherapy arms is multidisciplinary education for which the physiotherapy component is unknown</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Knobl-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Not properly randomised, placed in groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes not relevant, stroke outcomes used and patients trained on one side of the body only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover trial carried out over one day only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marchese-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Not properly randomised, pseudo-random number list used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Modugno-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Trial included a theatre training arm which could not be considered solely as physiotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Munneke-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial of systems of care for delivery of physiotherapy, not comparing different physiotherapy techniques</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pacchetti-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Two arm trial included active music therapy arm, not considered to be solely physiotherapy intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pohl-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised multiple intervention cross-over, over 4 consecutive days. Randomisation was of the sequence of the interventions, therefore not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rochester-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded as the study was a randomised crossover over a couple of hours</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sage-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>After contacting the author it was found that the study was not properly randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sage-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>After contacting the author it was found that the study was not properly randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sage-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>After contacting the author it was found that the study was not properly randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stallibrass-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>The method of therapy used - Alexander Technique - is not used by physiotherapists. Therefore this trial was excluded</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tamir-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised trial using alternate allocation of patients to arms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tickle_x002d_Degnen-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Multidisciplinary rehabilitation trail. Percentage component of physiotherapy was not specified, therefore unable to differentiate the contribution of physiotherapy to any change in the outcome measures</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wulf-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Multiple cross-over trial over a short period of time</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yen-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>No outcome measures relevant to our review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brauer-2011">
<CHAR_STUDY_NAME MODIFIED="2012-11-20 11:16:52 +0000" MODIFIED_BY="[Empty name]">
<P>Single and dual task gait training in people with Parkinson's disease: A protocol for a randomised controlled trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised with opaque envelopes containing allocations from a computer generated random number sequence prepared by offsite investigator not involved in recruitment, intervention or data collection</P>
<P>Analysed on an intention-to-treat basis</P>
<P>Treated as outpatients for 40 - 60 minutes session 3 times a week for 4 weeks, setting not stated</P>
<P>Assessed at baseline, immediately after treatment and after 6 months follow-up</P>
<P>Assessors blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Planning to recruit 60 participants.</P>
<P>Inclusion criteria: 18 years or older, IPD diagnosed using UKBB criteria, able to walk 100 m independently with or without gait aids, report reduced step length or slowed gait speed, confirmed by clinical examination, Hoehn and Yahr stage I-IV. Exclusion criteria: Neurological condition other than PD, musculoskeletal or cardiopulmonary conditions that affect the ability to safely walk, had surgery for PD such as deep brain stimulation, score &lt;24 on the mini-mental status examination.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Single task training: One-to-one therapy sessions with therapist. Individually progressed program of gait training aimed at improving step length via repeated practice of straight line walking, turning, obstacle negotiation and challenging gait tasks such as increasing speed and altering surface challenges. External cues to increase step length will be used when needed. Instructions will not be given while participant is walking to avoid dual tasking. A home program will be incorporated at week 2 for 6 months, which includes a walking program and a range of balance, strengthening and postural exercises.</P>
<P>Dual task training: One-to-one therapy sessions with therapist. Aim to improve step length under dual task conditions that is when concurrently performing added cognitive or motor tasks. Participants will undertake repeated practice of walking aiming to improve step length using external cueing techniques including verbal, visual or auditory approaches. Progressing to internal concurrent cueing of appropriate step length. The gait tasks undertaken will be progressed from simple to more complex tasks as outlined for the single task group. In addition a variety of added tasks will be progressively integrated into the training program. These include tasks such as listening, speaking, conversing, generation of simple and complex lists, language, calculation and motor tasks increasing in complexity. Tasks will include those designed to reflect functional everyday activities such as carrying bags, getting keys out of a pocket, counting money, recalling directions or making a shopping list. Complexity will be progressively integrated as more complex tasks result in greater dual task interference with gait in people with PD. If able, participants will be progressed to performing increasingly complex cognitive tasks while concurrently walking. Motor tasks such as carrying and manipulation will also be included as added tasks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Step length</P>
<P>Gait speed</P>
<P>Cadence</P>
<P>Stride length</P>
<P>Step length coefficient of variation</P>
<P>Double support time</P>
<P>Trail making A&amp;B tests</P>
<P>Strop colour-word interference test</P>
<P>Digit span test</P>
<P>Timed up and go</P>
<P>6-minute walk test</P>
<P>Measures of community mobility questionnaire</P>
<P>Activity measured using ActivPAL</P>
<P>Quality of life</P>
<P>PDQ-39</P>
<P>EQ-5D</P>
<P>Hoehn and Yahr</P>
<P>UPDRS III</P>
<P>Freezing of Gait questionnaire</P>
<P>Ambulatory self confidence questionnaire</P>
<P>Compliance</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-11-20 11:22:28 +0000" MODIFIED_BY="[Empty name]">
<P>s.brauer@uq.edu.au</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-11-20 11:21:54 +0000" MODIFIED_BY="[Empty name]">
<P>Protocol only</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Protas-2005">
<CHAR_STUDY_NAME MODIFIED="2012-11-01 15:05:27 +0000" MODIFIED_BY="[Empty name]">
<P>Gait and step training to prevent falls in Parkinson's disease</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Treatment delivered for 1 hour per day, 3 times per week for 8 weeks</P>
<P>Assessed at baseline, at 8 weeks, at 1 month follow-up and 5 month follow-up</P>
<P>Assessors blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Planning to recruit 90 participants.</P>
<P>Inclusion criteria: Diagnosis of PD, postural instability - gait disorder predominant PD, history of falls, gait freezing or a positive pull test, stable regimen of medications, ability to stand and walk 3 m without assistance, stage 2 or 3 of the Hoehn and Yahr disability scale and moderate or higher cognitive scores.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-20 16:07:31 +0000" MODIFIED_BY="[Empty name]">
<P>GSP: Gait and step perturbation. Gait training on a treadmill and in a safety harness while walking in four directions: frontwards, backwards, left sideways and right sideways. Training will start with a treadmill speed that is equivalent to fastest overground walking speed for forward walking and fastest possible for other directions and will increase during training. This group will also receive step training while positioned in 4 directions consisting of suddenly turning the treadmill on/off. The subjects will be required to maintain their balance during perturbations. </P>
<P>SPT: Seated exercise. This group will receive seated active range of motion, and upper and lower extremity aerobic training. </P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Usual and fastest gait speed</P>
<P>5-step test</P>
<P>UPDRS</P>
<P>Gait and balance scale</P>
<P>Center for Epidemiological Studies depression scale</P>
<P>Cognistat - a co-morbidity scale</P>
<P>Activities balance confidence</P>
<P>Physical activity scale for the elderly</P>
<P>Limits of stability</P>
<P>Falls frequency</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-11-20 16:20:31 +0000" MODIFIED_BY="[Empty name]">
<P>25th September 2006</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-11-01 15:09:28 +0000" MODIFIED_BY="[Empty name]">
<P>shinowara@nih.gov</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schenkman-2012b">
<CHAR_STUDY_NAME MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Endurance exercise in Parkinson's disease</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomisation method not stated</P>
<P>Treatment was delivered four times a week for 6 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-16 17:11:12 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated total enrolment, 126 participants. Three arm trial: No intervention control group (NT), vigorous exercise group (VE), moderate exercise group (ME).</P>
<P>Inclusion Criteria: Clinical diagnosis of primary Parkinson's disease, in a Hoehn and Yahr stage less than stage III, disease duration is less than 5 years, not likely to require dopaminergic therapy within 6 months.<BR/>Exclusion Criteria: Use of any PD medication within 60 days prior to the beginning the study, including levodopa, direct dopamine agonists, amantadine, Rasagiline (Azilect), Selegiline (Eldepryl), Artane (trihexyphenidyl). Duration of previous use of medications for PD that exceeds 90 days. Expected to require dopaminergic therapy in the next 6 months. Poorly controlled or unstable cardiovascular disease. Uncontrolled hypertension. Hypo- or hyperthyroidism, abnormal liver function, abnormal renal function. Mild cognitive impairment (Montreal Cognitive Assessment score&lt;26/30). Depression that precludes ability to exercise (Beck depression score&gt;13). Disorders that interfere with ability to perform endurance exercises. Regular participation in vigorous endurance exercise. Evidence of serious arrhythmias or ischemic heart disease. Any clinically significant medical condition, psychiatric condition, drug or alcohol abuse, or laboratory abnormality that would, in the judgment of the investigators, interfere with the ability to participate in the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-31 15:07:03 +0000" MODIFIED_BY="[Empty name]">
<P>NT: Control Group. Wait listed to moderate or vigorous exercise after 6 months of no exercise.</P>
<P>VE: Endurance exercise at 80-85% HR max.</P>
<P>ME: Endurance exercise at 60 - 65% HR max.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Adherence to exercise</P>
<P>UPDRS Motor</P>
<P>Adverse events</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-01-31 15:08:42 +0000" MODIFIED_BY="[Empty name]">
<P>April 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-11-21 15:35:16 +0000" MODIFIED_BY="[Empty name]">
<P>lindsey.pederson@ucdenver.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-10-24 14:48:21 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2009">
<CHAR_STUDY_NAME MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Strength training and medication effects in Parkinson's disease: effects on hypokinesia in Parkinson's disease</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Treated for 12 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-31 14:54:17 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Male or female at least 40 years of age, neurologist diagnosed idiopathic PD (using UK Brain Bank Criteria), ambulatory and medically cleared by their physician to participate in an exercise regimen, clinical signs of hypokinesia or postural instability, Folstein Mini-Mental State Examination score &gt; 23, currently taking dopamine replacement medication.</P>
<P>Exclusion criteria: Previous surgical management of PD (pallidotomy, DBS), motor fluctuations and/or dyskinesias uncontrolled by medications, central nervous system disorder (other than PD), myopathic disease (e.g. focal myopathy) that affects skeletal muscle structure/function rheumatological disease that has an effect on muscle and/or mobility, unstable cardiovascular disease that limits exercise abilities, impaired knee flexion, &lt;90°, extreme claustrophobia (secondary to the inability to perform the MRI scans) regular (2-3 times/week) aerobic or resistance exercise performed over the past 6 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>High force resistance training</P>
<P>Standard care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Muscle structure</P>
<P>Muscle force output</P>
<P>Hypokinesia</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-11-21 17:09:27 +0000" MODIFIED_BY="[Empty name]">
<P>August 2007</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-11-21 17:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>sheldon.smith@hsc.utah.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Uc-2010">
<CHAR_STUDY_NAME MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Effects of aerobic exercise in Parkinson's disease</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Assessors blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-21 18:45:43 +0000" MODIFIED_BY="[Empty name]">
<P>100 participants to be enrolled.</P>
<P>Inclusion criteria: Veteran or non-veteran, presence of all 3 cardinal features of Parkinson's disease (resting tremor, bradykinesia and rigidity) which must be asymmetrical, Hoehn &amp; Yahr stage I-III, men or women aged 50-80 capable of performing the planned exercise programs, intention to remain in the local area over the study period, stable dopaminergic treatment regimen for at least 4 weeks prior to baseline without any clinical need for medication adjustment at the time of screening.</P>
<P>Exclusion criteria: Secondary parkinsonism, Parkinson-plus syndromes, MMSE score&lt;24, participating in an aerobic exercise program, an unstable dosage of drugs active in the central nervous system during the 60 days before the baseline visit, participation in drug studies or the use of investigational drugs within 30 days before screening, structural brain disease, active epilepsy, acute illness or active confounding medical, neurological or musculoskeletal conditions, alcoholism or other forms of drug addiction, inability to complete the graded exercise test, lack of medical clearance from our pulmonologist, intention to move or take &gt; 1 month vacation during the study period, contraindications to MRI or claustrophobia requiring sedation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-22 09:43:23 +0000" MODIFIED_BY="[Empty name]">
<P>Aerobic exercise in the form of brisk walking using different training formats, four arms: group/continuous, group/interval, single/continuous and single/interval.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Cycle ergonometry</P>
<P>Functional and morphometric MRI</P>
<P>Trophic factor</P>
<P>Biomarker assays</P>
<P>Safety exams</P>
<P>Lab results (ECG, biochemistry, CBC)</P>
<P>Tests for Parkinsonism and cognition</P>
<P>Questionnaires about quality of life, mood and activities of daily living</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>February 2009</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-11-22 10:28:09 +0000" MODIFIED_BY="[Empty name]">
<P>ergun-uc@uiowa.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Nimwegen-2010">
<CHAR_STUDY_NAME MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>ParkFit study: A randomised controlled trial evaluating the effectiveness of a multifaceted behavioural program to increase physical activity in Parkinson patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group design</P>
<P>Randomised assigned using minimisation algorithm</P>
<P>Treatment delivered over 2 years, offered a maximum of 35 sessions per year, each session lasting 30 mins</P>
<P>Assessed at baseline, at 6 months, 12 months 18 months and 24 months</P>
<P>Assessors were blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>586 participants randomised, 299 in ParkFit group and 287 in ParkSafe group. No dropouts described.</P>
<P>Baseline characteristics for groups not stated</P>
<P>Inclusion criteria: PD according to UKBB criteria, aged between 40 and 75 years, sedentary lifestyle (&lt;3 times a week vigorous-intensity physical activity for &lt;60 mins or &lt;3 times a week moderate-intensity physical activity for &lt;150 mins), Hoehn &amp; Yahr score &#8804;3. Exclusion criteria: Unclear diagnosis (no gratifying and sustained response to dopaminergic therapy), MMSE score &lt;24, unable to complete dutch questionnaires, severe co-morbidity interfering with daily functioning, daily institutionalised care, deep brain surgery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-26 15:10:24 +0100" MODIFIED_BY="[Empty name]">
<P>Both interventions were delivered exclusively by experienced therapists who participate in the Dutch ParkinsonNet.</P>
<P>ParkFit: Brochure provided, <I>ParkFit</I>, covering specific strategies to promote behavioural change. Physical therapists serve as personal activity coaches who guide patients towards a more active lifestyle, during specific coaching sessions. Patient and coach create activity goals in order to obtain the 6-month goals. Patients receive a personal ambulatory monitor with automated visual feedback showing the amount of actually delivered daily physical activity, recorded by a triaxial accelerometer. The ParkFit program also included a maximum of 19 physical therapy sessions in year 1 and 23 in year 2. Based on individual disabilities, therapist and patient jointly formulate treatment aims based on the evidence-based guideline of physical therapy for PD.</P>
<P>ParkSafe: Patients receive a brochure, <I>ParkSafe</I> with information about the benefits of physical therapy. Specific emphasis is given to the importance of safety when performing daily activities. Patients receive an individualised physical therapy program. Total of 35 sessions per year: 19 physiotherapy plus 16 coach sessions). Physical therapist and patient jointly formulate the aims of the projected treatment plan, based on individual problems and disabilities. </P>
<P>Not stated whether the drug therapy was constant during trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Level of physical activity</P>
<P>6 minute walk test</P>
<P>PDQ-39</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-09-26 15:12:10 +0100" MODIFIED_BY="[Empty name]">
<P>September 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-09-26 15:13:34 +0100" MODIFIED_BY="[Empty name]">
<P>m.munneke@neuro.umcn.nl</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Subgroup analysis of those who succeeded in increasing their activity levels versus those who didn't, assessed for disease progression and physical fitness</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-11-30 11:56:43 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Eligibility Criteria</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Inclusion and exclusion criteria</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Eligibility criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-12 13:29:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Inclusion criteria stated, clear definition of disease</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Inclusion criteria IPD only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Inclusion criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Characteristics of included patients described but not stated whether these items were used for the selection of patients for trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Eligibility criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Charateristics of included patients described but not stated whether these items were used for the selection of patients for trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Eligibility criteria not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Inclusion and exclusion criteria confirmed with author correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Inclusion and exclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Inclusion criteria stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Randomisation Method</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Allocation pulled out of hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Random allocation list not clear how generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Not stated how random number list was generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Randomised by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Subjects self-selected a card with eyes closed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Numbers drawn from a hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Allocation pulled out of hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Randomised by selecting allocation from a hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-12 13:34:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Computer generated random number list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Permuted blocks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Participants randomised by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Randomised using generated random number sequences by an independent university source</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Randomised by computerised random-number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-12 13:52:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>List generated using www.randomization.com</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Computer generated sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Computer generated assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Randomisation list used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Randomised using a computerised random number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Table of random numbers, unclear how generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Computer generated randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Randomised by independent arbiter who picked out a sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Concealment of Allocation</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Allocation pulled out of hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Lists kept by independent 3rd party</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Randomisation method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Randomised by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Subjects self-selected a card with eyes closed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Randomisation method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Numbers drawn from a hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Allocation pulled out of hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Randomised by selecting allocation from a hat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Randomisation method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Method of Randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Sealed envelopes used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Participants randomised by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>By the envelope method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Envelope method used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Randomised using generated random number sequences by an independent university source</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Randomisation method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Randomisation performed by an independent researcher</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>List kept by principal investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Method of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Randomisation list kept in locked desk of principal investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Method of randomisation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Randomised using table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Randomisation method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Randomised by individual not involved in testing or treatment </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Randomised by sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Similarity at Baseline</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Hoehn and Yahr not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>No significant differences were found between groups in pretest demographic variables</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Baseline characteristics not split by group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Group characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Hoehn and Yahr not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Participant baseline characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Mean Hoehn and Yahr not given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Hoehn and Yahr not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Baseline characteristics not split into groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Only average age of groups given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>No significant difference between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Limited baseline data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>No significant difference in baseline demographic data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Hoehn and Yahr not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Group baseline characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Baseline characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Group characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Baseline characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Baseline characteristics of groups not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Hoehn and Yahr scores not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Baseline characteristics not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-22 11:32:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Group characteristics similar at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Intention to Treat Analysis</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Analysed on a per protocol basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Primary analysis was ITT then per protocol was carried out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Analysis method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Analysed on a per protocol basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Method of analysis not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Method of analysis not given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Method of analysis not given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Analysed on an intention-to-treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Per protocol analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Intention-to-treat analysis used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Intention-to-treat analysis used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Analysed on an intention-to-treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Analysed on an intention-to treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Analysed on an intention-to-treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Method of analysis not stated. ITT was not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>Per protocol analysis used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Attempted to assess all participants regardless of whether they had started or completed intervention. ITT not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Analysis method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Intention-to-treat analysis used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Method of analysis not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Analysed on an intention-to-treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Analysis method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Analysed on an intention-to-treat basis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Method of analysis not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="14">
<NAME>Withdrawals Described</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Withdrawals at less than 10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Withdrawals &gt; 15% prior to post-intervention assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Dropouts at 15%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Number of dropouts not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Withdrawals &lt;10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>No dropouts reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Withdrawals at 19%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Withdrawals at 31%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>13% withdrawal rate for muscle strength outcomes only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>No dropouts described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Withdrawals to 29%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Dropouts not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Withdrawals &lt;10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Dropouts not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Withdrawals at 13%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Withdrawals at 7% for post-intervention time point</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>No withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Withdrawals at 17%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Withdrawals at 7%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>No withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Withdrawals at 10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-06 17:09:19 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>Withdrawals at 12%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Withdrawals at 31%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Withdrawals at 10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>21% lost between 6 and 24 months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Withdrawals at 21%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Dropouts not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Withdrawals at 14%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Dropouts not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>No withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Withdrawals not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Withdrawals at 8%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>No withdrawals at post-intervention time point. Withdrawals at 42% for follow up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Withdrawals at 21%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="15">
<NAME>Cointerventions Constant</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Participants maintained stable drug regiment throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Not stated whether drug therapy was kept constant during the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Drug regimen remained constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Patients were excluded if medication changed during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Not stated whether drug regimen remained constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Not stated whether drug therapy was kept constant during the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Minor changes to medication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>All medication kept stable during course of study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Not stated whether drug regimen remained constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Drug regimen remained constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Patients excluded if change in medication was required</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Participants remained on a steady drug regimen throughout the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Not stated whether drug therapies were kept constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Medications kept stable throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Not stated whether drug regimen remained constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Drugs stable during therapy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Not stated whether drug therapies were kept constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>No significant change in medications</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Not stated whether drug therapies were kept constant throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Medications kept stable throughout trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Drug therapy was stable during therapy period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Changes in medication not allowed. Participants who changed their medication were excluded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Drug therapy was stable during therapy period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>No changes in medications as this was a criterion for exclusion</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Not clear whether the drug therapy was constant during treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Minor changes in 5 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Drug therapy kept constant for first four months only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Drug therapy not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Not stated whether the drug therapy was constant during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Drug therapy was stable during trial period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-16" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="16">
<NAME>Comparable arms</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Same time and attention given to both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Same time and attention given in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Home group no therapist time</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Same number of sessions of active therapy in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Time and attention greater in LSVT BIG and WALK groups than in HOME group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>No details of intervention schedules</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Same time and attention given to each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Same time and attention given to participants in each physio group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Half the amount of time and attention spent with delayed start group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>HE group received less time and attention than experimental groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Same time and attention given to participants in both T and TwC arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Treatment schedules not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-14 16:02:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Same time and attention given to both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Same time and attention given to participants in both arms</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-17" LEVEL="STUDY" MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="17">
<NAME>Blinded Assessors</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Almeida-2012">
<DESCRIPTION>
<P>Assessors blind for UPDRS III evaluation only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Braun-2011">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burini-2006">
<DESCRIPTION>
<P>Assessors blinded, patients instructed not to discuss treatment schedule</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chaiwanichsiri-2011">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2005">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diehl-2011">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ebersbach-2010">
<DESCRIPTION>
<P>Assessors blinded for primary outcome, not stated for secondary outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Assessors were blinded to group allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frazzitta-2009">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-04 13:11:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2007">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2009">
<DESCRIPTION>
<P>Assessors blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hackney-2010">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hass-2006">
<DESCRIPTION>
<P>Single blind study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hirsch-1996">
<DESCRIPTION>
<P>Assessors not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Joudoux-2011">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juncos-2006">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khallaf-2011">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2012">
<DESCRIPTION>
<P>Assessors blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loureiro-2010">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mak-2008">
<DESCRIPTION>
<P>Assessors blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGinley-2012">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miyai-2000">
<DESCRIPTION>
<P>Assessors were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miyai-2002">
<DESCRIPTION>
<P>Assessors were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morris-2009">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmer-1986">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pelosin-2010">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Picelli-2012">
<DESCRIPTION>
<P>Assessors blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Poliakoff-2009">
<DESCRIPTION>
<P>Assessors were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reuter-2011">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ridgel-2009">
<DESCRIPTION>
<P>Assessors blinded for UPDRS outcome only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Robichaud-2012">
<DESCRIPTION>
<P>Assessors blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schenkman-2012a">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shankar-2009">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shiba-1999">
<DESCRIPTION>
<P>Not stated whether the assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sigurgeirsson-2009">
<DESCRIPTION>
<P>Not stated whether the assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2010">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talakkad-2011">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thaut-1996">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toole-2005">
<DESCRIPTION>
<P>Not stated whether assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vivas-2011">
<DESCRIPTION>
<P>Assessors not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2010">
<DESCRIPTION>
<P>Assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2010">
<DESCRIPTION>
<P>Assessors were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2014-05-07 09:45:01 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-05-07 09:45:01 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-05-07 09:45:01 +0100" MODIFIED_BY="[Empty name]">Included trials: summary table of results</TITLE>
<TABLE COLS="12" ROWS="45">
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="MIDDLE">
<P>Study Group</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="MIDDLE">
<P>Location</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="4" VALIGN="MIDDLE">
<P>Interventions</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="4" VALIGN="MIDDLE">
<P>Withdrawals at post-test (with reasons)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="MIDDLE">
<P>Outcomes</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="MIDDLE">
<P>Summary of results at post-test</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Arm 4</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Almeida-2012" TYPE="STUDY">Almeida 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Waterloo, Canada</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Visual cueing on the ground (n=14; 30 minutes, 3 times per week, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Visual cueing on the treadmill (n=14; 30 minutes, 3 times per week, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control (n=14)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: Step length</P>
<P>Secondary:</P>
<P>UPDRS III, timed up and go, gait speed, cadence, double support time, step time, step-to-step variability, step time variability, 30 second chair stand</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Braun-2011" TYPE="STUDY">Braun 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Netherlands</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy with mental practice (n=25; 1 hour (or 2 x 30 minutes) weekly, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy with relaxation (n=25; 1 hour (or 2 x 30 minutes) weekly, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>3 (n=2; hospitalised with relapse, n=1; too confronting)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=3; hospitalised with relapse, n=1 died)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Visual analogue scale, timed up and go, 10 m walk test</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Burini-2006" TYPE="STUDY">Burini 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Ancona, Italy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Aerobic training (n=13; 45 minutes, 3 times per week, 7 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Qigong group (n=13; 45 minutes, 3 times per week, 7 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; poor compliance, n=1; back pain after 3rd session)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; poor compliance, n=1; fall-related fracture)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: UPDRS III, UPDRS II, Brown's disability scale (BDS), 6 minute walk test, Borg scale for breathlessness, Beck depression inventory (BDI), PDQ-39.</P>
<P>Secondary: Spirometry test,</P>
<P>Maximum cardiopulmonary exercise test</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms for primary outcomes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Chaiwanichsiri-2011" TYPE="STUDY">Chaiwanichsiri 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Bangkok, Thailand</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill with music cue (n=10; 30 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill (n=10; 30 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Home walking (n=10; 30 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Timed up and go,</P>
<P>Walking speed, Step length, Cadence, Stride length, 6-minute walk test, 6 metre walk time, Single leg stance, UPDRS I, II, III</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Dias-2005" TYPE="STUDY">Dias 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Brasil, South America</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy and cardiovascular exercise with visual cues (n=8; total 20 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Conventional physiotherapy (n=8; total 20 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS, Functional independence measurement scale, Berg balance scale, H&amp;Y scale</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy and cardiovascular exercise with visual cues significantly improved functional independent measure, step length, velocity (gait speed) and cadence compared to conventional physiotherapy</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Diehl-2011" TYPE="STUDY">Diehl 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Indiana, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Group Box training (n=unknown, total n=20)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Traditional group exercise (n=unknown, total n=20)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Berg balance scale,</P>
<P>Activities specific balance confidence scale, Functional reach test, Parkinson's disease quality of life scale</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Ebersbach-2010" TYPE="STUDY">Ebersbach 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Beelitz-Heilsãtten, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>LSVT BIG training (n=20; 1 hour, 4 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Nordic Walking (n=20; 1 hour, twice a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Home exercise (n=20; 1 session)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; withdrawal of consent)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; withdrawn due to psychosis)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: UPDRS III.</P>
<P>Secondary: PDQ-39, Timed up and go, time to walk 10 m</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Significant improvement of UPDRS, timed up and go and timed 10m walking in LSVT BIG group compared to Nordic walking and home exercise. There was no difference between treatment arms for PDQ-39</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Los Angeles, California</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill group (n=10; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy group (n=10; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control group (n=10; 1 hour, total of 6 sessions over 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS (Total, I, II and III subscores),</P>
<P>Hoehn and Yahr,</P>
<P>Functional assessments, Walking tests: average gait velocity, step length, stride length, cadence, double limb support time, ankle, knee, hip rotation.</P>
<P>Sit-to-stand test, Transcranial magnetic stimulation (subset)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Frazzitta-2009" TYPE="STUDY">Frazzitta 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Montescano, Italy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill with auditory and visual cues (n=20; 20 minutes daily, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Auditory and visual cues (n=20; 20 minutes daily, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS III, Gait speed, Freezing of gait questionnaire,</P>
<P>Stride length, 6 minute walking test</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>The treadmill with auditory and visual cues had significant improvement in gait speed, freezing of gait questionnaire, stride length and 6 minute walking test when compared to the auditory and visual cues group. There were no differences between treatment arms for UPDRS III</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Hackney-2007" TYPE="STUDY">Hackney 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>St. Louis, Missouri, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tango (n=9; 1 hour, 20 sessions within 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Exercise (n=10; 1 hour, 20 sessions within 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS III, Berg balance scale,</P>
<P>Freezing of gait, Timed up and go, Velocity of walking and dual-task walking</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Hackney-2009" TYPE="STUDY">Hackney 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>St. Louis, Missouri, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tango group (n=19; 1 hour, twice weekly, total 20 sessions in 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Waltz/foxtrot group (n=19; 1 hour, twice weekly, total 20 sessions in 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tai Chi group (n=17; 1 hour, twice weekly, total 20 sessions in 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control group (n=20; 13 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>5 (n= 1; personal problems, n=1; knee pain, n=2; transportation problems, n=1; change in medication)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; injury at home, n=1; infrequent attendance (unknown))</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=2; transportation problems, n=1; hospitalisation (unrelated), n=1; insufficiently intense exercise)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>3 (n=1; hospitalisation (unrelated), n=1; ankle injury, n=1; death in family)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>PDQ-39, UPDRS III,</P>
<P>Berg balance scale, Tandem stance test, Timed up and go test, One leg stance test</P>
<P>6 minute walk test, Gait</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>PDQ-39 significantly improved in the tango arm compared to the waltz/foxtrot and Tai Chi arms. Timed up and go test was significantly improved in the tango arm compared to the waltz/foxtrot and Tai Chi arms. There was no difference between treatment arms in UPDRS III</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Hackney-2010" TYPE="STUDY">Hackney 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>St. Louis, Missouri, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Partnered tango (n=19; 1 hour, twice weekly, 10 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Non-partnered tango (n=20; 1 hour, twice weekly, 10 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>7 (n=1; progressive decline in mental status, n=2; excessive travelling distance, n=1; felt classes were too fatiguing, n=3; unable to return for follow-up measures)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>5 (n=1; expressed lack of interest, n=1; new job interfered with class, n=1; unrelated medical problems, n=1; work commitments, n=1; unable to return for follow-up measures)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tandem stance, one leg stance, Timed up and go, 6 minute walk test, Gait velocity, Cadence, Stride length, Swing percentage, Double support percentage</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Hass-2006" TYPE="STUDY">Hass 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Florida, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tai Chi (n=unknown, total n=23; 1 hour, twice weekly, 16 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Qi-gong (n=unknown, total n=23; 1 hour, twice weekly, 16 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Gait initiation, Gait velocity, Stride length, Stance, Double limb support, Step duration</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Hirsch-1996" TYPE="STUDY">Hirsch 1996</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>North Carolina, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Combined balance and resistance training (n=6; 45 minutes, 3 times per week, 10 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Balance training group (n=9; 30 minutes, 3 times per week, 10 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Balance, Muscle strength (subset group): knee extensors, knee flexors, ankle plantar flexors.</P>
<P>Latency to fall, % of trials resulting in falls</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Combined balance and resistance training improved balance scores significantly more than the balance training group. There were no differences between treatment arms for the falls outcomes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Joudoux-2011" TYPE="STUDY">Joudoux 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Crétil, France</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Asymmetric motor training program (n=unknown, total n=50; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Broad program (n=unknown, total n=50; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS III, GMT score, Rapid alternating movements,</P>
<P>Handwriting and spiralography, PDQ-39, Dpression (GDS-15), Video recording of 8 activities of daily living and biomechanical evaluations</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Abatract describing methodology. No result data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Juncos-2006" TYPE="STUDY">Juncos 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Georgia, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Aerobic exercise (n=unknown, total n=56; 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tai Chi (n=unknown, total n=56; 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Qi-gong (n=unknown, total n=56; 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown (total n=16: n=2; serious adverse events, n=14; unrelated medical or logistical problems)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown (total n=16: n=2; serious adverse events, n=14; unrelated medical or logistical problems)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown (total n=16: n=2; serious adverse events, n=14; unrelated medical or logistical problems)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS total, UPDRS motor, UPDRS ADL, PDQ-39, Clinical global impression, Walking speed, Falls</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS ADL scores improved significantly more with Qi-gong than aerobic exercise. There was no difference between treatment arms for PDQ-39 and UPDRS total and motor subscores. There was insufficient information on clinical global impression, walking speed and falls</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Khallaf-2011" TYPE="STUDY">Khallaf 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Saudi Arabia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy and treadmill (n=15)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy (n=15)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS II &amp; III, Hamilton rating scale of depression, Walking speed, Walking distance</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Both treatment arms showed significant improvement in walking distance, speed and ADL. A significant improvement in depression only observed in physiotherapy and treadmill group. Unclear if there were any differences between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Li-2012" TYPE="STUDY">Li 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Oregon, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Tai Chi (n=65; 1 hour, twice weekly, 24 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Resistance training (n=65; 1 hour, twice weekly, 24 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control, stretching group (n=65; 1 hour, twice weekly, 24 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>9 (n=4; health problem, n=3; noncommittal/time conflict, n=2; relocating)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>6 (n=4; health problem, n=1; noncommittal/time conflict, n=1; relocating)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=3; health problem, n=1; noncommittal/time conflict)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: Two indicators of postural stability: maximum excursion and directional control.</P>
<P>Secondary: Stride length, Walking velocity, Strength of bilateral knee extensors and flexors, Functional reach test, Timed up and go, UPDRS III, Number of falls</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>The Tai Chi group performed significantly better than those in the resistance training and stretching groups on the primary outcomes. The Tai Chi group had significantly better performance/scores in many outcomes compared to the stretching group. The Tai Chi group out performed the resistance training group on the stride length and functional reach</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Loureiro-2010" TYPE="STUDY">Loureiro 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Católica do Paraná, Brazil</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Conventional physical therapy (n=6, sessions, twice weekly, total 12 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Complementary activities (n=6, sessions, twice weekly, total 12 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Timed up and go, Anterior functional reach</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Mak-2008" TYPE="STUDY">Mak 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Hong Kong, China</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Audio-visual cued task-specific training (n=21; 20 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Conventional exercise (n=21; 45 minutes, twice weekly, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control (n=18; 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; change of medication, n=1; heel pain)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; fall with fracture, n=1; went overseas)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=2; declined to come back, n=2; went overseas)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Peak horizontal velocity, Peak vertical velocity, Movement time,3 D Kinematics data of sit-to-stand</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>The audio-visual cued task-specific training group increased both peak horizontal and vertical velocities and reduced time taken to complete sit-to-stand. These improvements were greater than those of the conventional exercise group and control</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-McGinley-2012" TYPE="STUDY">McGinley 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Carlton, Australia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Movement strategy training (n=69; 2 hours + 2 hours home practice program, once a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Progressive strength training (n=70; 2 hours + 2 hours home practice program, once a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Life skills control (n=71; 2 hours + 2 hours home practice program, once a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; unable or unwilling to attend, n=1; death)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; health reasons)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>12 (n=2; unable or unwilling to attend, n=2; poor health, n=1; preference for exercise group, n=1; death, n=2; health reasons, n=1; unspecified, n=1; group was "depressing", n=2, not exercising or receiving falls education)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: Falls: no. of fallers per group, no. of multiple fallers per group, falls rate over 12 months in each group.</P>
<P>Secondary: Number of injurious falls, Walking speed, 6 minute walk test, Timed up and go, UPDRS II and III, PDQ-39, EuroQol-5D</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Time to first fall during the intervention phase did not differ across groups. Full trial results not yet published</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Miyai-2000" TYPE="STUDY">Miyai 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Osaka, Japan</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Body weight supported treadmill training (n=5; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physical therapy (n=5; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS, UPDRS subscales (mental, ADL, motor and complications), Overground ambulation endurance, Gait speed, No. steps taken for 10 metre walk</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Cross-over trial, combined data presented. Body weight-supported treadmill training showed greater improvement in UPDRS total, ambulation speed and number of steps than physical therapy arm. Additional data supplied by author allowed data to be separated and there was no difference between arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Miyai-2002" TYPE="STUDY">Miyai 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Osaka, Japan</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Body weight supported treadmill training (n=11; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physical therapy (n=9; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1, medication changed)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>3 (n=3, medication changed)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: UPDRS, Gait speed, No. steps taken for 10 metre walk.</P>
<P>Secondary: UPDRS subscales (mental, ADL, motor and complications)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Body weight-supported treadmill training had significantly greater improvement than the physical therapy group in gait speed at 1 month; and in the number of steps at 1, 3 and 4 months</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Morris-2009" TYPE="STUDY">Morris 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Melbourne, Australia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Movement strategy training (n=14; 45 minutes, max 16 sessions over 2 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Musculoskeletal exercise (n=14; 45 minutes, max 16 sessions over 2 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=2; lost to follow up, no details)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: UPDRS Motor and ADL (combined).</P>
<P>Secondary:</P>
<P>10 m walk test, Timed up and go, 2 min walk test, Balance-shoulder tug, PDQ-39</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>The movement strategy training group had a significant improvement in balance compared to the musculoskeletal arm. There were no other differences between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Palmer-1986" TYPE="STUDY">Palmer 1986</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Minneapolis, Minnesota, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>United Parkinson Foundation exercise program (n=7; 1 hour, three times per week, 12 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Upper body karate training program (n=7; 1 hour, three times per week, 12 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Forearm pronation/supination rate, Pursuit score walk index, Degree of activated rigidity, Degree of arm tremor, Activated rigidity, Grip strength, 9-hole peg test, Minnesota placing and turning test, Arm swings test, Rapid alternating arm movement test, Button board, Putting shirt on and off, Putting shoes and socks on and off, Getting up from chair, Long latency stretch response</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Study did not compare differences between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Pelosin-2010" TYPE="STUDY">Pelosin 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Genova, Italy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Action plus physical therapy group (n=9; 1 hour, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Landscape plus physical therapy group (n=9; 1 hour, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; found to have past history of neurological conditions other than PD or implantation for deep brain stimulation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; found to have past history of neurological conditions other than PD or implantation for deep brain stimulation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>FOG Questionnaire and FOG diary, Timed up and go,</P>
<P>10 metre walking test, Tinetti scale part I and II, Berg balance scale, PDQ-39</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>At post-test there was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Picelli-2012" TYPE="STUDY">Picelli 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Verona, Italy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Robot assisted gait-training group (n=21; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy group (n=20; 45 minutes, three times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>3 (n=3; lack of cooperation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=2; lack of cooperation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: 10 m walk test, 6 min walk test.</P>
<P>Secondary: Spatiotemporal gait parameters including stride length, Parkinson's fatigue scale, UPDRS Total</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Robot assisted gait-training significantly improved 10 m walk test, 6 min walk test,</P>
<P>Parkinson's fatigue scale, UPDRS Total compared to the physiotherapy group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Poliakoff-2009" TYPE="STUDY">Poliakoff 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Manchester, UK</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>20 week gym group (n=16; 1 hour, twice a week, 20 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>10 week gym group (n=16; 1 hour, twice a week, 10 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=1; randomised but did not start intervention, n=3; did not complete or insufficient sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>6 (n=1; randomised but did not start intervention, n=5; did not complete or insufficient sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Simple, choice and serial reaction time, Videotaped motor performance, PDQ-39, UPDRS III, Illness perceptions (BIPQ), Questionnaire assessing experiences of programme</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>No significant differences between arms, except for the learning sequence RT outcome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Reuter-2011" TYPE="STUDY">Reuter 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Giessen, Germany</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Nordic walking group (n=30; 70 minutes, three times per week, 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Walking group (n=30; 70 minutes, three times per week, 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Flexibility and relaxation group (n=30; 70 minutes, three times per week, 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Max walking speed on treadmill, 12 m and 24 m walking test, Stride length, Gait variability, UPDRS, PDQ-39, Physical activity in everyday life, Adverse effects</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Main reported differences were that the Nordic walking group was superior to the walking and flexibility and relaxation programme in improving postural stability, stride length, gait pattern, and gait variability</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Ridgel-2009" TYPE="STUDY">Ridgel 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Cleveland, Ohio, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Forced exercise group (n=5; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Voluntary exercise group (n=5; 1 hour, 3 times per week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS part III</P>
<P>Manual functional dexterity, Bimanual dexterity, Centre of pressure (CoP)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS motor scores showed a significantly greater improvement in the forced exercise arm compared to the voluntary exercise arm. Only forced exercise resulted in significant improvements in bimanual dexterity</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Robichaud-2012" TYPE="STUDY">Robichaud 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Chicago, Illinois, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Progressive resistance exercise (n=unknown (total n=48 at 6 month time point); 1 hour, twice per week, 24 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Fitness counts (n=unknown (total n=48 at 6 month time point); 1 hour, twice per week, 24 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>UPDRS motor, Timed up and go, Berg balance scale, Modified physical performance test</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Schenkman-2012a" TYPE="STUDY">Schenkman 2012a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Denver, Colorado, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Flexibilty/balance/function exercise group (n=39; 1 hour, 3 times per week for the first 4 months then tapered for 1 month to once monthly sessions out to 16 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Aerobic exercise group (n=41; 1 hour, 3 times per week for the first 4 months then tapered for 1 month to once monthly sessions out to 16 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Home exercise group (n=41; once monthly supervised sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>3 at 4 months (n=1; health problems, n=2; personal issues)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>7 at 4 months (n=1; not happy with the program, n=2; missed appointment, n=2; health problems, n=1; moved, n=1; deceased)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>6 at 4 months (n=3; not happy with the program, n=1; did not return calls, n=1 unable to commit the time, n=1; missed appointment)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: Overall physical function, Balance - functional reach, Walking economy - VO<SUB>2 </SUB>
</P>
<P>Secondary:</P>
<P>UPDRS ADL, UPDRS Motor, PDQ-39</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Overall physical function: improvement at 4 months was greater in the Flexibilty/balance/function exercise group than the aerobic and home exercise group. Functional reach was not different between groups. Walking economy: aerobic exercise improved compared to Flexibilty/balance/function exercise group. The only secondary outcome that showed significant differences was UPDRS ADL: Flexibilty/balance/function exercise group performed better than home exercise group at 4 months</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Shankar-2009" TYPE="STUDY">Shankar 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Calgary, Canada</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill with cueing group (n=10; 30 minutes, twice a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Treadmill without cueing (n=9; 30 minutes, twice a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Cueing only group (n=10; 30 minutes, twice a week, 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Gait and Balance Scale, UPDRS III, PDQ-39</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Limited data. There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Shen-2011" TYPE="STUDY">Shen 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Hong Kong, China</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Balance group (n=23; treatment delivered over 12 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Strength training (n=22; treatment delivered over 12 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Limit of stability, Walking speed, One leg stance time, Activities-specific balance confidence scale, UPDRS III</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Limited data. The balance group improved significantly more than the strength group in movement velocity and one leg stance</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Shiba-1999" TYPE="STUDY">Shiba 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Kanagawa, Japan</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Visual stimulation (n=unknown, total n=8; treated for an unknown period of time)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Auditory stimulation (n=unknown, total n=8; treated for an unknown period of time)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Stride length</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Stride length was significantly greater after visual stimulation than after auditory stimulation gait training</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Sigurgeirsson-2009" TYPE="STUDY">Sigurgeirsson 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Reykjalundur, Iceland</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Walking with visual cues (n=unknown, total n=26; 30 minutes, 4 sessions per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Walking without cues (n=unknown, total n=26; 30 minutes, 4 sessions per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Timed up and go, PDQ-39</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Limited data. There was no difference between treatment arms for Timed up and go</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Smania-2010" TYPE="STUDY">Smania 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Verona, Italy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Balance training (n=33; 50 minutes, 3 times per week, 7 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>General physical exercise (n=31; 50 minutes, 3 times per week, 7 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>5 (n=2; uncooperativeness, n=3; medical complications)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>4 (n=2; uncooperativeness, n=2; medical complications)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Primary: Berg balance scale, Activities-specific balance confidence, Postural transfer test, Self destabilization of the centre of foot pressure test, Falls diary.</P>
<P>Secondary:</P>
<P>UPDRS Total, Modified Hoehn and Yahr, Geriatric depression scale</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was a significant difference in favour of the balance training arm in the Berg Balance Scale and the self destabilization of the centre of foot pressure test when compared to the general physical exercise group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Talakkad-2011" TYPE="STUDY">Talakkad 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Bangalore, India</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Conventional gait training (n=unknown, total n=60; 8 hours over 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Partial weight supported treadmill training: 20% unweighting (n=unknown, total n=60; 8 hours over 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Control: No specific intervention (n=unknown, total n=60)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Dynamic posturography, UPDRS (total and motor subscore), Beat-to-beat finger blood pressure</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Limited data. Partial weight supported (-20%) treadmill training had a significantly greater improvement in UPDRS motor score compared to conventional gait training</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Thaut-1996" TYPE="STUDY">Thaut 1996</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Colorado, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Novel rhythmic auditory stimulation group (n=15; 30 minutes per day, total 10.5 hours over 3 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Standard self paced training group (n=11; 30 minutes per day, total 10.5 hours over 3 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>No treatment group (n=11)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Stride velocity, Stride cadence, Stride length, EMG analysis on leg muscles</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Rhythmic auditory stimulation group improved significantly for flat and incline velocity compared to the self paced training. The rhythmic auditory stimulation group's improvements in stride length were only significantly better than the no treatment group and changes in cadence were only significantly higher than the self paced training group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Toole-2005" TYPE="STUDY">Toole 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Florida, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Standard treadmill group (n=unknown, total n=23; 20 minutes, 3 times per week, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unweighted treadmill group (n=unknown, total n=23; 20 minutes, 3 times per week, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Weighted treadmill group (n=unknown, total n=23; 20 minutes, 3 times per week, 6 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Balance from dynamic posturography, Berg balance scale, UPDRS, Biomechanical assessment of strength and range of motion, Gait</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms for function and stability in gait and dynamic balance</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Vivas-2011" TYPE="STUDY">Vivas 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>A Coruña, Spain</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Water based exercise group (n=6; 45 minutes, twice weekly, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Land based exercise group (n=6; 45 minutes, twice weekly, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; influenza - did not receive intervention)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Functional reach test, Berg balance scale, Gait -turn time, velocity, cadence, step amplitude, Timed up and go, UPDRS</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>The water based exercise group significantly improved Berg Balance Scale and UPDRS compared to the land based exercise group. There was no difference between treatment arms for the remaining outcomes</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Werner-2010" TYPE="STUDY">Werner 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>New York, USA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Verbal instruction with augmented feedback group (n=6; 90 minutes, 2 times per week, 2 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Verbal instruction only group (n=6; 90 minutes, 2 times per week, 2 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Stride length, Cadence, Gait velocity, Shoulder excursion</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>There was no difference between treatment arms</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>
<LINK REF="STD-Yang-2010" TYPE="STUDY">Yang 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Taipei, Taiwan</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Downhill walking group (n=16; 30 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Physiotherapy group (n=17; 30 minutes, 3 times per week, 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>1 (n=1; low motivation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>2 (n=1; conflicting work schedule, n=1; transport problem)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Speed, Candence, Stride length, Thoriacic kyphosis, Muscle strength</P>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE">
<P>Downhill walking significantly improved gait speed, stride length and muscle strength of knee extensors compared to physiotherapy</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-05-15 20:58:40 +0100" MODIFIED_BY="[Empty name]"/>
<FIGURES MODIFIED="2014-05-06 11:39:20 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-05-06 11:37:04 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZMAAAd2CAYAAADIRUBqAACAAElEQVR42uydDcRV2d/+f4wxxkgi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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-05-06 11:39:20 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeAAAAEyCAMAAAAV/PODAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-05-06 11:39:20 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZgAAAWyCAIAAACiIWFBAAB15UlEQVR42u2dv24iSde4W0JCBAQO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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-05-07 09:58:46 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-05-07 09:58:46 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-05-07 09:58:46 +0100" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2014-05-06 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Cochrane Movement Disorders Specialised Register (search end of January 2012).</B>
</P>
<P>#1. SR-Movement</P>
<P>#2. physiotherapy</P>
<P>#3. exercise</P>
<P>#4. physical therapy</P>
<P>#5. rehabilitation</P>
<P>#6. #2 or #3 or #4 or #5</P>
<P>#7. Parkinson</P>
<P>#8. Parkinsons disease</P>
<P>#9. parkinsonism</P>
<P>#10. #7 or #8 or #9</P>
<P>#11. #1 and #6 and #10</P>
<P>
<B>The Cochrane Library and The Cochrane Controlled Trials Register (Wiley online library) (Issue 1, 2012).</B>
</P>
<P>#1. MeSH descriptor: [Parkinson Disease] explode all trees</P>
<P>#2. parkinson*</P>
<P>#3. parkinsonism</P>
<P>#4. {or #1-#3}</P>
<P>#5. MeSH descriptor Physical Therapy (Speciality) explode all trees</P>
<P>#6. MeSH descriptor Physical Therapy Modalities explode all trees</P>
<P>#7. physical therapy</P>
<P>#8. physiotherapy</P>
<P>#9. MeSH descriptor Exercise explode all trees</P>
<P>#10. exercise</P>
<P>#11. MeSH descriptor Rehabilitation explode all trees</P>
<P>#12. rehabilitation</P>
<P>#13. {or #5-#13}</P>
<P>#14. #4 and #13</P>
<P>
<B>MEDLINE (Ovid) 1966 - Jauary (Week 4) 2012.</B>
</P>
<P>1. randomized controlled trial.pt</P>
<P>2. controlled clinical trial.pt</P>
<P>3. randomized.ab.</P>
<P>4. placebo.ab.</P>
<P>5. drug therapy.fs.</P>
<P>6. randomly.ab.</P>
<P>7. trial.ab.</P>
<P>8. groups.ab.</P>
<P>9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8</P>
<P>10. exp animals/ not humans.sh.</P>
<P>11. 9 not 10</P>
<P>12. exp Parkinson Disease/</P>
<P>13. "parkinson*".ab.ti.</P>
<P>14. 12 or 13</P>
<P>15.exp "Physical Therapy (Specialty)"/</P>
<P>16. physiotherapy.mp.</P>
<P>17. exp Exercise/</P>
<P>18. exp Rehabilitation/</P>
<P>19. exercise*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]</P>
<P>20. rehabilitation*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]</P>
<P>21. 15 or 16 or 17 or 18 or 19 or 20</P>
<P>22. 11 and 14 and 21</P>
<P>23. limit 22 to yr="2001 -Current"</P>
<P>
<B>EMBASE (Ovid) 1974 - January (Week 4) 2012.</B>
</P>
<P>1. random$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>2. factorial$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>3. (crossover$ or cross-over$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>4. placebo$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>5. (doubl$ adj blind$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>6. (singl$ adj blind$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>7. assign$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>8. allocat$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>9. volunteer$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>10. crossover procedure.sh.</P>
<P>11. Double-blind Procedure.sh.</P>
<P>12. Randomized Controlled Trial.sh.</P>
<P>13. Single-blind Procedure.sh.</P>
<P>14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13</P>
<P>15. exp Parkinson Disease/</P>
<P>16. parkinson*.mp.</P>
<P>17. 15 or 16</P>
<P>18. exp physiotherapy/</P>
<P>19. physical therapy.mp.</P>
<P>20. exp Exercise/</P>
<P>21. exp Rehabilitation/</P>
<P>22. physiotherapy.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>23. exercise.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>24. rehabilitation.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]</P>
<P>25. 18 or 19 or 20 or 21 or 22 or 23 or 24</P>
<P>26. 14 and 17 and 25</P>
<P>27. limit 26 to yr="2001 - Current"</P>
<P>
<B>CINAHL (EBSCO) (1982-2012).</B>
</P>
<P>S1. (MH "Random Assignment")</P>
<P>S2. (MH "Comparative Studies")</P>
<P>S3. (MH "Clinical Research+")</P>
<P>S4. (MH "Clinical Trials+")</P>
<P>S5. (MH "Evaluation Research+")</P>
<P>S6. TX ((control* or clinic* or prospective*) adj5 (trial* or study or studies))</P>
<P>S7. TX cross*over*</P>
<P>S8. TX (compar* adj5 (trial* or study* or studies))</P>
<P>S9. "random$"</P>
<P>S10. "placebo"</P>
<P>S11. "RCT"</P>
<P>S12. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11)</P>
<P>S13. (MH "Parkinson Disease")</P>
<P>S14. "Parkinson*"</P>
<P>S15. "physiotherapy"</P>
<P>S16. (MH "Physical Therapy+")</P>
<P>S17. (MH "Exercise+")</P>
<P>S18. rehabilitation</P>
<P>S19. S13 or S14</P>
<P>S20. S15 or S16 or S17 or S18</P>
<P>S21. S12 and S19 and S20</P>
<P>
<B>ISI Web of Science: Science Citation Index Expanded (SCI-EXPANDED) (1981 to January 2012), ISI Web of Science: Conference Proceedings Citation Index-Science (CPCI-S) (1982 to January 2012).</B>
</P>
<P>#1. TS=clinical trial*</P>
<P>#2. TS=research design</P>
<P>#3. TS=comparative stud*</P>
<P>#4. TS=evaluation stud*</P>
<P>#5. TS=controlled trial*</P>
<P>#6. TS=follow-up stud*</P>
<P>#7. TS=prospective stud*</P>
<P>#8. TS=random*</P>
<P>#9. TS=placebo*</P>
<P>#10. TS=(single blind*)</P>
<P>#11. TS=(double blind*)</P>
<P>#12. #11 OR #10 OR #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1</P>
<P>#13. TS=(parkinson disease)</P>
<P>#14. TS=parkinson*</P>
<P>#15. #13 OR #14</P>
<P>#16. TS=physiotherap*</P>
<P>#17. TS=(physical therap*)</P>
<P>#18. TS=exercise*</P>
<P>#19. TS=rehabilitation*</P>
<P>#20. #19 OR #18 OR #17 OR #16</P>
<P>#21. #20 AND #15 AND #12</P>
<P>
<B>AMED (EBSCO) (1985-2012).</B>
</P>
<P>S1. (MH "Random Assignment")</P>
<P>S2. (MH "Comparative Studies")</P>
<P>S3. (MH "Clinical Research+")</P>
<P>S4. (MH "Clinical Trials+")</P>
<P>S5. (MH "Evaluation Research+")</P>
<P>S6. TX ((control* or clinic* or prospective*) adj5 (trial* or study or studies))</P>
<P>S7. TX cross*over*</P>
<P>S8. TX (compar* adj5 (trial* or study* or studies))</P>
<P>S9. "random$"</P>
<P>S10. "placebo"</P>
<P>S11. "RCT"</P>
<P>S12. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11)</P>
<P>S13. (MH "Parkinson Disease")</P>
<P>S14. "Parkinson*"</P>
<P>S15. "physiotherapy"</P>
<P>S16. (MH "Physical Therapy+")</P>
<P>S17. (MH "Exercise+")</P>
<P>S18. rehabilitation</P>
<P>S19. S13 or S14</P>
<P>S20. S15 or S16 or S17 or S18</P>
<P>S21. S12 and S19 and S20</P>
<P>
<B>REHABDATA (1995-2012). </B>Searched using the term Parkinson*</P>
<P>
<B>REHADAT (1990 - 2012). </B>Searched using the term Parkinson.</P>
<P>
<B>PEDro (1929-2012). </B>Searched using the term Parkinson.</P>
<P>
<B>GEROLIT (1979-2012). </B>Searched using the terms "parkinson*" AND "physi*", "parkinson*" AND "exercise*", "parkinson* AND rehabilitation*"</P>
<P>
<B>LILACS (Virtual Health Library) (1982-2012); MedCarib (Virtual Health Library) (17th Century-2012); IMEMR (1984-2012). </B>Searched using the terms "Parkinson$" AND "physi$", "Parkinson$" AND "exercise$", "Parkinson$" AND "rehabilitat$", "Parkinson$" AND "physiotherap$".</P>
<P>
<B>The Cochrane Controlled Trials Register. </B>See the Cochrane Library.</P>
<P>
<B>The CentreWatch Clinical Trials listing service. </B>Screened all entries under the Medical Condition 'Parkinson's Disease'.</P>
<P>
<B>The metaRegister of Controlled Trial; NIDRR. </B>Searched using the term Parkinson.</P>
<P>
<B>ClinicalTrials.gov. </B>Searched using the terms "parkinson" AND "(physical therapy OR physiotherapy OR exercise OR rehabilitation)".</P>
<P>
<B>RePORT. </B>Searched using the terms "Parkinson" and "Rehabilitation", "Parkinson" and "Exercise", "Parkinson" and "Physical Therapy", "Parkinson" and "Physiotherapy".</P>
<P>
<B>NRR. </B>Searched using the terms "Parkinson" and "Exercise", "Parkinson" and "Exercising", "Parkinson" and "Physiotherapy", "Parkinson" and "Physiotherapies", "Parkinson" and "Physical", "Parkinson" and "rehabilitation", "Parkinson" and "Rehabilitating", "Parkinson" and "Rehabilitate".</P>
<P>
<B>Conference Proceedings Citation Index (1982-2012). </B>See ISI Web of Science.</P>
<P>
<B>DISSABS (DISSertation ABStracts) (1999-2012). </B>Search using the term "parkinson".</P>
<P>
<B>Conference Papers Index (ProQuest) (1982-2012); Index to Theses (1970-2012); ProQuest dissertations and theses databases (1861-2012).</B>
</P>
<P>Searched using the terms (all(Physical therapy*) OR all(physiotherap*) OR all(exercise) OR all(rehabilitation*)) AND all(parkinson*).</P>
<P>
<B>Electronic Theses Online Service (EThOS) (16<SUP>th</SUP> Century-2012). </B>Searched using the terms "parkinson" AND "physical therapy", "parkinson" AND "physiotherapy", "parkinson" AND "exercise", "parkinson" AND "rehabilitation".</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;43 studies (61 articles and 6 reports) included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;78 potentially appropriate studies (110 articles and 12 reports) to be included in review&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;177 articles and 12 reports retrieved for more detailed evaluation&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2595 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2595 records after duplicates removed&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;4377 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;92 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;2406 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;67 articles excluded: not randomised or not properly randomised (n = 24), review or systematic review (n = 21), intervention not usually delivered by physiotherapist (n = 11), confounded (n = 3), subgroup of larger trial (n = 3), article not available (n = 1), trial over 1 day only (n = 1), not PD patients (n = 1), outcomes not relevant (n = 1), multidisciplinary therapy rehabilitation trial (n = 1).&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;6 ongoing studies (8 articles and 4 reports).&lt;/p&gt;&lt;p&gt;29 studies (41 articles and 2 reports) excluded: not randomised or not properly randomised (n = 12), cross-over study with data not adequately separated (n = 4), intervention not usually delivered by physiotherapist (n = 4), outcomes not relevant (n = 2), multidisciplinary therapy rehabilitation trial (n = 2), trial over 1 day only (n = 1), insufficient information available for inclusion into review (n = 1), unsuitable comparator arm (n = 1), confounded (n = 1), comparison of physiotherapy delivery not technique (n = 1).&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>